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ABSTRACT 
Escherichia coli is one of a few organisms with a well characterized and complete 
metabolic model for lipoic acid metabolism. In this thesis I make discoveries through 
analysis of the diversity of lipoic acid metabolic genes in other organisms. By examining 
the distribution and phylogeny of the lipoate ligase protein family, I and others have 
found gaps and inconsistencies in our knowledge of lipoic acid metabolic pathways. I 
examine select proteins through heterologous expression in E. coli, allowing 
complementation studies and biochemical analysis. This enables prediction of lipoic acid 
metabolism in various organisms and reveals novel pathways and enzymology. 
In the second chapter I investigate the lipoyl ligase from Thermoplasma 
acidophilum. Half of the members of the LplA family detected in silico, such as 
Thermoplasma LplA, have only the large catalytic domain. Two X-ray structures of the T. 
acidophilum LplA have been reported, although the protein was reported to lack ligase 
activity. McManus et al. hypothesized that the product of an adjacent gene was also 
required for ligase activity. I have shown this to be the case and have named the second 
protein LplB. I found that complementation of E. coli strains lacking lipoate ligase with T. 
acidophilum LplA was possible only when LplB was also present. LplA had no detectable 
ligase activity in vitro in the absence of LplB. Moreover LplA and LplB were shown to 
interact and were purified as a heterodimer. LplB was required for lipoyl-adenylate 
formation but was not required for transfer of the lipoyl moiety of lipoyl-adenylate to 
acceptor proteins. This provides a function for a previously cryptic protein family. 
Surveys of sequenced genomes show that most lipoyl ligases of the kingdom Archaea 
are heterodimeric. I propose that the presence of an accessory domain provides a 
diagnostic to distinguish lipoyl ligase homologues from other members of the 
lipoate/biotin attachment enzyme family. A survey of the lipoate protein ligase family 
reveals that half of the members lack a detectable accessory domain and therefore are 
likely to be catalyzing other reactions. 
In the third chapter I find a new class of octanoyltransferase, LipM. LipM lack an 
accessory domain and is a non-homologous isozyme catalyzing the same reaction as 
iii 
 
LipB. LipB is essential for lipoic acid biosynthesis in E. coli, but no obvious orthologue 
could be found in Bacillus subtilis. Using a cosmid library approach, I isolate an 
octanoyltransferase that has virtually no sequence resemblance to E. coli LipB, but 
instead has a sequence that resembles that of the E. coli lipoate ligase, LplA. On the 
basis of this resemblance, these genes have generally been annotated as encoding a 
lipoate ligase, an enzyme that in E. coli scavenges lipoic acid from the environment but 
plays no role in de novo synthesis. I named the B. subtilis octanoyltransferase LipM and 
find that, like LipB, the LipM reaction proceeds through a thioester-linked acyl enzyme 
intermediate. The LipM active site nucleophile was identified as C150 by the finding that 
this thiol becomes modified when LipM is expressed in E. coli. The level of the octanoyl-
LipM intermediate can be significantly decreased by blocking fatty acid synthesis during 
LipM expression, and C150 was confirmed as an essential active site residue by site-
directed mutagenesis. LipM homologues are the only known type of octanoyltransferase 
present in Firmicutes and are also present in the Cyanobacteria. LipM type 
octanoyltransferases represent a new clade of the PF03099 protein family, suggesting 
that octanoyl transfer activity has evolved at least twice within this superfamily. 
 In the fourth chapter we characterize three lipoyl ligase homologues from B. 
subtilis, one of them being LipM. I performed this in collaboration with a fellow 
graduate student Natalia Martin from the laboratory of Diege de Mendoza, who 
performed molecular biology work in B. subtilis. The B. subtilis genome encodes three 
lipoyl ligase homologues: yhfJ, yqhM, and ywfL, which we have renamed lplJ, lipM, and 
lipL, respectively. We show that lplJ encodes the sole lipoyl ligase of this bacterium. 
Physiological and biochemical characterization of a ΔlipM strain showed that LipM is 
absolutely required for the endogenous lipoylation of all lipoate-dependent proteins, 
confirming its role as the B. subtilis octanoyltransferase. However, we also report that in 
contrast to E. coli, B. subtilis requires a third protein for lipoic acid assembly, LipL. B. 
subtilis ∆lipL strains are unable to synthesize lipoic acid despite the presence of LipM 
and LipA, which based on the E. coli model should suffice for lipoic acid biosynthesis. 
LipM is only required for the endogenous lipoylation pathway, whereas LipL also plays a 
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role in lipoic acid scavenging. Expression of E. coli lipB allows growth of B. subtilis ΔlipL 
or ΔlipM strains in the absence of supplements. In contrast, growth of an E. coli ΔlipB 
strain can be complemented with lipM, but not lipL. These data demonstrate that LipM 
and LipL are both required for lipoyl domain octanoylation and hence lipoic acid 
biosynthesis. Unexpectedly, B. subtilis requires an additional gene for lipoic acid 
biosynthesis. 
 In Chapter Five I characterize the product of this extra gene and discover a novel 
enzyme used in lipoic acid biosynthesis. This new enzyme lacks an accessory domain and 
is the third B. subtilis lipoyl ligase homologue, LipL. I report that LipM specifically 
modifies the glycine cleavage system protein, GcvH, and therefore another mechanism 
must exist for modification of other lipoic acid requiring enzymes (e.g., pyruvate 
dehydrogenase). I show that this function is provided by LipL which catalyzes the 
amidotransfer (transamidation) of the octanoyl moiety from octanoyl-GcvH to the E2 
subunit of pyruvate dehydrogenase. LipL activity was demonstrated in vitro with 
purified components and proceeds via a thioester-linked acyl-enzyme intermediate. As 
predicted, ∆gcvH strains are lipoate auxotrophs. LipL represents a new enzyme activity.  
It is a GcvH:[lipoyl domain] amidotransferase that probably employs a Cys-Lys catalytic 
dyad. Although the active site cysteine residues of LipL and LipB are located in different 
positions within the polypeptide chains, alignment of their structures show these 
residues occupy similar positions. Thus, these two homologous enzymes have 
convergent architectures. 
I Chapter Six I summarize my findings, provide a personal narrative to the work 
presented, and discuss the implications of the research presented. This Thesis not only 
expands on previous knowledge but also defines new paradigms in lipoic acid 
metabolism. This is especially true for the novel lipoylamidotransferase, which is an 
enzyme that has been overlooked through over fifty years of lipoic acid research. I also 
suggest further avenues for research resulting from examination of the phylogeny and 
distribution of lipoic acid metabolic enzymes. Further study of lipoylamidotransfer will 
define the role of LipL orthologues in pathogenic microorganisms. Also, I predict that a 
v 
 
lipoylamidotransferase isozyme is present in yeast and humans based on LplA family 
phylogeny and research from other labs. Overall, the work in this Thesis provides many 
avenues for further investigation and will improve our ability to understand and predict 
central metabolism in diverse organisms. 
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CHAPTER 1 
BACKGROUND AND SIGNIFICANCE 
 
THE DISCOVERY OF LIPOIC ACID 
The discovery of lipoic acid was made through careful study of microbial 
metabolism. Lipoic acid was one of the last cofactors discovered at the end of the 
“vitamin era” (Carpenter, 2003). It was also covalently bound to protein and not very 
abundant. As a result, lipoic acid was independently discovered three times before its 
isolation. It was first discovered by Esmond E. Snell as a graduate student in W.H. 
Peterson’s lab at the University of Wisconsin. He found that Lactobacillus delbrueckii 
grew poorly on a peptone-glucose-salts medium unless potato extract was also added. 
This factor could be partially extracted by ether. It could be replaced by acetate and so 
was called “acetate-replacing factor”. Further studies using defined media with acetate 
were performed by various labs to study bacterial nutrition, and acetate-replacing factor 
fell by the wayside (Snell et al., 1937; Snell, 1993). It was discovered a second time from 
the effort of multiple labs as a growth factor II for Tetrahymena geleii (Kidder et al., 
1945) and was later renamed “Protogen” (Stokstad et al., 1949). The last discovery was 
by Dan O’Kane, a graduate student in the laboratory of Irwin C. Gunsalus. They 
discovered a factor for Enterococcus (Streptococcus) faecalis required for pyruvate 
oxidation; the factor was aptly named “pyruvate oxidation factor” (O'Kane et al., 1947). 
This factor was found to be tightly bound but present in a variety of substances, and was 
found in acetate-replacing factor as well (Gunsalus, 1984). Shortly after this, acetate-
replacing factor was investigated further by a graduate student in the Snell lab and the 
project was eventually given to Lester Reed, who was a friend and colleague of Snell at 
the University of Texas.  Both the laboratory of Irwin Gunsalus and Lester Reed found 
purification of sufficient factor difficult, and both independently collaborated with Eli 
Lilly to obtain sufficient material. Both labs agreed to merge projects at the suggestion 
of Eli Lilly. Finally about 30 mg of lipoic acid was obtained from an estimated 10 tons of 
liver residue. In hindsight it is no wonder Lester Reed’s lab could not isolate it from 6 L 
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bacterial cultures. The trivial name “α-lipoic acid” was proposed by Reed due to its 
lipophilicity and it being a carboxylic acid. Reed designated the compound “alpha” in 
order to differentiate it from a second isolated compound with a sulfur oxidized to the 
sulfoxide, which was designated “β-lipoic acid” (Reed et al., 1951; Reed, 2001). Further 
characterization was made in a collaborative effort between Gunsalus, Reed and 
chemists at Eli Lilly who proved the natural isolate contained an aliphatic chain of eight 
carbons and two sulfur atoms (one of which was terminal), was acidic, and by 
polarimetry was of the dextro- (+)-configuration (Reed et al., 1953). Different positions 
for sulfur attachment were possible candidates for the correct structure for RLA, 
depending on attachment of sulfur at C4, C5 or C6, which were designated 4-, 5-, or 6-
thioctic acid. Synthesis of the racemic compound proved the tentative assignment of 6-
thioctic acid had been correct (Bullock et al., 1952). While the optical activity of 
biological lipoic acid was known as (+), the configuration was found to be the R 
enantiomer (Mislow et al., 1956). This was later supported by synthesis of the S 
enantiomer  (Brookes et al., 1983) (Figure 1-1). The discovery and characterization of 
lipoic acid led to elucidation of the the mechanism of lipoic acid dependent complexes, 
and was followed by understanding of the critical role of lipoic acid in aerobic 
metabolism. 
 
LIPOIC ACID DEPENDENT COMPLEXES 
Lipoic acid was discovered as a factor necessary for pyruvate metabolism, and it 
is in this capacity that it has been most studied. The pyruvate dehydrogenase (PDH) 
complex is the only enzyme capable of energy-conserved decarboxylation of pyruvate in 
an aerobic environment (Figure 1-2). Generally lipoate biosynthesis is not required 
anaerobically, because oxygen-labile ferredoxin oxidoreductases, such as pyruvate-
formate lyase, can be used instead (Buckel et al., 2006). The PDH serves as a model for 
related complexes, which have similar structures. PDH is composed of three different 
enzymes which are designated E1-3 in order of decreasing molecular weight, which also 
corresponds to the reaction order (Figure 1-3A). The E1 is a thiamine diphosphate-
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dependent decarboxylase (EC 1.2.4.1), that catalyzes the decarboxylation of pyruvate 
and the reductive acetylation of protein bound lipoic acid. Lipoic acid is covalently 
attached to the ε-amino group of a conserved lysine of the lipoyl domain (LD).  The 
lipoyl domain is typically found at the N terminus of the E2 (EC 2.3.1.12) catalytic 
subunit, which is a dihydrolipoyl acetyltransferase that transfers the acyl group to CoA. 
The E3 dihydrolipoamide dehydrogenase (EC 1.8.1.4) regenerates the disulfide bond in 
the lipoyl group and transfers the electrons to NAD+ via a flavin cofactor. This prepares 
the lipoyl group for another round of catalysis. The energy from decarboxylation is 
conserved by thioester formation and through formation of NADH  (Perham, 1991; 
Perham, 2000; Reed, 2001) (Figure 1-3A). 
2-Oxoacid and acetoin dehydrogenase (ADH) complexes have a central E2 core 
and the other subunits surround this core to form the complex.  In the space between 
these two subunits, the LD ferries intermediates between the active sites.  The 
geometry of the PDH E2 core, which doesn’t include lipoyl domains, can either be cubic 
or dodecahedral depending on the organism and complex.  The LD itself is attached by a 
flexible linker typically to the E2 core and the number of LDs varies from one to three for 
a given organism and complex.  The number of domains has been experimentally varied 
in E. coli PDH.  This seemed to have little effect on growth until over nine are present, 
although the presence of more than three decreased activity of the complex (Perham, 
2000).  The cloned LD is based on the catalytically competent product of proteolyzed 
purified complexes, which was determined for Bacillus stearothermophilus and E. coli  
(Packman et al., 1987; Packman et al., 1988). 
 The 2-oxoglutarate dehydrogenase and branched-chain keto-acid 
dehydrogenase (BDH) complexes closely resemble the PDH complexes. They are 
comprised of three subunits, and the E3 or lipoamide dehydrogenase for all these 
complexes can orginate from the same gene. The PDH and ODH are critical components 
for a functioning citric acid cycle due to PDH supplying acetyl-CoA and ODH itself being 
an enzyme in the cycle (Figure 1-2). PDH-derived acetyl-CoA is also required as a 
substrate for fatty acid biosynthesis. As such, lipoic acid is required for aerobic 
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respiration in E. coli and other organisms  (Cronan et al., 2005). The BDH is widely used 
in catabolism of isoleucine, leucine, and valine. BDH performs this role in organisms 
from all three domains of life  (Massey et al., 1976; Brosnan et al., 2006; Sisignano et al., 
2010). In bacteria that synthesize branched fatty acids, the BDH is required for synthesis 
of branched-CoA starting units derived from amino acids. Branched fatty acids are used 
to regulate membrane fluidity, disruption of which results in a defect in virulence and 
tolerance to environmental stress  (Kaneda, 1991; Keeney et al., 2009). BDH is also 
required for secondary metabolite biosynthesis in some bacteria  (Chan et al., 2009).  
Lipoic acid is also required for catabolism of acetoin (3-hydroxy-2-butanone or 
acetylmethylcarbinol) by the acetoin dehydrogenase (ADH) complex (EC 2.3.1.190) 
(Figure 1-2). Acetoin is produced as a fermentation product by certain microbes and is 
produced by decarboxylation of alpha-acetolactate  (Xiao et al., 2007). Enzymatic 
condensation of acetaldehyde with pyruvate to form acetoin is possible, although little 
has been done to determine the physiological relevance of this pathway (Neuser et al., 
2000; Xiao et al., 2007). Yeast pyruvate decarboxylase appears to be good at this 
reaction (Neuser et al., 2000). Condensation products of acetoin can be oxidized to 
diacetyl or reduced to 2,3-butanediol, which is of particular interest to the brewing 
industry  (Ostergaard et al., 2000). The production of acetoin has been used as an 
identification criterion using the Voges-Proskauer test  (Eddy, 1961). Acetoin and related 
C4 compounds are not acidic and are advantageous during stationary phase compared 
to acetic acid production. This has been well studied in Vibrio cholerae, where different 
fermentation strategies are proposed to be responsible for the dominance of El tor 
strain over the classical strain  (Yoon et al., 2006; Pradhan et al., 2010). The acetoin 
dehydrogenase (ADH) is homologous to the PDH complex and catalyzes a similar 
reaction except ADH produces acetyl-CoA and acetaldehyde (Figure 1-2). Although other 
pathways for utilization of acetoin have been proposed, acetoin dehydrogenase is the 
only one proven so far  (Xiao et al., 2007).  
The glycine cleavage system (also called glycine decarboxylase and glycine 
dehydrogenase) is significantly different from the other complexes, and accordingly has 
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a different nomenclature. The glycine cleavage system is technically not a complex, as 
all the component proteins dissociate easily and behave as independent proteins. The H 
protein, GcvH, is a free LD similar to E2 subunit lipoyl domains except the H protein 
contains additional helices. The GcvH lipoyl domain, unlike other lipoyl domains, exists 
as a free protein. The L protein, GcvL, is a dihydrolipoamide dehydrogenase (EC 1.8.1.4) 
which can also be replaced by the E3 lipoamide dehydrogenase, lpd, in some organisms 
such as E. coli. The P protein, GcvP, is the PLP dependent glycine decarboxylase (EC 
1.4.4.2), which transfers methylamine from PLP to lipoyl-GcvH. The T protein is an 
aminomethyltransferase (EC 2.1.2.10) that transfers methylamine from lipoate to 
tetrahydrofolate (THF), yielding methylene-THF and ammonia. Methylene-THF can then 
be used by serine hydroxymethyltransferase in a reversible reaction to synthesize serine 
from glycine, although the glycine cleavage system itself is not reversible  (Douce et al., 
2001) (Figure 1-2).  This system is used in many organisms and plays a crucial role in the 
photosynthetic carbon cycle. In Escherichia coli the glycine cleavage system is not 
required for growth of wild type E. coli strains  (Plamann et al., 1983), but glycine 
cleavage is required for growth of Arabidopsis (Engel et al., 2007) where the H protein 
can be present at millimolar concentrations in chloroplasts (Bauwe et al., 2003). 
From the large amount of research summarized above, it is apparent that lipoic 
acid is indeed a central cofactor for aerobic life. All of the complexes mentioned above 
play important roles in degredation and carbon source utilization. In particular, the 
pyruvate and 2-oxoglutarate dehydrogenase are essential components of the citric acid 
cycle. The pyruvate and branched chain dehydrogenase also provide essential 
substrates for biosynthesis of fatty acids and other molecules. The diverse roles of lipoic 
acid dependent complexes are due to their role in central metabolic processes; this is 
why lipoic acid is important for aerobic life. 
 
LIPOIC ACID AS A DIETARY SUPPLEMENT 
Considerable attention has been given to the effects of lipoic acid as a dietary 
supplement; the effects of which are currently speculated to occur by thiol oxidation 
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and reduction. Although it has been uncertain if free lipoate can affect thiol oxidation-
reduction (redox) in a physiologically relevant way, recent studies have promising 
results. Lipoic acid has been considered as a remedy to a variety of ailments beginning 
shortly after its discovery. Due to its role in metabolism and abundance in mammalian 
liver, it was the subject of a variety of studies with questionable controls and relevance. 
An early study finds that some rats on a diet of B vitamins prefer lipoic acid to ethanol, 
although liver was preferred even more (Mardones et al., 1954). It was first 
administered to humans by injection to 63 patients suffering from various diseases and 
32 of them responded well to lipoic acid. These patients had a sense of “well-being” and 
one subject woke from a vegetative coma after being administered lipoic acid. In the 
same report it was suggested that some people suffer from a deficiency of lipoic acid 
(Rausch, 1955). Addition of lipoic acid to liver slices increased metabolism of glucose 
and pyruvate (without addition of another reducing agent) (Bornstein et al., 1955). Later 
these physiological effects were considered to be due to various biochemical properties 
making it an “antioxidant” (when lipoic acid acts as reductant). Lipoic acid has been 
called this because of the ability of reduced dihydrolipoate to reduce thiols, to scavenge 
reactive oxygen species, and to chelate metals in biochemical assays. More recent 
studies have also demonstrated it can also act as a “prooxidant”, so perhaps it is best to 
consider lipoic acid as neither an antioxidant nor prooxidant (Moini et al., 2002).  
Lipoic acid has a short lifetime when injested or injected in mammals; this casts 
doubt on the hypothesis that lipoic acid consumption directly affects physiology. 
Through the use of lipoic acid radiolabeled at carbons 7 and 8, it was found that over 
70% of lipoic acid and its degradation products are excreted within 24 hours by various 
mammals (Schupke et al., 2001). In humans, lipoic acid is rapidly metabolized; being 
present in plasma for less than an hour, while only 0.2% is excreted unmodified 
(Teichert et al., 2003). With such a short lifetime, it is doubtful that biochemical studies 
of free lipoic acid reactions have physiological relevance. Studies determining if the 
metabolites of lipoic acid have any effect on cell physiology may yield insight. 
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Instead of a direct catalytic effect of lipoic acid, recent evidence supports lipoic 
acid affects cellular regulation. No studies have provided data supporting a mechanism 
for this effect, although there are changes in the levels of the regulators NRF2 and NF-κB 
due to lipoic acid supplementation. It is clear that the transcription of glutathione-S-
transferase is increased after administration of lipoic acid, providing a possible 
mechanism for effects attributed to lipoic acid reduction. It has been proposed that 
regulatory changes are due to changes in the redox state of the cysteine residues of 
regulator proteins, but thus far no evidence supports this idea (Shay et al., 2008; Shay et 
al., 2009). It is interesting to note that peak NRF2 induction occurs 24 hours after 
injection of 40 mg/kg lipoic acid. The long response time suggests NRF2 induction is 
indirect and may be the result of a lipoyl degradation product (Suh et al., 2004).   A 
technical issue with the use of lipoic acid as a supplement is the large dose required: at 
least 600 mg daily (Moini et al., 2002; Shay et al., 2008; Shay et al., 2009). Uncertainty 
about the mechanism of action is a significant barrier to further insight into the 
physiological effects and therapeutic benefits of lipoic acid. 
 
THE EMERGING ROLE OF LIPOIC ACID IN HYDROPEROXIDE REDUCTION 
Lipoic acid is typically a cofactor that participates in oxidative metabolism, but 
recent findings demonstrate its role in reductive metabolism as well (Figure 1-3B). 
Certain types of lipoamide dehydrogenases, or E3 subunit proteins, are present in 
microorganisms, without the other components of the multienzyme complexes, and are 
also membrane associated (Danson et al., 1987). These less common E3 proteins were 
found to have an attached N-terminal lipoyl domain and were found to be a surface 
antigen in Neisseria meningitides (Li de la Sierra et al., 1997). Lipoyl-domain-containing 
E3 proteins, or Lpd, were found to be a virulence factor first in Streptococcus 
pneumoniae, deletion mutants being deficient in carbohydrate metabolism (Smith et al., 
2002). An orthologous gene was shown to be important to virulence of Mycoplasma 
gallisepticum (Hudson et al., 2006). The physiological role of these orphan E3 proteins 
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has yet to be established, although they would be ideal participants in reductive 
metabolism by lipoic acid. 
The function of Lpd was uncertain until the recent discovery of a lipoic acid 
dependent peroxidase, Ohr, from Xyllela fastidosa (Cussiol et al., 2010). This peroxidase 
was dependent on dithiol reduction by lipoic acid, which could not be done with 
thioredoxin, glutaredoxins, or glutathione. Catalytic production of reduced lipoic acid 
required a lipoamide dehydrogenase as well. Cussiol et al. extend these finding to a 
related protein from E. coli, OsmC, which is periplasmic. Both ohr and osmC mutants 
have been shown to be sensitive to hydroperoxides (Mongkolsuk et al., 1998; Conter et 
al., 2001), so lipoic acid appears to be indirectly involved in scavenging of 
hydroperoxide. An ongoing study in the laboratory of Jon Beckwith also has evidence 
that lipoic acid can serve as a cellular reductant in E. coli in the absence of thioredoxin 
and glutathione  (Beckwith, 2009). Reductive metabolism by lipoic acid is a new 
discovery so much more work is required to understand how widespread these systems 
are and their physiological relevance. 
 
DEGRADATION AND SCAVENGING OF LIPOIC ACID 
The discovery of lipoic acid depended on the study of natural auxotrophs which 
could be grown without it. This facilitated further study into utilization of lipoic acid, or 
the relevant basic form lipoate. Reed et al. found that Lipoic acid was found to be 
utilized via lipoate-protein ligase (EC 2.7.7.63) (Reed et al., 1958). Using partially purified 
protein from E. faecalis and E. coli they demonstrated ligation proceeded via a lipoyl-
adenylate intermediate with production of pyrophosphate (Figure 1-4). Strangely, E. 
faecalis lipoyl ligase could be separated into two fractions, whereas the E. coli ligase 
could not. One fraction was responsible for adenylation while the other was required for 
transfer and could be destroyed by trypsin (Reed et al., 1958). Two forms of lipoic acid 
ligase were later purified from E. coli (Brookfield et al., 1991), but this appears to be an 
artifact of the purification procedure as only one form was observed in a later study 
(Green et al., 1995).  The existence of a lipoyl ligase findings were extended to 
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Azotobacter vinladii and Phaseolus radiates (mung bean), which also contained a lipoyl 
ligase capable of adenylation and transfer (Mitra et al., 1965). 
The gene encoding a lipoate:protein ligase, lplA, was first isolated from E. coli 
(Morris et al., 1994). LplA was the first such ligase purified to homogeneity. Assays with 
a fully defined system have demonstrated that LplA with lipoate and Mg-ATP are 
sufficient to reconstitute lipoylation in vitro (Morris et al., 1994; Green et al., 1995). 
Strains with lplA disrupted showed that LplA does not play a role in lipoic acid 
biosynthesis but rather acts to scavenge lipoic acid from the environment (Morris et al., 
1994; Morris et al., 1995). This conclusion was further validated by isolation of 
spontaneous mutants of lplA conferring resistance to the toxic analog selenolipoate 
(Reed et al., 1994). 
 In addition to selenolipoate, E. coli lipoate:protein ligase is able to use various 
alternative acyl substrates with reduced effeciency. It is also able to use octanoate, 
which is equivalent to the acyl chain of lipoic acid (Brookfield et al., 1991; Green et al., 
1995; Hermes et al., 2009). Purified lipoic acid ligase from E. coli was shown to use 8-
methyllipoate as a substrate, but to have reduced activity with (S)-lipoic acid (Brookfield 
et al., 1991).  E. coli lipoic acid auxotrophs are reported to have restored growth on 
analogs of different lengths as well as on the S isomer. Contamination by trace amounts 
of R-lipoate is a concern, as all analogs required higher concentrations. Incorporation of 
the shorter bisnorlipoic (Figure 1-1) acid was confirmed by selective antibody 
(Loeffelhardt et al., 1996). Incorporation of (R)-[S35]-lipoic acid is significant in E. coli, 
while no incorporation of (S)-[S35]-lipoic acid was detected  (Oehring et al., 1992). 
Capitalizing on lipoyl ligase promiscuity, mutant lipoyl ligases have been developed to 
use fluorescent substrates for protein labeling studies (Uttamapinant et al., 2010). 
Due to the role of lipoic acid in central metabolism, it is not surprising that it is 
required for virulence. This was first proven by identifying a lipoyl ligase of Listeria 
monocytogenes, lplA1. As the name suggests another ligase homologue, lplA2, was also 
apparent. LplA1 was required for intracellular growth but not growth on rich media  
(O'Riordan et al., 2003).   Lipoic acid scavenging has also been shown to be required for 
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virulence in acomplexan parasites Toxoplasma gondii and Plasmodium falciparum  
(Crawford et al., 2006; Allary et al., 2007). The presence of small lipoyl peptides was 
detected in cytosol and lplA1 is required for efficient utilization of these, although the 
mechanism for their utilization is unclear (Keeney et al., 2007). The loss of BDH and the 
resulting change in membrane composition are responsible for the avirulence of lplA1 
mutants  (Keeney et al., 2009; Sun et al., 2010). These studies establish scavenging of 
host lipoic acid as a general pathogen strategy. Also, they reveal scavenging of lipoic 
acid is more complex than previously thought. 
Lipoic acid is synthesized while covalently attached to protein and yet 
lipoate:protein ligases are widely distributed. In the process of testing various 
lipoylamide compounds as inhibitors of lipoyl ligation, it was observed that E. faecalis 
could use these compounds as a source of lipoic acid, which was dependent on ATP. This 
led to the discovery and characterization of a lipoyl-X-hydrolase (Reed et al., 1958), 
which was also capable of cleaving lipoic acid from lipoyl domains and so was renamed 
lipoamidase. It appeared in this study that lipoamidase activity was present in two 
separate fractions, suggesting there may be two hydrolases (Suzuki et al., 1963). This 
was also seen in a later purification of lipoamidase (Liu et al., 1995). No lipoamidase 
activity was found in E. coli (Reed et al., 1958). Also, no exchange of lipoate was seen 
after five hours in pulse-chase experiments with E. coli suggesting lipoyl domains aren’t 
degraded appreciably during exponential phase in this organism (Griffith et al., 1974). 
Lipoamidase activity was also found in extracts from many different mammalian tissues. 
When measured, these enzymes were capable of hydrolyzing a variety of substrates 
making their physiological role of the enzyme uncertain (Oizumi et al., 1997). Through a 
cosmid library approach, the gene encoding lipoamidase, lpa, was isolated and 
identified from Enterococcus faecalis. Pure Lpa also had some biotinidase activity with 
biotinyl-lysine, but less than lipoamidase activity (Jiang et al., 2005). L. monocytogenes 
has been shown to be able to utilize lipoamide and smaller lipoyl-peptides, but not 
intact lipoyl-domains. This ability is dependent on one of two lipoyl ligases (LplA1), but 
the mechanistic details are unknown (Keeney et al., 2009). 
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 Little is known about the degradation and utilization of aliphatic sulfides such as 
lipoic acid, with the exception of cysteine. A strain of Pseudomonas putida was isolated 
that could use lipoic acid as a sole carbon, sulfur, and energy source. An abundant 
intermediate was the shorter bisnorlipoic acid (Shih et al., 1975). Oxidative products 
lipoic sulfinate and bisnorlipoic sulfinate were also detected, which may be 
intermediates of sulfur utilization (Furr et al., 1978). A selection for mutants of Bacillus 
subtilis which require lipoic acid led to the identification of 3’-phosphoadenosine 5’-
phosphosulfate sulfotransferase, CysH, which was required for sulfate utilization. This 
study demonstrated that lipoic acid can serve as a sulfide or sulfite source in this 
organism (Mansilla et al., 1997). Although fatty acid degradation enzymes are likely 
involved, gene products responsible for use of lipoic acid as a sulfur source are 
unknown. Lipoic acid is metabolized in a variety of ways when given as a dietary 
supplement in mammals (Schupke et al., 2001). Lipoic acid is partially degraded by a 
variety of transformations, which can occur in various combinations. Degradation to 
tetranorlipoic acid, oxidation of one or both of the sulfur atoms to the sulfoxide, and S-
methylation of the sulfide were observed. Conjugation of unmodified lipoic acid to 
glycine was detected especially in mice (Schupke et al., 2001). This is interesting because 
lipoic acid has been found to competitively inhibit benzoic acid excretion in rats, which 
occurs via conjugation to glycine (Gregus et al., 1996). Degradation of lipoic acid is 
similar in humans, although it is not clear if the sulfur atoms become significantly 
oxidized (Teichert et al., 2003). Apparently mammals are not capable of utilizing the 
dithiolane moiety as a sulfur source. 
The mechanism of transport of lipoic acid is uncertain. Studies of lipoic acid 
transport in E. coli find that transport is not saturable at a physiologically relevant 
concentration  (Oh et al., 1969; Griffith et al., 1983). Data of transport rates at different 
concentrations of lipoic acid are lacking. In two separate selections for lipoic acid 
utilization, no mutants of E. coli have been found that are unable to take up lipoate from 
the media  (Reed et al., 1994; Morris et al., 1995).  This suggests that in bacteria lipoate 
is sufficiently membrane permeable, or that it uses multiple transporters. However, 
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lipoic acid is transported across an epithelial-cell-culture layer in a proton-dependent 
manner competitive with octanoic acid  (Takaishi et al., 2007). A sodium dependent 
transporter was identified that also transports biotin and pantothenate. As this 
transporter is similar to many other transporters, including E. coli PanF, it is not clear 
which are used for lipoic acid transport  (Prasad et al., 1998). It appears that transport 
may be important in Eukarya, but not in bacteria. Clearly more work remains to 
understand lipoic acid transport.   
 
LIPOIC ACID BIOSYNTHESIS 
 Although scavenging of lipoic acid was explored after the discovery of lipoic acid, 
its biosynthesis remained a mystery. Octanoate was shown to serve as a precursor to 
lipoic acid in E. coli. The sulfur atoms were exchanged for protons at carbons 6 and 8 
without loss of protons at carbons 5 and 7, suggesting a direct replacement without an 
unsaturated intermediate (Parry, 1977). Introduction of the sulfur at carbon 6 
proceeded with inversion of configuration (Parry et al., 1978; White, 1980a; White, 
1980b). A multiple step insertion was proposed with hydroxylation as an intermediate, 
as direct sulfur insertion was unprecedented (Parry et al., 1978). Precursor feeding 
studies suggested direct sulfur insertion, as 8- and 6-hydroxyoctanoate could not be 
used for biosynthesis but 8- and 6-thiooctanoate could. 6-thioocanoate yielded 10-20% 
less lipoic acid than 8-thiooctanoate (White, 1980a). Injection of various radiolabeled 
compounds into rats and determination of the amount of lipoic acid labeled 
demonstrated that cysteine and octanoate were the most direct carbon and sulfur 
precursors for lipoic acid biosynthesis (Dupre et al., 1980). 
 Mutants of E. coli that required lysine and methionine for growth were also 
found to grow with supplementation of acetate and succinate or lipoic acid. 
Supplementation was found to not be required anaerobically (Vise et al., 1967). 
Selection for mutants of E. coli requiring acetate and succinate identified mutants that 
also responded to lipoic acid. Multiple mutations mapped to a single locus designated 
lip  (Herbert et al., 1968). It is still not clear why supplementation with lysine and 
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methionine allows growth without active pyruvate dehydrogenase. It was suggested 
that pyruvate oxidase may supply sufficient acetate  (Vise et al., 1967). Large innocula 
are required for lysine and methionine bypass, suggesting nutrient carryover may 
contribute to bypass  (Herbert et al., 1968). Expression of a subgene encoding the PDH 
lipoyl domain in a lip- strain resulted in octanoylation at the same lysine as lipoylation, 
suggesting it may be a biosynthetic intermediate (Ali et al., 1990). The lip locus was 
identified by transposon mutagenesis (Vanden Boom et al., 1991) and cosmid library 
complementation (Hayden et al., 1993). The locus was found to contain two genes 
required for lipoic acid biosynthesis: lipA and lipB. The previously described lip mutants 
were found to be in the lipA gene (Vanden Boom et al., 1991). The lip locus was also 
identified in Salmonella typhimurium using the Mu dJ transposon creating a lacZ fusion. 
The expression of this locus was unchanged under a variety of conditions, suggesting 
expression is constituitive (Smith et al., 1991).  
Initially both LipA and LipB were purified but found to be inactive. The 
translation start site for lipA was found to be 40 codons upstream from where it was 
originally annotated (Reed et al., 1993). Point mutants of lipA were found to be partially 
or fully deficient in the use of 6 and 8-thiooctanoate, indicating that LipA was 
responsible for sulfur insertion (Hayden et al., 1993). LipB and LplA appeared to have 
somewhat redundant roles in lipoic acid biosynthesis. Overexpression of lplA bypassed 
the requirement for lipB, while the converse did not restore growth (Morris et al., 1995). 
This and the inexplicable purification of two forms of ligase (Brookfield et al., 1991) 
caused confusion resulting in LipB being incorrectly called lipoate protein ligase B (Kim 
do et al., 2005; Gunther et al., 2007). Enzymatic activity of LipB was elusive until it was 
determined that translation started at a TTG codon upstream of the predicted ATG start 
codon. LipB was shown to be a lipoyl (octanoyl)-Acyl Carrier Protein:Protein Transferase 
(EC 2.3.1.181). LipB was shown to be inhibited by octanoyl-CoA, and had a similar 
reaction rate with octanoyl-ACP; but had tenfold less affinity than with lipoyl-ACP  
(Nesbitt et al., 2005). LipB was shown to proceed via a thioester intermediate with a 
conserved cysteine  (Zhao et al., 2005). The structure of the M. tuberculosis LipB 
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suggests a conserved lysine interacts with the cysteine nucleophile. The crystal structure 
was only obtained with a covalent decanoyl thioether, presumably from cis-3-decanoate  
(Ma et al., 2006). The structure of Thermus thermophilus LipB was obtained as a 
covalent dimer linked by the conserved cysteine active site residues (Kim do et al., 2005; 
Kim do et al., 2008). Attempts to crystalize E. coli LipB have failed, presumably due to 
the flexible nature of the enzyme which was seridipitously overcome in currently solved 
structures. 
It was noticed that LplA was able to complement a LipB mutation when 
overexpressed, but the reason was not known  (Morris et al., 1995). Low transferase 
activity was also detected with LplA (Jordan et al., 2003). This transferase activity was 
likely due to trace amounts of octanoate in the preparation of octanoyl-ACP, evident by 
the extremely low rate. It was determined lplA mutations conferring increased affinity 
were responsible for the most common class of lipB supressors. This demonstrated that 
LplA’s ability to bypass LipB depends on ligation of trace amounts of intracellular free 
octanoic acid, not transferase activity (Hermes et al., 2009). Because of this 
phenomenon, use of an E. coli lipB (or lipB lplA) strain to demonstrate complementation 
does not distinguish well between an octanoyltransferase or lipoyl ligase. 
LipA was purified and shown to be an iron-sulfur protein similar to biotin 
synthase  (Busby et al., 1999; Ollagnier-de Choudens et al., 1999; Ollagnier-De Choudens 
et al., 2000). LipA was found have lipoyl synthase activity (EC 2.8.1.8). It inserts sulfur 
atoms into PDH-bound octanoate using S-adenosylmethionine as a substrate to 
generate a radical electron  (Miller et al., 2000). Coexpression of the isc system 
increased LipA yield suggesting it is involved in LipA iron sulfur cluster assembly  (Kriek 
et al., 2003). It was unclear whether LipA or LipB came first in the biosynthetic pathway 
until biochemical assays of LipA demonstrated it preferred octanoyl-lipoyl domain over 
octanoyl-ACP as a substrate (Zhao et al., 2003). The thioester intermediate attached to 
LipB after purification is octanoate and no lipoic acid was detected  (Hassan et al., 2011). 
This further supports octanoyl-ACP as the physiologically relevant substrate for LipB, 
confirming that lipoic acid is synthesized on requiring enzymes (Figure 1-4). LipA was 
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also shown to be active using octanoyl-GcvH and uses two molecules of S-
adenosylmethionine  (Cicchillo et al., 2004). The enzyme contains two 4Fe-4S clusters, 
one having a novel motif  (Cicchillo et al., 2004). Both sulfur atoms are derived from the 
same enzyme molecule (Cicchillo et al., 2005). The enzyme proceeds in a stepwise 
manner, first inserting the sulfur at position 6, then 8  (Douglas et al., 2006). The 
structure of LipA is unsolved, but efforts in at least two labs are underway. 
 
LIPOIC ACID METABOLISM IN EUKARYA 
The discovery and elucidation of lipoic acid metabolism was largely achieved in 
bacteria. This knowledge has been extended to understand lipoyl metabolism in 
eukarya. The compartementalization of cells into organelles and differentiation of cells 
into different tissues makes the study of lipoic acid metabolism technically and 
theoretically more complicated. Opportunites for further study exist in these areas, and 
emerging evidence suggests new enzymes are on the horizon. 
Orthologues of lipoic acid ligase from mammals differ from the bacterial 
counterparts. The bovine orthologue was purified and shown to be unable to adenylate 
lipoic acid, but was able to use various adenylates as substrates for lipoyl domain 
modification, and so is called lipoyltransferase (Fujiwara et al., 1994; Fujiwara et al., 
1997). As expected, the human lipoyltransferase orthologue had similar properties. 
Shortly after the discovery of the bacterial lipoate protein ligase, adenylation of lipoic 
acid was detected from beef liver homogenate, and lipoate-activating enzyme was 
partially purified. Interestingly, no activity was found from heart homogenate (Tsunoda 
et al., 1967). Recently this enzyme was purified from mitrochondria, and although it had 
a higher affinity for ATP, it had a better rate with GTP as a substrate (Fujiwara et al., 
2001). Lipoyl-activating enzyme is the same enzyme as a xenobiotic acyl-CoA ligase 
(Vessey et al., 1995), whose substrate preference can vary greatly depending on 
monovalent ion concentrations (Vessey et al., 2000). Expression of lipoyl activating 
enzyme was shown to vary in different cell lines. Also, incorporation of lipoic acid and 
other analogs into PDH is possible in cell free assays  (Walden et al., 2008). Endogenous 
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lipoic acid biosynthesis is required for embryogenesis in mice. The lipA homologue, LIAS, 
was disrupted in mice, and homozygous progeny perished during embryogenesis. 
Injection of lipoic acid failed to allow growth of embryos  (Yi et al., 2005). This shows 
lipoic acid scavenging does not occur in the embryo, although it does not rule out lipoic 
acid scavenging by adults. Although much is known about lipoic acid metabolism in 
mammals, direct evidence for lipoic acid scavenging is lacking. 
The lipoic acid metabolic enzymes in plants appear to be similar to those 
characterized in E. coli. A homolog of E. coli lipB, LIP2, was identified in Arabidopsis 
thaliana. This gene could complement E. coli lipB and was actively expressed in leaves. 
Another lipB homologue, which was presumably the lipoyl ligase, was found but was not 
actively expressed in leaves. LIP2p was also found to be located in the chloroplast, which 
provides a mechanism for lipoylation of the chloroplast PDH (Wada et al., 2001a; Wada 
et al., 2001b). The lipoyl synthase of A. thaliana, LIP1, was identified, shown to be 
actively expressed, and to complement an E. coli lipA mutation. LIP1p was also shown to 
be also localized to the chloroplast, consistent with LIP2p  (Yasuno et al., 1998; Yasuno 
et al., 2002). Unlike mammalian systems the lipoyl ligase homologue from rice, OsLplA, 
is able to ligate lipoic acid. The lipoyl ligase from rice was found to be able to 
complement a lipB lplA strain of E. coli and careful measurement of growth showed a 
significant improvement upon addition of free lipoic acid, demonstrating lipoyl ligase 
activity. This gene was actively expressed in various tissues including leaves, which is in 
contrast to A. thaliana ligase  (Kang et al., 2007). Disruption of fatty acid biosynthesis in 
the chloroplast of A. thaliana reduced lipoylation in some tissues but did not eliminate 
it. This suggests either that ligation is widespread or that our knowledge of fatty acid 
biosynthesis is incomplete  (Ewald et al., 2007).  Lipoylation in plants is similar to E. coli 
but futher study is required to understand lipoic acid transport and scavenging. 
Apicomplexan parasites are unique in that lipoic acid biosynthesis, but not 
scavenging, are dispensible. Lipoic acid metabolism in these organisms is complicated by 
the PDH being localized in the apicoplast while other lipoate-requiring enzymes are 
localized in the mitochondrion. The LipA of T. gondii is also located in the apicoplast  
17 
 
(Thomsen-Zieger et al., 2003). Lipoylation in the apicoplast is dependent on fatty acid 
biosynthesis and use of the inhibitor 8-bromooctanoate demonstrates that scavenging 
of lipoic acid is required for growth  (Crawford et al., 2006).  The P. falciparum LipA 
homologue is also localized to an organelle outside the mitochondrion, likely the 
apicoplast. One ligase homologue LplA1 is localized to the mitochondrion  (Wrenger et 
al., 2004). P. falciparum also possesses a second lipoyl ligase homologue, LplA2, which 
weakly complements an E. coli lipB lplA strain. External lipoic acid is primarily 
incorporated into the mitochondrion, as in T. gondii the inhibitor 8-bromooctanoate 
arrests growth in P. falciparum (Allary et al., 2007). Disruption of lipB is not lethal but 
results in reduced lipoylation of the PDH. LplA2 is localized to both the apicoplast and 
the mitochondrion, suggesting it is redundant with LipB; although it is not clear what 
reaction it is catalyzing  (Gunther et al., 2007). Disruption of lplA1 is not possible without 
a complementing copy, demonstrating it is essential for growth and virulence  (Gunther 
et al., 2009). It appears these parasites always have access to host lipoic acid and so 
biosynthesis is dispensible in these organisms under the conditions tested. 
Lipoic acid biosynthesis in yeasts initially appeared to by similar to E. coli. A lipA 
homologue in Saccharomyces cerevisiae, LIP5, was identified that resulted in elevated 
levels of tRNAfMet by an unknown mechanism. The mutation was slightly rescued by 
ethanol, but not by lipoic acid  (Sulo et al., 1993). A homologue of E. coli lipB, LIPB of 
Kluveromyces lactis, was found to be required for growth and glycine utilization. Growth 
could be restored with ethanol and succinate, but unexpectedly, lipoic acid had no 
effect  (Chen,1997). An orthologue of LIPB, LIP2, was characterized in S. cerevisiae. 
Mutants of LIP2 behaved like LIPB and lacked PDH activity  (Marvin et al., 2001). Even 
though there was an absence of ligase activity, a lipoyl ligase homologue is encoded in 
the genome. Disruption of this gene, LIP3 (also LPLA and AIM22), resulted in loss of 
lipoylation of the PDH and OGH which is not consistent with a lipoyl ligase. 
Unexpectedly, the glycine cleavage system H protein of yeast, GCV3, was still lipoylated 
in a LIP3 strain. Disruption of GCV3 also resulted in a lipoic acid deficient strain. 
Mutation of the lipoylation site of GCV3 and conserved catalytic residues of LIP3 also 
18 
 
resulted in loss of lipoylation. The reasons for these novel phenotypes are not known, 
although a model where a protein complex is required is proposed (Schonauer et al., 
2009). The uncertainty regarding lipoic acid metabolism in yeast suggests novel enzymes 
are employed. A novel mechanism for lipoic acid biosynthesis in yeast is provided by the 
work of this thesis. 
 
AIMS AND SCOPE OF THIS THESIS 
Previous work has established the role of lipoic acid dependent complexes in 
central metabolism of a variety of organisms (Figure 1-2 and 1-3). Although a complete 
model for lipoic acid metabolism is known for E. coli (Figure 1-4), the details of lipoic 
acid metabolism in other organsims is less clear. In Chapter 2 a careful analysis of the 
Thermoplasma acidophilum lipoyl ligase yields greater insight into the biochemical 
function of this protein. In light of this finding, analysis of the lipoate protein ligase 
family reveals the potential for novel enzymes. Chapters 3, 4, and 5 of this Thesis focus 
on B. subtilis as a subjet of study. The genome of B. subtilis encodes two proteins that 
from Chapter 2 are predicted to be novel enzymes. B. subtilis does not have an obvious 
orthologue to E. coli LipB, and I find a new octanoyltransferase isozyme called LipM. In 
collaboration with Natalia Martin, we also find another gene, lipL, required for lipoic 
acid biosynthesis; this is described in Chapter 3. In Chapter 4 I find that LipL is a novel 
amidotransferase enzyme, and that B. subtilis employs a novel biosynthetic pathway. 
Finally, in Chapter 5, I summarize our knowledge of the lipoate protein ligase family. I 
also describe how this new enzyme impacts our understanding of lipoic acid metabolism 
in diverse organisms.
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FIGURES 
 
 
Figure 1-1. Lipoic acid and related compounds. Lipoic acid is the oxidized, uncharged, 
protonated, acid form, while lipoate is the basic salt form; the salt form is the 
physiologically relevant form. Lipoate is reduced to dihydrolipoate inside bacteria and 
mitochondria. The chiral center at carbon six means that a molecule of lipoic acid must 
be one of two enantiomers, the R configuration being the one biosynthesized. 
Octanoate can be a precursor to biosynthesis, while bisnorlipoate is a degradation 
product after a single round of β-oxidation. Asp-Lys-Ala (DKA) is the conserved amino 
acide residue sequence of mammalian lipoyl domains and the lipoylated DKLA tripeptide 
is the primary source of lipoic acid utilized by L. monocytogenes during infection. 
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Figure 1-2. Net reactions of lipoic acid dependent systems. The net reaction for 2-
oxoacid dehydrogenase complexes (pyruvate, 2-oxoglutarate, and branched-chain keto 
acid) is the same with different acyl groups. The acetoin dehydrogenase complex is 
homologous to 2-oxoacid dehydrogenases, but produces acetaldehyde instead of CO2. 
The glycine cleavage system is different from the other systems at every step except for 
oxidation of the dihydrolipoyl group. 
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Figure 1-3. Cycle of the lipoyl group in oxidative and reductive catalysis. In well 
characterized lipoic acid dependent enzyme systems, lipoic acid is oxidized for another 
round of catalysis which results in the production of NADH. In the novel organic 
hydroperoxidase (Ohr) system, reduced lipoic acid is the substrate which can be 
regenerated by a dihydrolipoamide dehydrogenase. 
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Figure 1-4. The current model for lipoic acid synthesis and scavenging in E. coli is shown. 
E. coli uses two independent pathways for lipoic acid attachment. Panel A: Lipoic acid is 
cleaved from peptides or proteins by lipoamidation. Exogenous lipoate (or octanoate) is 
transferred to unmodified acceptor lipoyl domains (LD) in an ATP-dependent two-step 
reaction catalyzed by LplA. Panel B: The endogenous synthesized octanoate is 
transferred from acyl carrier protein (ACP) to apoproteins by LipB, an octanoyl- 
ACP:protein-N-octanoyltransferase. The octanoylated domains then become substrates 
for sulfur insertion by LipA. 
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CHAPTER 2 
THE THERMOPLASMA ACIDOPHILUM LPLA-LPLB COMPLEX DEFINES A NEW CLASS OF 
BIPARTITE LIPOATE-PROTEIN LIGASES 
 
INTRODUCTION 
 Recently crystal structures of E. coli LplA and of LplA homologues have been 
reported including an E. coli LplA-lipoic acid complex (Fujiwara et al., 2005; Kim do et al., 
2005; McManus et al., 2006). The reported structures of the unliganded proteins agree 
well and show E. coli LplA to be a two-domain protein consisting of a large N-terminal 
domain and a small C-terminal domain (Figures 2-1 and 2-2). However, the E. coli LplA-
lipoic acid complex is difficult to interpret because lipoic acid molecules were 
heterogeneously bound to LplA molecules within the crystals and were poorly resolved. 
In one case the lipoic acid carboxyl was hydrogen-bonded to Ser-72, whereas in another 
case Arg-140 was the hydrogen bond donor (Fujiwara et al., 2005). Because enzymes 
rarely show such plasticity and lipoic acid is a hydrophobic molecule, it seemed possible 
that the observed association of the cofactor with a hydrophobic LplA surface in the 
interdomain cavity was artifactual. Moreover prior work (Reed et al., 1994) had isolated 
LplA mutants resistant to inhibition by an analogue of lipoic acid in which the sulfur 
atoms had been replaced with selenium. Because this is a very discrete modification of 
the LplA substrate, the mutant protein would be expected to have an alteration close to 
the pocket that binds the lipoic acid thiolane ring. However, the site of this mutation 
(Gly-76 to Ser (Morris et al., 1995)) was distal from the lipoate binding site reported. 
This dilemma was resolved by two lipoic acid-containing structures of an LplA 
homologue from the archaeon T. acidophilum (Kim do et al., 2005; McManus et al., 
2006) that can be readily superimposed on the E. coli LplA structure except that the T. 
acidophilum protein lacks the E. coli LplA C-terminal domain (Figure 2-2). In both T. 
acidophilum structures the lipoate thiolane ring was adjacent to the glycine residue that 
corresponds to E. coli Gly-76, the residue giving resistance to the selenium analogue, 
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and a plausible reorganization of the molecule to prevent binding of the slightly larger 
analogue was proposed (McManus et al., 2006). Moreover addition of lipoic acid to a 
complex of the T. acidophilum LplA with ATP gave lipoyl-AMP showing that the lipoic 
acid was bound in a physiologically meaningful manner (Kim do et al., 2005). The lipoyl-
AMP was bound in a U-shaped pocket and was well shielded from solvent. Thus, it 
seems that the locations of the lipoate moieties in the two T. acidophilum LplA 
structures indicate that these represent catalytically competent lipoate binding sites 
(rather than the sites of E. coli LplA where lipoate bound).  
A caveat was that the T. acidophilum LplA was inactive in catalysis of the overall 
LplA reaction (McManus et al., 2006). Because T. acidophilum LplA lacks the C-terminal 
domain (CTD) of E. coli LplA (Kim do et al., 2005; McManus et al., 2006), this suggested 
that the missing domain was required for activity, and a second protein was proposed to 
interact with T. acidophilum LplA to allow the complete reaction  (McManus et al., 
2006). If this were the case, the T. acidophilum lipoyl ligase would provide an unusually 
facile system to investigate the role of the CTD in lipoate-protein ligases.  
If the lipoate-protein ligase reaction can be catalyzed by a heteromeric protein 
this may allow better discrimination of lipoyl ligases from acyl carrier protein:protein 
octanoyltransferases. Although the two classes of LD-modifying enzymes, LplA and LipB, 
show very low amino acid sequence conservation and utilize different chemistries, the 
proteins surprisingly show structural conservation and have related active site 
architectures (Ma et al., 2006; Kim do et al., 2008) (Figure 2-2). The Mycobacterium 
tuberculosis LipB and T. acidophilum LplA can be superimposed by using all matching Cα 
positions. This yields a root mean square deviation of ~2.5 Å with good topological 
matching of most secondary structural elements (Ma et al., 2006). Hence in length and 
structure, LipBs resemble LplAs that lack the C-terminal domain. Although the E. coli 
LipB and LplA sequences align very poorly, a large number of proteins in the data bases 
have similarities to both proteins, and therefore annotation of a given protein as a ligase 
or octanoyltransferase is not straightforward. If an LplA CTD can be a separate protein, 
an additional criterion to distinguish lipoate ligases and octanoyltransferases would be 
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available. It should be noted that biotin ligases also show structural (but not sequence) 
conservation with LipB and LplA, and this group of proteins comprises the Pfam family 
PF03099 (Finn et al., 2010). However, all known biotin ligases have a C-terminal domain 
that greatly aids in their annotation. I report that, as predicted (McManus et al., 2006), 
the CTD function essential for lipoate-protein ligase activity is encoded by a gene 
located immediately upstream of T. acidophilum lplA that I call lplB. 
 
EXPERIMENTAL PROCEDURES 
Chemicals, Bacterial Strains, and Growth Media 
Strains and plasmids used in this study are listed in Table 2-1. LB rich and M9 
minimal media were prepared as described previously (Miller, 1972). Bacterial cultures 
were grown at 37 °C. T. acidophilum DSM 128 genomic DNA was purchased from the 
ATCC. Oligonucleotides were synthesized by Integrated DNA Technologies and their 
sequences are shown in Table 2-2. PCR amplification was performed using Pfu 
polymerase (Stratagene), and A overhangs were added with Taq polymerase (New 
England Biolabs). The TOPO TA Cloning kit was used for cloning PCR products into the 
pCR2.1 vector (Invitrogen) using the Topoisomerase Cloning kit was used for pET101 
(Invitrogen). DNA constructs were sequenced by the Roy J. Carver Biotechnology Center 
of the University of Illinois. All reagents and biochemicals were obtained from Sigma-
Aldrich unless otherwise noted. Radiolabeled [α-32P]ATP and [35S]methionine were 
purchased from American Radiolabeled Chemicals.  
All E. coli strains were derivatives of E. coli K-12. Strain QC146 was constructed 
by the method of Datsenko and Wanner (Datsenko et al., 2000). The lplA gene was 
replaced with a kanamycin resistance cassette by transformation of the PCR product 
obtained using primers Q017 and Q018. The lipB gene was replaced with a 
chloramphenicol resistance cassette using the PCR product obtained using primers Q019 
and Q020. The insertions were transduced with phage P1 into the wild type strain 
MG1655, the antibiotic cassettes were removed using the Flp protein encoded by the 
temperature-sensitive plasmid pCP20 (Datsenko et al., 2000), and the lipB lplA 
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phenotype was verified on M9 0.2% glucose medium comparing growth with 5 μg/ml 
lipoic acid or 5 mM sodium acetate plus 5 mM sodium succinate. The strains are 
described in Table 2-1.  
Plasmid Constructions 
The TA0513 and TA0514 open reading frames were amplified as a single 
fragment by PCR from T. acidophilum genomic DNA using primers Q007 and Q008, 
which added terminal NcoI and HindIII sites. This product was directly cloned into the 
same sites of pBAD322G (Cronan,2006) under the control of an arabinose-inducible 
promoter to give pQC005. TA0514 was amplified with primers Q027 and Q008, which 
added NcoI and HindIII sites, and TA cloned into pCR2.1 to give pQC019 followed by 
insertion between the NdeI and HindIII site of pBAD322G to give pQC021. TA0513 was 
amplified with primers Q007 and Q025 and TA cloned into pCR2.1 to give pQC020 
followed by insertion between the NdeI and XbaI sites of pBAD322G to give pQC022. A 
derivative of TA0514 having an N-terminal hexahistidine tag was amplified from 
genomic DNA using primers Q026 and Q008, which also added the N-terminal 
hexahistidine tag sequence. The product was TOPO cloned directly into pET101 to give 
pQC017. TA0513m was amplified using primers Q069 and Q068, which added an EcoRI 
site, a ribosome binding site, an N-terminal hexahistidine tag, and an XhoI site. This 
product was directly cloned between the EcoRI and XhoI sites of pET19b to give pQC043.  
The lipoyl domain of the E2 subunit of the branched chain dehydrogenase was 
determined by alignment to the lipoyl domain derived by proteolytic digestion of 
Bacillus stearothermophilus pyruvate dehydrogenase E2 subunit (Packman et al., 1984). 
The domain contains the first 86 amino acids of the branched chain dehydrogenase E2 
from open reading frame TA1436. The domain was amplified from genomic DNA with 
primers Q032 and Q033 creating an NdeI restriction site within the initiation codon and 
a stop codon following codon 86. This was TA cloned into pCR2.1 to give pQC028. The 
gene was then ligated between the NdeI and SacI sites of pET30 (a)+ to give pQC024. A 
putative T. acidophilum gcvH, open reading frame TA1366m, was found by similarity 
searches and was amplified with primers Q050 and Q049, which introduced a C-terminal 
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hexahistidine tag and a BspHI site that overlapped the initiation codon. The product was 
TA cloned into pCR2.1 to give pQC034 and subsequently inserted into the NcoI and XbaI 
sites of pET28 (b)+ to give pQC035. TA0514 was cut from pQC021 with NcoI and HindIII 
and inserted between the same sites of pRSF-1b to give pQC055. TA0513 was digested 
from pQC022 and ligated into the NcoI and XbaI sites of pRSF-1b to give pQC056.  
Bioinformatic Analyses 
Identification and bioinformatics characterization of single domain homologues 
of LplB were done using the Berkeley Phylogenomics Website (Glanville et al., 2007). 
Twenty-six homologues were identified using the TA0513m protein sequence from 10 
iterations of SHMM (subfamily hidden Markov model) and PSI-BLAST (position-specific 
iterative basic local alignment search tool). Genome comparison, similarity searches, 
and lipoic acid subsystem analyses were performed using the National Microbial 
Pathogen Database Resource (McNeil et al., 2007). Alignments were generated using 
ClustalW2 (Larkin et al., 2007). 
Complementation and 2-Oxoacid Dehydrogenase Assays 
Strains JK1 and TM131 containing pBAD322G expressing the indicated ligase 
proteins were grown in LB medium supplemented with 0.2% glucose, 5 mM sodium 
acetate, 5 mM sodium succinate, and 5 mg/L lipoic acid. The cells were harvested at an 
A600 of 0.6 by centrifugation and resuspended in 10 mM Tris-HCl buffer (pH 7.5) at ∼100 
mg of wet weight/mL. Cells were lysed by two passages through a French pressure cell 
at ∼20,000 p.s.i. Lysates were cleared by centrifugation at 27,000 × g for 15 min. Assays 
of the pyruvate dehydrogenase and oxoglutarate dehydrogenase complex activities 
were a modification of previous continuous spectrophotometric assays (Amarasingham 
et al., 1965; Guest et al., 1997). The reaction mixture contained 150 mM Tris-HCl buffer 
(pH 8.5), 3 mMl-cysteine, 0.1 mM CoA, 0.5 mM thiamin pyrophosphate, and 2 mM 
acetylated NAD analogue (2-acetylpyridine adenine dinucleotide). For assays of 
pyruvate dehydrogenase, 5 mM MgCl2 was also included to give maximal activity. Cell 
extract protein contents were determined using the using the Bio-Rad Protein Assay kit. 
The amount of extract assayed varied from 100 to 1 μg/ml final concentration. Each 
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assay began by addition of 50 mM substrate (pyruvate or 2-oxoglutarate) at 25 °C. The 
reduction of 2-acetylpyridine adenine dinucleotide was measured at 366 nm, and the 
extinction coefficient of the reduced form in assay buffer was experimentally 
determined to be 7.0 mM−1 cm−1.  
Purification of LplA and LplB 
Purification of hexahistidine-tagged versions of LplA and LplB was done using 
Ni2+ affinity chromatography followed by anion exchange chromatography. Plasmids 
QC048 and QC049 were transformed into strain Rosetta2 DE3, and the transformants 
were grown at 37 °C in 2 liters of LB medium with 100 μg/ml ampicillin and 25 μg/ml 
chloramphenicol. At an A600 of 0.6 expression was induced with 1 mM isopropyl 1-thio-
β-D-galactopyranoside for 4 h before harvest and storage of the cell pellets at −80 °C. All 
chromatography steps were performed at 4 °C. The cell pellets were resuspended in 
lysis buffer (50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 1 mM dithiothreitol, and 10 mM 
imidazole) and lysed using a French pressure cell. The lysate was cleared at 48,000 × g 
for 15 min, and 5 ml of a 50% slurry of Ni2+-NTA-agarose resin (Qiagen) was added to the 
cleared lysate and incubated for 1 h at 4 °C with mixing. The resin was packed into a 
0.75-inch column and washed with at least 10 column volumes of wash buffer (50 mM 
Tris-HCl (pH 8.0), 300 mM NaCl, and 20 mM imidazole) by gravity flow. The protein was 
eluted with the same buffer (elution buffer) containing 250 mM imidazole. The eluate 
was dialyzed overnight in 50 mM Tris-HCl (pH 8.0) and subjected to anion exchange 
using a 1-ml POROS HQ 20 column with a gradient of 10–500 mM NaCl using an AKTA 
Purifier 10 FPLC run at 5 ml/min. Fractions containing pure protein, as judged by SDS gel 
electrophoresis followed by Coomassie Blue staining, were dialyzed overnight in storage 
buffer that contained 10 mM sodium phosphate buffer (pH 7.0), 100 mM NaCl, 1 mM 
dithiothreitol, and 10% glycerol. The proteins were concentrated using Vivaspin 
concentrators (Sartorius), flash frozen in dry ice and ethanol, and stored at −80 °C. The 
masses of purified proteins were determined after dialysis against 10 mM ammonium 
acetate followed by drying under vacuum. The samples were submitted to the 
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University of Illinois at Urbana-Champaign Mass Spectrometry Laboratory for matrix-
assisted laser desorption ionization mass spectrometry analysis.  
Purification of Lipoyl Domain Substrates 
The E. coli E2p hybrid domain was a gift from Dr. Xin Zhao of this laboratory and 
had been purified by precipitation and ion exchange chromatography as described 
previously (Zhao et al., 2003). Plasmid pQC024 in Acella λDE3 cells (Edge Biosystems) 
was used to express the E2 domain in LB medium with 50 μg/ml kanamycin. The culture 
was induced at an A600 of 0.5 for 4 h. The collected cell pellet was washed with 10 mM 
sodium phosphate buffer (pH 7.0) and stored at −80 °C. Purification of T. acidophilum E2 
domain of the branched chain dehydrogenase was performed as described previously 
for E. coli E2p domain. This anion exchange protocol allows resolution of the apo and 
holo forms of the domain as shown by 20% native PAGE. Pure apo domain was dialyzed 
and stored as described for LplA and LplB. The masses of apo- and holo-LDs were 
verified as described for LplA and LplB except that electrospray mass spectrometry was 
performed. All E2 domain preparations were found to lack the N-terminal methionine 
residue. 
Plasmids pQC035 and pTara were used to express the putative glycine cleavage 
H protein TA1366m in the LD modification-deficient strain QC146 grown in LB medium 
containing 0.1% glucose, 5 mM sodium acetate, 5 mM sodium succinate, 50 μg/ml 
kanamycin, and 25 μg/ml chloramphenicol. When the cells reached an A600 of 0.6, 0.2% 
arabinose was added as an inducer, and cells were harvested by centrifugation 4 h later. 
GcvH was purified by Ni2+ affinity and anion exchange as described above for LplA and 
LplB.  
Assay of Lipoyl Domain Modification 
Protein concentrations were determined using extinction coefficients calculated 
from the ProtParam program on the ExPASy Tools Website. The assays contained 50 
mM sodium phosphate buffer, 1 mM sodium lipoate, 5 mM disodium ATP, 5 mM 
dithiothreitol, 1 mM MgCl2, and 20 μM apo-LD. The 2 μM LplA and 20 μM LplB were 
added as indicated. Three different apo-LDs were used. Reactions (20 μl) were 
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incubated at 55 °C for 1 h in the case of the T. acidophilum proteins and 16 h for the E. 
coli LD domain. Lipoyl domain modification was determined by gel shift by native 
polyacrylamide gel electrophoresis using 20% Tris-glycine gels.  
Lipoyl-AMP was synthesized by the method of L. J. Reed et al. (Reed et al., 1958). 
Lipoyl-AMP was weighed and dissolved in 100 mM sodium phosphate buffer (pH 7.0) 
before use as a substrate for lipoyl domain modification by LplA and LplB. The reaction 
contained 50 mM sodium phosphate (pH 7.0), 1 mM tris(2-carboxyethyl)phosphine, 0.1 
mM MgCl2, 20 μM apo-LD, and 1 mM lipoyl-AMP. LplA (2 μM) and LplB (20 μM) were 
added as indicated. Reactions (20 μl) were incubated at 55 °C for 30 min. Lipoyl domain 
modification was determined as described above.  
Assay of Enzymatic Lipoyl-adenylate Intermediate Formation 
Formation of lipoyl-AMP was assayed using radiolabeled [α-32P]ATP. The 
reactions contained 50 mM sodium phosphate (pH 7.0), 1 mM tris (2-
carboxyethyl)phosphine, 10 nM [α-32P]ATP, 10 μM MgCl2, and 0.1 mM sodium lipoate. 
15 μM LplB and 10 μM LplA were added as indicated. The reaction was incubated for 30 
min at 55 °C. 1 μl of the reaction was subjected to cellulose thin layer chromatography 
on plates containing a fluorescent indicator developed in isobutyric acid:NH4OH:water 
(66:1:33). Lipoyl-AMP had an Rf of 0.68, whereas the Rf of AMP was 0.41. The thin layer 
chromatograms were dried and exposed to a phosphorimaging plate for 10 min to 10 h 
and visualized using a Fujifilm FLA-3000. The same reaction as above was also run with 
0.1 μM [α-32P] ATP and 1 μM LplA. Additionally 3 μM apo-LD was added to this and 
preincubated for 15 min without ATP to remove any enzyme-bound ATP or adenylate.  
Isolation of enzyme-bound lipoyl-adenylate was performed after the reaction 
above with LplA and LplB using a 10-kDa Microcon centrifugal filter device (Millipore). 
The reaction was diluted with 600 μl of 50 mM sodium phosphate buffer (pH 7.0), 
applied to the filter, and centrifuged at 14 × g for 15 min. This was followed by four 400-
μl buffer washes of the filter after which the protein was recovered. The fractions were 
analyzed by TLC and phosphorimaging as described above.  
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Determination of the Size and Stoichiometry of the LplA-LplB Complex 
Strains QC049, QC108, QC164, and QC165 were used to determine the size and 
stoichiometry of the lipoyl ligase complex. These strains have T. acidophilum lipoyl ligase 
proteins expressed from a T7 promoter. All proteins were hexahistidine-tagged except 
for TA0513 in QC164 and TA0514 in QC165. LplA and LplB were expressed together in 
Rosetta2 DE3 cells using plasmids with compatible origins of replication. Strain QC164 
contained pQC017 and pQC056 that expressed a hexahistidine-tagged LplA and native 
LplB. Strain QC165 contained pQC043 and pQC055 that expressed a hexahistidine-
tagged LplB and native LplA. The strains were grown in 50 ml of LB medium with 100 μM 
ampicillin and 50 μg/ml kanamycin where appropriate. Cultures were grown to an A600 
of 0.6, and expression was induced with 1 mM isopropyl 1-thio-β-d-galactopyranoside 
for 4 h. The cells were harvested by centrifugation and stored at −80 °C. Cellytic Express 
(Sigma) was dissolved at 50 mg/ml in 10 mM Tris-HCl (pH 8.0) and used to resuspend 
cells at ∼400 mg/ml wet weight. Lysis occurred after incubation at room temperature 
for 20 min. The extract was cleared by centrifugation at 18,000 × g for 20 min. The 
extract was then applied twice to a pre-equilibrated Ni2+-NTA spin column (Qiagen). The 
column was washed thrice with 600 μl of wash buffer. Finally the products were eluted 
with 100 μl of elution buffer and were analyzed by SDS-PAGE or gel filtration 
chromatography.  
Gel filtration chromatography was performed in 50 mM sodium phosphate 
buffer (pH 7.0) containing 150 mM NaCl using a Superdex 200 10/300 GL column on an 
AKTA purifier 10 FPLC run at 0.5 ml/min. The void volume was found to be 7.7 ml using 
blue dextran. Low range molecular weight standards (GE Healthcare) were also run to 
establish a standard curve. The partition coefficient, Kav, was calculated from Kav = (Ve − 
V0)/ (Vt − V0) where V0 is the void volume, Ve is the elution volume, and Vt is the total 
column volume.  
The ratio of LplA to LplB was determined by protein labeling with 
[35S]methionine (Tabor et al., 1985). Strain QC164 was grown in M9 medium with 0.4% 
glucose, 50 μg/ml l-methionine, 50 μg/ml ampicillin, 25 μg/ml kanamycin, and 12 μg/ml 
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chloramphenicol. Cells were grown to an A600 of 0.6, 1 mM isopropyl 1-thio-β-D-
galactopyranoside was added, and 10 min later cells were washed thrice with M9 
medium. Cells were added to M9 medium with 0.4% glucose, 1 mM isopropyl 1-thio-β-
d-galactopyranoside, and 0.2 μg/ml rifampicin. After 15 min 5 μCi/ml l-[35S]methionine 
and 50 μg/ml l-cysteine were added to label methionine residues and prevent labeling 
of cysteine residues. Cultures were allowed to grow for 2 h until harvest by 
centrifugation. The cells were lysed using Cellytic Express (Sigma) as above. The complex 
was purified using a Ni2+-NTA spin column (Qiagen), and the eluate was subjected to gel 
filtration as described above. Fractions were subjected to SDS-PAGE followed by 
Coomassie Blue staining. The gel was dried and analyzed using a Fujifilm FLA-3000 and 
phosphorimaging plate. The ratio of LplA to LplB was determined by comparing the ratio 
of the intensities of each band. The ratio was corrected for the number of methionine 
residues in each protein (14 for hexahistidine-tagged LplA and 5 for native LplB). The 
ratio was further corrected for differences in acrylamide concentration, which is not 
included in the puplication corresponding to This chapter. Previously published data 
(Harding et al., 1983) was plotted and fit to a line of y=3.83e-0.11x. The acrylamide 
percentage at the positions of LplA and LplB was estimated by measuring 3 independent 
gels run with the same conditions as used for autoradiography.  
 
RESULTS 
Complementation of E. coli lplA Mutants by T. acidophilum lplA and lplB 
An E. coli lipA lplA mutant was used for complementation studies because the 
lack of lipoyl ligase has no phenotype when lipoic acid biosynthesis is intact (Morris et 
al., 1994; Morris et al., 1995). The lplA null mutation of E. coli the host was 
complemented when lplA and lplB of T. acidophilum were coexpressed but not when 
the genes were expressed separately. This was shown by restoration of growth on 
minimal medium supplemented with lipoic acid (Figure 2-3A). Complementation was 
due to activation of 2-oxoacid complexes, an activity expected of a lipoyl ligase (Figure 
2-3B). A slight increase in 2-oxoglutarate dehydrogenase activity was seen with LplA 
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alone suggesting that the protein has some ability to modify lipoyl domains. This was 
also seen by the very weak complementation of growth by LplA alone (Figure 2-3A). This 
was unexpected because previous in vitro assays demonstrated no activity (McManus et 
al., 2006) and suggested that LplA has low levels of activity in the absence of LplB. The 
greater modification of 2-oxoglutarate dehydrogenase suggests that T. acidophilum 
lipoyl ligase may have a greater relative affinity for this E2 domain than does E. coli LplA.  
Requirement of LplB in Lipoyl Ligation 
The LplA/LplB ligation reaction was reconstituted in vitro. Purified hexahistidine-
tagged LplA and LplB proteins were tested for the ability to modify the T. acidophilum E2 
and GcvH LDs in the presence of lipoate and ATP. Lipoylation was observed only when 
both LplA and LplB were present (Figure 2-4). Although as mentioned above a very weak 
activity was observed with LplA alone in vivo, I detected no activity in vitro in agreement 
with a prior report (McManus et al., 2006). Octanoate was also a substrate for LplA-LplB 
as was demonstrated previously with E. coli lipoyl ligase (Morris et al., 1994; Green et 
al., 1995). The E. coli E2p LD was a substrate, but full modification required very long 
incubations.  
The Role of LplB in Lipoyl-AMP Formation 
LplB provides a test for the function of the CTD of the canonical single subunit 
lipoyl ligases. Based on the reported synthesis of adenylate within LplA crystals (Kim do 
et al., 2005) I hypothesized that LplB would be required for transfer of lipoate from 
lipoyl-AMP but not for adenylate formation. To test this hypothesis the interactions of 
LplA and LplB with the lipoyl-adenylate intermediate were tested by two approaches: by 
direct measurement of adenylate formation (Figure 2-5A) and by use of chemically 
synthesized lipoyl-adenylate as a substrate (Figure 2-5C). I found that lipoyl-adenylate 
was formed with [α-32P]ATP as substrate in the absence of LD acceptor. The adenylate 
intermediate was resolved from other products by thin layer chromatography using the 
solvent system used for chemical lipoyl-adenylate synthesis (Reed et al., 1958) followed 
by autoradiography and phosphorimaging (Figure 2-5A). About 1 eq of lipoyl-
adenylate/eq of the LplA-LplB ligase was formed after 30 min of incubation, a result 
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similar to that obtained for E. coli biotin ligase (Xu et al., 1994). The lipoyl-AMP 
intermediate fractionated with the ligase complex indicating that the intermediate 
remained protein-bound (Figure 2-5B). I also attempted to demonstrate association of 
the synthesized lipoyl-adenylate using Ni2+ affinity column fractionation. However, 
elution resulted in significant lipoyl-AMP hydrolysis due to nucleophilic attack of lipoyl-
AMP by the imidazole eluant (Jencks,1957). This result suggests that little or no lipoyl-
AMP remained bound to the Ni2+ affinity-purified enzyme. To our surprise, LplB was 
required for adenylate formation (Figure 2-5A). No adenylate was formed with LplA 
alone even in the presence of 100-fold molar excesses of ATP and lipoic acid. To 
eliminate the possibility that the active site contained unlabeled adenylate or ATP, the 
reaction was pretreated with apo domain (equimolar with enzyme) before addition of 
[32P]ATP (data not shown). The results obtained were similar to those shown, and no 
lipoyl-adenylate was detected unless both LplA and LplB were present. 
I also tested transfer of lipoate from chemically synthesized lipoyl-AMP to an LD. 
The results (Figure 2-5C) demonstrated that only the LplA protein was required for 
transfer of the lipoyl moiety and that LplB is not required for interaction with the LD. 
This latter finding is not surprising because the related LipB octanoyltransferases 
interact with LDs although they lack a CTD (Figure 2-2). Lipoic acid and AMP were also 
seen among the reaction products because of the lability of the lipoyl-AMP mixed 
anhydride. Based on findings with biotinyl-AMP, lipoyl-AMP could chemically modify the 
domain (Streaker et al., 2006). However, little such modification was seen under our 
reaction conditions (Figure 2-5C). 
Properties of the LplA-LplB Complex 
The LplA-LplB complex was recovered during Ni2+ affinity, anion exchange, and 
size exclusion chromatographic separations indicating reasonably stable interaction. 
Affinity-tagged LplA bound native LplB (Figure 2-6). In contrast tagged LplB coexpressed 
with native LplA resulted in little or no protein upon elution of the Ni2+ affinity columns. 
This is presumably due to the poor solubility of LplB and the low efficiency of the LplB 
affinity tag that may be further decreased when LplB is complexed with LplA. Size 
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exclusion chromatography indicated an LplA-LplB complex size that was considerably 
smaller than the molecular weight calculated for an equimolar A-B complex. However, 
LplA and LplB when chromatographed alone also appeared smaller than their calculated 
masses such that a 1:1 complex is a reasonable interpretation. I have no explanation for 
this aberrant behavior but note that similar atypical elution was reported for another 
member of this protein family, E. coli LipB  (Nesbitt et al., 2005). Specific biosynthetic 
labeling of the proteins with [35S]methionine allowed the ratio of LplA to LplB to be 
determined. An LplA to LplB ratio of 1.6 ± 0.2:1 was obtained by size exclusion 
chromatography. However, the elution positions of LplA and the complex overlap such 
that excess LplA present in the chromatographed extract could have falsely increased 
the ratio. Excess LplA might be expected because of greater relative expression resulting 
from the higher copy number of pET101 relative to pRSF-1b. In a second approach I 
purified the [35S]methionine-labeled complex by Ni2+ affinity chromatography and 
separated the subunits by denaturing gel electrophoresis (Figure 2-6B). 
Phosphorimaging analysis of the gel gave a ratio of LplA to LplB of 1.4:1. Adjusting for 
the absorbance of the acrylamide gradient based on previous observations  (Harding et 
al., 1983), this ratio becomes 1.2:1. This result suggests that the complex is somewhat 
unstable and together with the gel filtration data indicate that an A-B heterodimer was 
the best fit of the data. 
 
DISCUSSION 
This chapter confirms the hypothesis of McManus et al.  (McManus et al., 2006) 
that LplB is the missing CTD of the T. acidophilum LplA. Although LplB is the defining 
member of the “bacterial lipoate-protein ligase C terminus” family (Pfam PF10437), it is 
doubly misnamed because it is not of bacterial origin, nor is it always a C-terminal 
domain. Many actinomycete LplA homologues have a domain at their N termini 
homologous to a CTD suggesting that they are circularly permuted LplAs (this is 
currently under investigation). As a result of the misnaming of the PF10437 family, it 
contains only one single domain sequence: that of T. acidophilum LplB. I suggest this 
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family might better be called the lipoyl ligase accessory domain family. I detected other 
single domain LplB candidates using a Phylobuilder global-global homology search. LplB 
homologues are present in many Archaea and Bacteria but are not necessarily encoded 
near the lplA gene. Alignments of selected sequences are shown in Figure 2-7. Although 
the number of sequenced Archaea is few, the lplB-lplA gene arrangement appears to be 
the typical form of archaeal lipoyl ligases. Exceptions are the putative lipoyl ligases of 
Sulfolobus that encode putative LplAs that both have and lack an LplB-like CTD. There 
are few LplB homologues in Bacteria with the exception that all sequenced Bordetella 
strains contain an LplB homologue and a T. acidophilum-like LplA. Although cultured 
methanogens do not require lipoic acid, a putative two-subunit lipoyl ligase is found in 
the genome of the uncultured methanogen RC1. 
The existence of two classes of LplAs, with and without accessory domains, was 
proposed previously (McManus et al., 2006). The results of our study show that lipoyl-
AMP formation requires the accessory domain. Because LipB octanoyltransferases have 
only a catalytic domain but bind and modify their protein substrate, I hypothesize that 
lipoyl ligase homologues lacking an accessory domain in the genome perform a different 
reaction. This is the case for the mammalian lipoyl ligase homologues, which have a CTD 
that has almost no sequence similarity with LplB (Figure 2-7). Like T. acidophilum LplA, 
these enzymes are unable to catalyze lipoyl-adenylation but transfer the lipoyl moiety 
when lipoyl-AMP is provided  (Fujiwara et al., 2007). This raises the question of the 
function of the mammalian CTD if it is not involved in adenylation. I found that both LplB 
and LplA are required for efficient complementation of an lplA mutant of E. coli and for 
efficient activation of the pyruvate and 2-oxoglutarate dehydrogenases. In vitro both I 
and McManus et al.  (McManus et al., 2006) found that LplA failed to modify the E2p 
lipoyl domain. However, it was previously reported that upon first soaking LplA crystals 
in ATP and then in lipoate the crystals contained lipoyl-AMP (Kim do et al., 2005). I was 
unable to detect lipoyl-AMP formation by LplA despite use of a sensitive radiochemical 
assay. Moreover because LplA alone can catalyze lipoyl transfer from exogenously 
supplied lipoyl-AMP to LD (Figure 2-3C), McManus et al.  (McManus et al., 2006) and I 
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should have observed lipoylation activity if lipoyl-AMP had been formed. The difference 
between the crystal and solution studies of LplA cannot be due to lipoyl-AMP stability. If 
this were the case I should have observed increased AMP accumulation in the lipoyl-
AMP synthesis reaction; this was not the case (Figure 2-5A). It therefore seems possible 
that the function of LplB is to modulate the structure of LplA such that lipoyl-AMP 
synthesis can occur and that perhaps crystal packing somehow mimicked this 
modulation. However, the weak modification of the 2-oxoglutarate dehydrogenase seen 
in the presence of only LplA (Figure 2-3) suggests that some lipoyl-AMP is formed in 
vivo. This could be due to trace ligase activity by LplA alone or by the presence of an E. 
coli factor that can mimic LplB. The E. coli pyruvate dehydrogenase domains seem poor 
substrates for the T. acidophilum ligase. Expression of LplA alone or LplA and LplB 
together in E. coli results in more 2-oxoglutarate dehydrogenase activity than pyruvate 
dehydrogenase activity, although the latter enzyme has three LDs per E2 subunit, and a 
single lipoylated LD is sufficient for activity  (Perham, 2000). Indeed the E. coli E2p 
domain was a poor substrate in vitro (Figure 2-4). 
The available structures of lipoyl ligases provide a possible mechanism for LplB 
action. The structure of E. coli LplA shows that the conserved CTD Asp (Asp-42 in LplB) 
residue faces the catalytic domain and is close to the loop formed by residues 72–82, 
highly conserved residues that line the lipoyl-AMP binding pocket  (Fujiwara et al., 
2005). The G76S mutation conferring resistance to selenolipoic acid is also present in 
this loop, consistent with its role in substrate binding (Reed et al., 1994). In an 
unpublished Streptococcus pneumonia LplA structure (Protein Data Bank accession code 
1VQZ), the conserved Asp of the accessory domain is also in close proximity to 
conserved residue Gln-47, and both residues are close to the conserved loop that lines 
the active site. A structure of a catalytically active lipoyl ligase of known activity 
complexed with lipoyl-adenylate is not yet available, but an analogous biotin ligase 
structure has been solved (Wood et al., 2006). Although some LplB residues are 
conserved in the biotin ligase accessory domain, it appears that the interaction of the 
CTD with the catalytic domain is different. The biotin ligase accessory domain is shorter 
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and lacks the two outward facing α helices that are present in the lipoyl ligase accessory 
domain. 
Because of their unique ATP binding motif, it has been argued that members of 
the biotin ligase superfamily originally evolved to bind small molecules and that 
adenylation activity arose independently  (Wood et al., 2006). The role of the accessory 
domain in adenylation suggests that it may be important for binding of a small molecule 
substrate. Indeed the CTD of biotin ligase has also been shown to be important for 
binding ATP  (Chapman-Smith et al., 2001). Within the lipoyl ligase family the lipoyl 
ligase accessory domain can be found as an N-terminal domain, a CTD, or as a separate 
protein or is not found at all (Figure 2-8). The accessory domains found as separate 
proteins are closely related (Figure 2-7), so the variable domain architecture of these 
lipoate ligases could be a recent development. The advantage of a multimeric lipoyl 
ligase complex is not obvious. Perhaps the accessory domain was initially absent and 
was later added during evolution of ligase function. This is reasonable given that the 
LplA protein family is rooted in such sequences (Figure 2-8). If so, the T. acidophilum 
lipoyl ligase complex may be an evolutionary relic. The activity of the T. acidophilum 
LplA and LplB complex with octanoate in place of lipoate was first reported for the E. 
coli enzyme  (Morris et al., 1994). However in E. coli the octanoyl-LD can be converted 
to lipoyl-LD by lipoyl synthase (LipA). In contrast, T. acidophilum lacks a recognizable 
lipoyl synthase homologue, and thus octanoylation would render the LD inactive. Hence 
to obtain function of its lipoic acid-requiring enzymes T. acidophilum would need an 
environment rich in lipoic acid and deficient in octanoic acid.  
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TABLES 
 
Table 2-1. Strains and plasmids used in this chapter.  
Strain/plasmid Relevant characteristics Source or Ref. 
MG1655  CGSC* 
JK1 rpsL (Strep
R
)  (Morris et al., 1995) 
TM131 rpsL lipA ::Tn1000 lplA ::Tn10 (Morris et al., 1995)  
Acella DE3 ompT hsdSB (rB
−
 mB
−
) gal dcm (DE3) ΔendA ΔrecA Edge Biosystems 
Rosetta2 DE3 ompT hsdSB (rB
−
 mB
−
) gal dcm (DE3)/pRARE2  Novagen 
ZX221 rpsL ΔlipB ::FRT ::aac This chapter 
QC144 ΔlplA ::FRT ::kan This chapter 
QC145 ΔlplA ::FRT ::kan ΔlipB ::FRT ::cat This chapter 
QC146 ΔlplA ::FRT ΔlipB ::FRT This chapter 
QC038 rpsL lipA ::Tn1000 lplA ::Tn10/pBAD322G  This chapter 
QC090 rpsL lipA ::Tn1000 lplA ::Tn10/pQC005  This chapter 
QC091 rpsL lipA ::Tn1000 lplA ::Tn10/pQC021  This chapter 
QC092 rpsL lipA ::Tn1000 lplA ::Tn10 pQC022  This chapter 
QC064 ompT hsdSB (rB
−
 mB
−
) gal dcm (DE3) ΔendA ΔrecA /pQC024  This chapter 
QC096 ompT hsdSB (rB
−
 mB
−
) gal dcm (DE3) ΔendA ΔrecA/pQC035  This chapter 
QC049 ompT hsdSB (rB
−
 mB
−
) gal dcm (DE3)/pRARE2, pQC017  This chapter 
QC108 ompT hsdSB (rB
−
 mB
−
) gal dcm (DE3)/pRARE2, pQC043  This chapter 
QC164 ompT hsdSB (rB
−
 mB
−
) gal dcm (DE3)/pRARE2, pQC017, 
pQC056  
This chapter 
QC165 ompT hsdSB (rB
−
 mB
−
) gal dcm (DE3)/pRARE2, pQC043, 
pQC055  
This chapter 
QC166 ΔlplA ::FRT ΔlipB ::FRT/pTara/pQC035  This chapter 
pBAD322G Gm
R
 arabinose-inducible expression vector  (Cronan, 2006) 
pTARA Chl
R
 arabinose-inducible T7 polymerase  (Wycuff et al., 2000) 
pET19b Amp
R
 T7 expression vector  Novagen 
pET28b+ Kn
R
 T7 expression vector  Novagen 
pET30b+ Kn
R
 T7 expression vector  Novagen 
pET101/TOPO Amp
R
 T7 expression vector  Invitrogen 
pRSF-1b Kn
R
 T7 expression vector with RSF origin  Novagen 
pCR2.1 TOPO TA cloning vector Invitrogen 
pQC005 pBAD322G encoding a TA0513-4 operon This chapter 
pQC017 pET101 encoding N-terminal hexahistidine-tagged TA0514 This chapter 
pQC019 pCR2.1 with TA0514 insert This chapter 
pQC020 pCR2.1 with TA051 insert This chapter 
pQC021 pBAD322G encoding TA0514 This chapter 
pQC022 pBAD322G encoding TA0513 This chapter 
pQC028 pCR2.1 encoding E2 LD gene This chapter 
pQC024 pET30 (a)+ encoding the E2 LD This chapter 
pQC034 pCR2.1 encoding C-terminal hexahistidine-tagged GcvH This chapter 
pQC035 pET28 (b)+ encoding C-terminal hexahistidine-tagged GcvH This chapter 
pQC043 pET19b encoding N-terminal hexahistidine-tagged 
TA0513m 
This chapter 
pQC055 pRSF1b encoding TA0514 This chapter 
pQC056 pRSF1b encoding TA0513 This chapter 
*CGSC, The Coli Genetic Stock Center. 
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Table 2-2. Oligonucleotides used in this chapter. 
Oligonucleotides Sequence 
Q007 tagccatggttctcaattatactatgcat 
Q008 tacaagcttacagggatatcgagacgtt 
Q017 agcgagaaaaaagagtgacccattactacaagaaaggaaatcgttgtgtaggctggagctgcttc 
Q018 aaaatccggcaaatcgaagagaaagttgcccgcatgggcgggtaacatatgaatatcctccttag 
Q019 cccccacttttactcattctccacggagatgccgttttgtatcagtgtgtaggctggagctgcttcgaa 
Q020 gtaatgacccagtgtaaattgggccattgatgtatggaattaagccatatgaatatcctcctt 
Q025 tcagatcaccctcaaagc 
Q026 caccatgcatcatcatcatcatcatatggaaggcaggcttctt 
Q027 tagccatggaaggcaggcttctt 
Q032 aatcatatgtacgaattcaaactgccagacataggtg 
Q033 attgagctcttaaggctgctgtaccggagcc 
Q049 tcatgacagaggtaccagagggttt 
Q050 ttaatgatgatgatgatgatgttgtattaacttcctgtactccgatg 
Q068 actcgagtcagatcaccctcaaagc 
Q069 ttctagataaggaggagaccaatgcatcaccatcaccatcacatgcatatgatgtacagc 
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FIGURES 
 
 
Figure 2-1. Lipoic acid metabolism in E. coli. Panel A: the lipoyl ligase (LplA) reaction that 
proceeds through the lipoyl-adenylate intermediate. In E. coli LplA acts to scavenge 
lipoic acid from the growth medium. Panel B: schematic of lipoic acid synthesis in E. coli. 
LipB transfers an octanoyl moiety from the fatty acid biosynthetic intermediate, 
octanoyl-acyl carrier protein, to the LD domain of a lipoate-accepting protein (in this 
case the E2 subunit of a 2-oxoacid dehydrogenase). The octanoylated LD domain is the 
substrate of LipA, an S-adenosylmethionine radical enzyme that replaces one hydrogen 
atom on each of octanoate carbons 6 and 8 with sulfur atoms. Panel C: the differing 
arrangements of genes and domains found in lipoate ligases in T. acidophilum, E. coli, 
and Streptomyces coelicolor. Only a single nucleotide lies between the T. acidophilum 
LplB and LplA coding sequences.  
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Figure 2-2. Alignments of LplA and LipB structures. Previously published crystal 
structures were aligned using DeepView  (Guex et al., 1997). Panel A: E. coli LplA 
(Protein Data Bank code 1X2H in green) aligned with T. acidophilum LplA (Protein Data 
Bank code 2ART in orange). The lipoyl-adenylate intermediate bound to T. acidophilum 
LplA is shown in purple. The adenylate binding loop is indicated with an arrow. Panel B: 
M. tuberculosis LipB (Protein Data Bank code 1W66 in gray) is aligned with the E. coli 
LplA structure of panel A. The purple line denotes the covalent decanoate adduct 
present in the M. tuberculosis LipB structure. The substrate binding pocket is conserved 
among members of the protein family. The accessory domain is not part of the binding 
pocket and appears to play an indirect role in catalysis. 
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Figure 2-3. Complementation of an E. coli lipoyl ligase null mutant strain. The lipA lplA 
strain, TM131, was transformed with pBAD322G-derived plasmids, p (lplA), p (lplB), and 
p (lplA plus B), expressing the T. acidophilum genes (as indicated) from an arabinose-
inducible promoter. The wild type (WT) and lipA lplA both with an empty vector are the 
control strains. The complementation assays were performed on M9 minimal agar 
containing 0.2% arabinose and 0.1% vitamin assay casamino acids. Where indicated, 5 
mM sodium acetate plus 5 mM sodium succinate or 5 μg/ml lipoic acid was added. To 
prevent carryover of lipoic acid, before testing the strains were grown on the same 
medium containing 5 mM sodium acetate, 5 mM sodium succinate, and 24 mg/L 
gentamicin. Panel A: ability of expression of LplA and LplB alone or together to restore 
growth of E. coli strain TM131 (lplA lipA) when supplemented with lipoic acid. 
Representative plates of three replicate experiments are shown. Panel B: activation of 
the pyruvate dehydrogenase (PDH) and 2-oxoglutarate dehydrogenase (OGDH) 
complexes upon expression of LplA and LplB alone or together was assayed using an 
acetylated NAD analogue as a substrate for the overall reaction of the dehydrogenase 
complex. Results are reported as μMol of NAD analogue reduced/mg of cell extract h−1. 
The error bars denote twice the S.D. from at least four assays. 
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Figure 2-4. Gel shift assay for lipoyl domain modification. The modified lipoyl domain 
loses a charge upon modification of the target lysine residue resulting in more rapid 
migration on native gels than the unmodified domain. Representative gels of three 
independent experiments are shown. Lane designations given in parentheses below are 
the same in all three panels. Lane 1, no enzyme (NE); lane 2, LplA (A); lane 3, LplB (B); 
lane 4, LplA plus LplB (AB); lane 5, LplA plus LplB with octanoate in place of lipoate (Oct). 
Panel A: modification of the T. acidophilum branched chain dehydrogenase E2 lipoyl 
domain by lipoate or octanoate attachment. Panel B: modification of the putative T. 
acidophilum GcvH. Panel C, modification of the E. coli hybrid E2p domain. Note that 
efficient lipoylation of the E. coli domain required a 16-fold longer incubation time than 
the T. acidophilum domains.  
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Figure 2-5. The role of LplB in lipoyl ligation. Panel A: synthesis of 32P-labeled lipoyl-
adenylate from [α-32P]ATP was analyzed by cellulose thin layer chromatography and 
visualized by autoradiography. Lane 1, no enzyme (NE); lane 2, LplA (A); lane 3, LplB (B); 
lane 4, LplA plus LplB (AB). Panel B: demonstration of enzyme-bound lipoyl-AMP with a 
centrifugal filter device. Lane 1, reaction (R); lane 2, flow-through (F); lane 3, final wash 
(W); lane 4, retained enzyme fraction (E). Panel C, transfer of lipoate from synthetic 
lipoyl-adenylate to LD assayed by gel shift. Lanes 1–4 are labeled as in panel A.  
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Figure 2-6. Characterization of the LplA-LplB complex. Panel A: size exclusion 
chromatography of the purified proteins. The calibration curve was prepared using (in 
order of ascending molecular mass) ribonuclease A, chymotrypsinogen, ovalbumin, and 
bovine serum albumin as standards, shown as “×” symbols. Hexahistidine-tagged LplA is 
shown as a circle and was estimated to have a mass of 16.6 ± 0.5 kDa, whereas mass 
spectrometry gave a mass of 30.8 kDa. Hexahistidine-tagged LplB eluted after the linear 
range of the column (<10 kDa), although it had a mass of 11.2 kDa as determined by 
mass spectrometry. The lipoyl ligase (LplA-LplB) complex is shown as a square and elutes 
soon after LplA and has an estimated mass of 18.2 ± 0.4 kDa and a mass calculated from 
the individual mass spectra of 41.1 kDa. The estimated sizes are the average of four runs 
with independent protein samples. The S.D. is also reported. Panel B: demonstration of 
the lipoyl ligase complex by Ni2+ affinity chromatography. The elution products were 
subjected to SDS-PAGE on a 4–20% gradient Tris-glycine gel and visualized with 
Coomassie Blue R-250. LplB copurified with hexahistidine-tagged LplA (lane AB). 
Hexahistidine-tagged LplA and LplB were also purified individually as references (lanes A 
and B, respectively). The rightmost lane is a phosphorimaging scan of L-[35S]methionine-
labeled lipoyl ligase complex after SDS-PAGE on a 4–20% gradient Tris-glycine gel.  
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Figure 2-7. ClustalW alignment of representative LplB homologues. The first six 
sequences are representative single domain LplB homologues. Black shading denotes 
identical residues whereas gray shading denotes residues of similar properties. The 
putative S. coelicolor (Sc) ligase has an N-terminal LplB domain. E. coli LplA (Ec) is the 
canonical C-terminal domain ligase. The putative S. pneumoniae (Sp) LplA also has a C-
terminal domain. The Bos taurus (Bt) bLT has a C-terminal domain of unknown function. 
Conserved Gly residues correspond to flexible loops in the E. coli LplA structure 
(Fujiwara et al., 2005). Most conserved residues are predicted to be in the interior of the 
protein and probably serve structural roles. Close relatives to LplB, including single 
domain proteins, contain a GDFF motif. The aspartate residue of this motif (Asp-41 in 
LplB) is well conserved among LplB homologues. The Genbank accession numbers of the 
aligned sequences (all previously published) are (from top to bottom) NP_393989, 
NP_579363.1, NP_880065, YP_687213.1, ZP_02512737, ACB07333.1, CAA18910, 
NP_345629, AAC77339, and BAA24354. Ta, T. acidophilum; Pf, Pyrococcus furiosus; Bp, 
Bordetella pertussis; M, methanogen, uncultured; MM, Mycoplasma mycoides; Kc, 
Korarchaeum cryptofilum. 
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Figure 2-8. Phlylogeny of lipoyl ligase homologues. The lipoyl ligase subtree of the 
BPL_LplA_LipB Pfam family (PF03099) are displayed using Dendroscope  (Huson et al., 
2007). Domain architecture is annotated by color. Black clade proteins contain a 
catalytic domain but no detectable LplB homologue in the genome. The green clade 
proteins have a C-terminal accessory domain. Blue clade proteins are found only in 
mammalian genomes and have a C-terminal domain of unknown function that has only 
background sequence similarity with the green clade C-terminal accessory domains 
(Figure 2-7). The orange clade proteins have a variable domain architecture including N-
terminal accessory domains and independently coded accessory domains. The deeply 
branching and multiclade presence of LplAs with independent LplBs suggests that this 
architecture is an evolutionary relic. The tree root, determined with biotin ligases and 
octanoyltransferases as outgroups, is within the black clades. This suggests that the 
catalytic domain was originally independent of any other domains in the common 
ancestral protein. 
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CHAPTER 3 
LIPOIC ACID SYNTHESIS: A NEW FAMILY OF OCTANOYLTRANSFERASES GENERALLY 
ANNOTATED AS LIPOATE PROTEIN LIGASES 
 
INTRODUCTION 
Although Bacilli have an unusually large number of lipoic acid-dependent 
enzymes, the annotation of their genomes argues that these bacteria have an 
incomplete lipoic acid synthesis pathway. Although Bacillus subtilis encodes a readily 
recognized and functional LipA homologue (Martin et al., 2009), as well as multiple 
putative LplA homologues, no LipB homologue can be recognized. Hence, it was unclear 
how this organism produces the octanoyl-LD substrates required for the insertion of 
sulfur by LipA. A similar situation was found in the other firmicutes including important 
organisms such as the Staphylococci and Clostridia. I provide evidence that the 
octanoyltransferase of B. subtilis is one of the proteins previously annotated as a lipoate 
protein ligase, and thus, this protein, LipM, defines a new class of octanoyltransferases. 
 
EXPERIMENTAL PROCEDURES 
Media and Chemicals  
E. coli K-12 strains were grown on LB or M9 minimal medium (Sambrook et al., 
2001). Antibiotics were used at the following concentrations: 100 μg/mL sodium 
ampicillin, 50 μg/mL kanamycin sulfate, 12 μg/mL chloramphenicol, 25 μg/mL 
gentamicin sulfate, and 12 μg/mL tetracycline hydrochloride. All chemicals were 
obtained from Sigma unless otherwise indicated. Difco Vitamin-Assay Casamino Acids 
was obtained from Becton-Dickenson. [1-14C]octanoic acid and [1-14C]octanoyl-CoA 
were purchased from Moravek. American Radiolabeled Chemicals provided n-[2,2′,3,3′-
3H]octanoic acid. 
Bacterial Strains and Plasmids Constructed  
Strains used in this chapter are listed in Table 3-1, plasmids in Table 3-2, and 
primers in Table 3-3. B. subtilis strain 168 was from the Bacillus Genetic Stock Center. 
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Bacterial cultures were grown in shake flasks at 37 °C, and growth was measured by the 
optical density at 600 nm using a Beckman DU600 spectrophotometer unless otherwise 
indicated. Standard techniques  (Sambrook et al., 2001) for DNA manipulation and 
cloning were employed unless otherwise indicated. Polymerase chain reaction (PCR) 
amplification was performed using either Taq (New England Biolabs) or Pfu (Stratagene) 
polymerases according to the manufacturer's recommendations except with the 
addition of 5% DMSO to the Pfu reaction mixtures. The lipB and lplA derivatives of strain 
EPI300 (Epicenter) were constructed by P1 phage transductions of the mutant alleles 
from strains QC144 and ZX221 to give strains QC067 and QC068. A functional recA gene 
was provided by temperature-sensitive plasmid pEK2. FLP recombinase-mediated 
removal of the antibiotic resistance cassettes was conducted using temperature-
sensitive plasmid pCP20 to yield strain QC069. To obtain a strain deficient in 
unsaturated fatty acid biosynthesis, a previously described (Henry et al., 1992) null 
mutant-fusion derivative of E. coli fabA tagged with chloramphenicol resistance was 
transduced from strain MH120 to strain W3110 to yield strain QC134. The strain was 
maintained in LB medium supplemented with 0.5 mM sodium oleate and 0.1% Tergitol 
NP-40. The fabA allele was also transduced into strain TM131 to yield strain QC168. This 
strain was maintained on LB medium adjusted to pH 7.0 after supplementation with 5 
mM sodium acetate, 5 mM sodium succinate, 0.5 mM oleate, and 0.1% Tergitol NP-40. 
For complementation analysis, candidate genes were amplified from genomic 
DNA by PCR and inserted into pBAD322G (Cronan,2006). The B. subtilis 168 lipM (yqhM) 
coding sequence was amplified using primers Q005 and Q006 and inserted into the 
EcoRI and XbaI sites of pBAD322G to give pQC004. E. coli MG1655 lplA was amplified 
with primers Q044 and Q046 and inserted into the NcoI (using a PciI end) and HindIII 
sites of pBAD322G to give pQC007. Note that the construction of pQC007 is incorrect in 
the publication corresponding to this chapter. The E. coli MG1655 lipB coding sequence 
was obtained by NcoI and HindIII digestion of pSJ112 (Jordan et al., 2003). The lipB 
fragment was then inserted into the same sites of pBAD322G to give pQC008. These 
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manipulations placed each of these genes under the control of the arabinose inducible 
araBAD promoter. 
For purification of the lipM protein product, the gene was amplified with primers 
Q022 and Q023, which added a sequence encoding an N-terminal hexahistidine tag. The 
PCR product was cloned into pET101 using the TOPO cloning kit (Invitrogen). Point 
mutations within lipM were introduced using the QuikChange II site-directed 
mutagenesis kit (Stratagene) with primers Q133−Q140. The gene encoding the B. subtilis 
168 glycine cleavage H protein (gcvH or yusH) was PCR amplified with primers Q047 and 
Q048, which added a C-terminal hexahistidine tag to the gene product. This PCR product 
was inserted into pCR2.1 using the TA cloning kit (Invitrogen). The gcvH insert was 
subsequently inserted into the NdeI and SacI sites of pET30a+ to give pQC057. In each of 
these final constructs, the genes were placed under the control of a promoter 
dependent on phage T7 polymerase (Studier et al., 1986). 
Cosmid Library Selection for Octanoyltransferases  
Selection of a complementing cosmid was conducted using the CopyControl 
Cosmid Library system (Epicenter) as described. Briefly, genomic DNA from B. subtilis 
168 was mechanically sheared by repeated pipetting, and fragments of 40 kb were 
extracted from an agarose gel run overnight at 15 V (1.25 V/cm) and gel purified. Size-
selected DNA was then end repaired and ligated into the predigested pCC1FOS vector. 
The ligation mix was packaged in vitro into λ phage particles, and the particles were 
used to infect strain QC069. After being washed three times, the cells were titered on LB 
containing 0.4% glucose, 5 mM sodium acetate, 5 mM sodium succinate, and 24 μg/mL 
chloramphenicol. To select for lipoic acid prototrophy, cells were plated on M9 minimal 
medium containing 0.4% glycerol, 12 μg/mL chloramphenicol, and isoleucine, leucine, 
and valine (each at 0.1 mM). The plates were incubated at 37 °C for 4 days, and eight 
colonies were obtained from 580 clones tested. These colonies were reisolated on the 
same medium to verify their phenotypes, and their cosmids were isolated and 
transformed into strain QC069 to confirm their complementation abilities. The end 
sequences of the B. subtilis chromosomal fragments were determined by sequencing 
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into the inserts from the flanking vector sequences by the Keck Biotechnology Center 
using primers purchased from Epicenter. 
The growth phenotype of strain QC069 retransformed with the COS1 cosmid was 
measured. Strains were grown on M9 minimal agar plates of the same composition as 
that given above and then subcultured overnight in liquid medium of the same 
composition. The cells were washed thrice with medium lacking acetate and succinate 
and then diluted to an OD600 of 0.05. Growth of the cultures (0.4 mL per well) was 
followed by the optical density at 600 nm using a Bioscreen C instrument with 
continuous and robust shaking. Growth was measured every 15 min. 
Complementation of E. coli Lipoate Auxotrophs  
Genes were expressed in E. coli from plasmids with an arabinose inducible 
promoter. The strains were first grown on M9 minimal agar and then overnight in liquid 
with 0.2% arabinose, 0.1% Vitamin-Assay Casamino Acids, 5 mM sodium acetate, 5 mM 
sodium succinate, and gentamicin. Complementation of lipB lplA strain TM136 was 
tested using M9 minimal medium containing 0.2% arabinose and gentamicin. 
Complementation of lipA lplA strain TM131 was tested using M9 minimal medium 
containing 0.2% arabinose, gentamicin, and 5 μg/mL sodium lipoate. Overnight cultures 
were washed thrice before being subcultured to an OD600 of 0.1. Growth curves were 
obtained using the Bioscreen C instrument as described above for cosmid 
complementation. 
Phylogenetic Analysis and Bioinformatics  
Comparison of genes homologous to characterized lipoic acid metabolic genes of 
different bacteria was conducted using the SEED database subsystems tool  (Overbeek 
et al., 2005). SEED was also used to compare genome contexts in different organisms 
and to predict functional coupling. 
The phylogeny of the LipB_LplA_BirA family (PF03099) was determined with 
sequences selected from the Pfam database (Finn et al., 2010). An unweighted 
alignment of protein sequences was performed using T-Coffee  (Notredame et al., 2000) 
at the European Bioinformatics Institute Web site (http://www.ebi.ac.uk) using the 
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default settings. The edges of the alignment were trimmed using Jalview (Waterhouse et 
al., 2009) so only the catalytic domain remained. A minimum evolution tree was 
constructed with bootstrap analysis of 1000 replicates using Mega4 (Tamura et al., 
2007) with the default settings. 
Purification of B. subtilis AcpP  
The acyl carrier protein of fatty acid biosynthesis was purified from strain 
EMM99 by a modification of the method previously described (Martinez et al., 2010). All 
protein steps were conducted at 4 °C unless otherwise indicated. Following nickel 
affinity chromatography, the hexahistidine tag was cleaved from approximately 30 mg 
of ACP with 500 units of AcTEV protease (Invitrogen). The reaction was conducted for 24 
h at room temperature during dialysis against the reaction buffer and then subjected to 
subtractive nickel affinity chromatography as described previously (Chapter 2). The 
modification state of AcpP was verified using conformationally sensitive native PAGE 
using 20% acrylamide, 2.5 mM urea gels buffered with Tris-glycine (Cronan et al., 2009). 
The TEV protease-digested AcpP migrated much slower than the undigested tagged 
protein. Fractions containing the TEV-cleaved apo and holo AcpP were pooled, 
concentrated with a Vivaspin concentrator (GE Healthcare), and flash-frozen for storage 
at −80 °C. Quantitative conversion of the mixture to holo-ACP was achieved using the B. 
subtilis Sfp phosphopantetheinyl transferase as previously (Quadri et al., 1998). Strain 
QC120 was grown in LB with kanamycin and induced for 2 h with 1 mM isopropyl β-D-1-
thiogalactopyranoside at an OD600 of 0.6. Sfp was purified from strain QC120 extracts by 
nickel affinity chromatography as described for LplA described (Chapter 2). Pooled 
fractions containing Sfp were precipitated with ammonium sulfate (35−55% of 
saturation) as described previously  (Quadri et al., 1998) and dialyzed overnight against 
50 mM sodium phosphate (pH 7.0), 10 mM MgCl2, 10% glycerol, and 1 mM DTT. The 
protein was concentrated with a Vivaspin concentrator (GE Healthcare) and flash-frozen 
for storage at −80 °C. Conversion to holo-ACP was verified using conformationally 
sensitive gel electrophoresis as described previously  (Cronan et al., 2009). The AcpP 
modification state was also assayed by electrospray ionization mass spectrometry 
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performed by the University of Illinois School of Chemical Sciences Mass Spectrometry 
Facility. The sample was prepared by dialysis overnight against 10 mM ammonium 
bicarbonate, and then the solvent was removed by evaporation under a stream of 
nitrogen. The mass was determined by electrospray ionization mass spectrometry in 
positive ion mode using a Micromass Quattro II instrument with 100 pmol/mL protein in 
50% aqueous acetonitrile containing 0.1% formic acid. 
Preparation of [3H]Octanoyl-ACP  
Octanoyl-ACP was prepared using Vibrio harveyi acyl-ACP synthetase (AasS) 
purified by nickel affinity and ion exchange chromatography as previously described  
(Jiang et al., 2006). The 100 μL reaction mixture contained 10 mM Tris-HCl (pH 8.0), 10.1 
mM MgCl2, 10 mM ATP, 1 mM TCEP, 5 mM sodium [
3H]octanoate, 0.5 mM holo-ACP, 
and 5 μM AasS. The reaction was allowed to proceed for 2 h at 37 °C. The product was 
precipitated at 4 °C overnight after addition of an equal volume of acetone. The pellet 
was resuspended in 100 mM Tris-HCl (pH 8.0) and dialyzed overnight against 10 mM 
sodium 2- (N-morpholino)ethanesulfonic acid (pH 6.1). The protein was found to be 
>95% octanoyl-ACP by gel electrophoresis using conformationally sensitive native PAGE  
(Cronan et al., 2009). Proteins were quantified by use of extinction coefficients 
calculated using PROTPARAM on the EXPASY website  (Gasteiger et al., 2003). Octanoyl-
ACP was quantified at 280 nm using a calculated extinction coefficient of 1490 M−1 cm−1. 
Purification of B. subtilis GcvH  
To purify hexahistidine-tagged B. subtilis GcvH, I used the lipoic acid auxotrophic 
strain QC146. The strain was grown in LB with 0.1% glucose, 5 mM sodium acetate, and 
5 mM sodium succinate (pH 7.0) to an optical density of 0.5 at 600 nm. Expression was 
induced with 0.2% arabinose and the culture incubated for an additional 4 h before the 
cells were pelleted by centrifugation and frozen at −80 °C. The protein was purified by 
nickel affinity and anion exchange chromatographic steps and analyzed by mass 
spectroscopy as described above for AcpP. GcvH was quantified at 280 nm using a 
calculated extinction coefficient of 16960 M−1 cm−1. 
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Purification of LipM  
LipM was initially purified from strain QC103 by nickel affinity and anion 
exchange chromatographic steps as previously described for Thermoplasma 
acidophilum LplA (Chapter 2) except that the reducing agent was 5 mM TCEP instead of 
DTT. Unmodified LipM was obtained using the fabA strain QC142. The strain was grown 
in LB with 0.1% glucose, 0.5 mM sodium oleate, 0.1% Tergitol NP-40, ampicillin, and 
kanamycin to an OD600 of 0.5. At that point, T7 polymerase expression was induced by 
addition of 0.2% arabinose for 1.5 h. Then fatty acid biosynthesis was inhibited by 
addition of 0.1 μg/mL triclosan for 40 min. Cells were harvested by centrifugation and 
frozen at −80 °C. Lysis and purification were performed as described for the initial 
purification. A calculated extinction coefficient of 45380 M−1 cm−1 at 280 nm was used 
for LipM. The purified protein was analyzed by matrix-assisted laser desorption 
ionization (MALDI) mass spectrometry at the University of Illinois School of Chemical 
Sciences Mass Spectrometry Facility. The sample was prepared by dialysis overnight in 
10 mM ammonium acetate, dried under a stream of nitrogen, and subjected to MALDI 
performed using a Voyager-DE STR mass spectrometer (Applied Biosystems) equipped 
with a UV laser (337 nm N2 laser). All measurements were taken using the linear mode, 
and the positive ion was recorded. I prepared samples by mixing 2 μL of the sample and 
10 μL of the matrix, α-cyano-4-hydroxycinnamic acid. 
Liquid Chromatography−Tandem Mass Spectrometry Analysis of LipM 
LipM was purified from strain QC103 as described for LplA (Chapter 2) and was 
subjected to size exclusion chromatography using a Sephadex 200 column developed 
with 10 mM sodium phosphate (pH 7), containing 100 mM sodium chloride and 1 mM 
DTT. Fractions containing pure LipM as judged by SDS−PAGE were pooled, dialyzed 
against 10 mM ammonium acetate, and dried under a stream of nitrogen. The protein 
was then dissolved in 100 mM Tris-HCl (pH 8.5) containing 1 M urea and 20 mM 
methylamine and digested with one-tenth mass of modified sequencing grade trypsin 
(Roche) for 16 h at 37 °C. Liquid chromatography−tandem mass spectrometric analysis 
was performed by the University of Illinois Biotechnology Center Protein Sciences 
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Facility on a Waters Q-Tof API-US Quad-ToF mass spectrometer with a nanoAcquity 
UPLC system. The columns used were Waters nanoAcquity UPLC (75 μM × 150 mM, 3 
μM, Atlantis dC18) and Atlantis dC18 5 μM Nanoease trap columns. A 60 min linear 
gradient from 1 to 60% acetonitrile in 0.1% formic acid was used to elute the peptides 
from the columns. Tandem mass spectrometric data were collected using the Data 
Directed Analysis method in MassLynx to fragment the top four ions in each survey scan. 
ProteinLynx (Waters) was used to process the mass spectral data into peak list files for 
analysis via Mascot (Matrix Science). Database searches were performed against the 
NCBI nonredundant database. 
Assay of Enzyme-Bound Fatty Acids  
LipM was purified from 2 L cultures with and without addition of triclosan by 
nickel affinity chromatography as described above. The eluates were twice dialyzed 
against 10 mM ammonium acetate first overnight and then again for 4 h. The dialysate 
was evaporated under a stream of nitrogen while being heated to 42 °C. A modification 
of previously described syntheses of fatty acid butyl esters was then conducted  
(Hallmann et al., 2008; Hermes et al., 2009). To each glass vial were added 500 μL of 
hexanes, 500 μL of butanol-BF3, and 100 μg of anhydrous magnesium sulfate. Heptanoic 
acid (10 μg) was added as an internal standard. Transesterification was conducted at 65 
°C for 2 h. Salts and butanol were removed by three extractions with water. Butyl esters 
were analyzed by gas chromatography and mass spectrometry (GC−MS) by a 
modification of the method of Hermes and Cronan (Green et al., 1995). 
Samples (5 μL) were injected in split-less mode into the GC−MS system that 
consisted of an Agilent (Palo Alto, CA) 7890A gas chromatograph, an Agilent 5975 mass 
selective detector, and an Agilent 7683B autosampler. Injections were performed on a 
30 m ZB-WAX column with a 0.32 mM inside diameter and a 0.25 mM film thickness 
(Phenomenex) with an injection port temperature of 230 °C, the interface set to 250 °C, 
and the ion source adjusted to 230 °C. The helium carrier gas was set at a constant flow 
rate of 3 mL/min. The temperature program consisted of isothermal heating at 90 °C for 
5 min followed by an oven temperature increase of 5 °C/min to 260 °C for 10 min. The 
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mass spectrometer was operated in positive electron impact mode (EI) at a 69.9 eV 
ionization energy in the m/z 30−800 scan range. The spectra of all chromatogram peaks 
were evaluated using HP Chemstation (Agilent) and AMDIS [National Institute of 
Standards and Technology (NIST), Gaithersburg, MD]. The spectra of all chromatogram 
peaks were compared with electron impact mass spectrum libraries NIST08 (NIST) and 
WILEY08 (Palisade Corp.). 
To determine the efficiency of esterification, I created octanoyl-LipM in vitro. 
AasS was used to generate octanoyl-ACP in the LipM reaction mixture. The 200 μL 
reaction mixtures contained 100 mM sodium phosphate (pH 7.0), 50 mM NaCl, 5 mM 
TCEP, 10 mM ATP, 10 mM MgCl2, 10 mM [
14C]octanoate, 50 μM holo-ACP, 5 μM AasS, 
and 5 μM LipM. After incubation at 37 °C for 2 h, the reaction mixture and the control 
reaction mixture without LipM were dialyzed. The proteins were dried, esterified, and 
analyzed by GC−MS as described above. 
Assay of LipM-Catalyzed Octanoyl Transfer  
The transfer of octanoate from octanoyl-ACP to GcvH was assayed using a 
coupled system in which AasS provided the octanoyl-ACP substrate. The 25 μL reaction 
mixtures contained 100 mM sodium phosphate (pH 7.0), 50 mM NaCl, 5 mM TCEP, 1 
mM ATP, 1 mM MgCl2, 250 μM [
14C]octanoate, 50 μM holo-ACP, 20 μM GcvH, 2 μM 
AasS, and 1 μM LipM. When formation of the acyl-enzyme intermediate was studied, 
the concentrations of wild type and mutant LipM proteins were increased to 10 μM. To 
test octanoyl-CoA as a LipM substrate, a coupled assay was also used. The 25 μL 
reaction mixtures contained 100 mM sodium phosphate (pH 7.0), 50 mM NaCl, 5 mM 
TCEP, 1 mM ATP, 1 mM MgCl2, 1 mM [
14C]octanoate, 50 μM trilithium CoA, 20 μM GcvH, 
0.1 unit of acyl-CoA synthetase (Pseudomonas sp. from Sigma), and 1 μM LipM. The 
reaction mixtures were incubated at 37 °C for 1 h and subjected to SDS−PAGE using a 
loading buffer that lacked reducing agents and 4 to 20% Tris-glycine gels. The gels were 
stained with Coomassie R-250, soaked in Amplify fluorographic reagent (GE Healthcare), 
and dried onto Whatman filter paper. Dried gels were exposed to Biomax XAR film 
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(Kodak) flashed with an Amersham Sensitize Preflash Unit (GE Healthcare)  (Laskey et 
al., 1975). The exposure period was 16−24 h at −80 °C. 
Isolation and Transfer of the Octanoyl Moiety of the Octanoyl-LipM Intermediate  
Synthesis of the octanoyl-LipM intermediate was conducted in a 500 μL assay 
containing 50 mM sodium phosphate (pH 7.0), 5 mM TCEP, 10 mM MgCl2, 10 mM ATP, 1 
mM [14C]octanoate, 0.1 mM holo-ACP, 2 μM AasS, and 10 μM LipM. The reaction 
mixture was incubated at 37 °C for 1 h. The product was diluted 10-fold in 25 mM Tris-
HCl (pH 8.0) and purified by anion exchange chromatography as described for LplA 
(Chapter 2). LipM eluted at 110 mM sodium chloride, the same point as apo-LipM. 
Fractions containing pure LipM were pooled, concentrated, and exchanged into 10 mM 
sodium phosphate (pH 7.0) using a Vivaspin concentrator (GE Healthcare). The mixture 
for the transfer from octanoyl-LipM to GcvH or holo-ACP contained 100 mM sodium 
phosphate (pH 7.0), 5 mM TCEP, 15 μM LipM, and either 20 μM GcvH or 20 μM holo-
ACP. The reaction mixtures were incubated at 37 °C for 1 h and visualized by SDS−PAGE 
and radiography as previously described for the LipM assay. 
Competition Assay Using CoA and ACP Octanoyl Thioesters  
LipM was assayed for its ability to utilize a mixture of octanoyl-ACP and octanoyl-
CoA in a competition assay similar to that described previously  (Hermes et al., 2009). 
The 100 μL reaction mixtures contained 10 mM sodium phosphate (pH 7.0), 100 mM 
sodium chloride, 5 mM TCEP, 250 μM [14C]octanoyl-CoA, 50 μM [3H]octanoyl-ACP, 100 
μM GcvH, 2 μM AasS, and 1 μM LipM. The reaction mixture was preincubated at 37 °C 
for 3 min before addition of LipM. After 30 min at 37 °C, the assay was stopped via 
addition of guanidine HCl to a final concentration of 5 M. The entire reaction mixture 
was applied to a Ni-NTA spin column (Qiagen) pre-equilibrated with 50 mM Tris-HCl (pH 
8.0) containing 4 M urea. The column was washed four times with 600 μL of the same 
buffer. Hexahistidine-tagged LipM and GcvH were eluted with 400 μL of the same buffer 
containing 500 mM imidazole. The eluate was diluted to 1 mL with water and mixed 
with 4 mL of Biosafe II scintillation cocktail. The mixture was subjected to scintillation 
counting using a Beckman LS 6500 instrument. The 3H and 14C isotopes were 
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differentially counted using channels 0−400 and 0−670, respectively. The 3H counts were 
adjusted by subtraction of 67% of the 14C counts for that sample, which was 
experimentally determined from six different amounts of [14C]octanoyl-CoA in the assay 
elution buffer. 
 
RESULTS 
Genetic Complementation of an E. coli lipB Strain  
Although amino acid homology is a useful tool for predicting function, the B. 
subtilis genome encoded no recognizable homologue of LipB. Therefore, to find the 
gene (s) responsible for the octanoyl transfer step of the B. subtilis lipoic acid synthetic 
pathway, I constructed a library of B. subtilis chromosomal fragments in a cosmid vector 
and used the resulting phage particles to transfect an E. coli lipB lplA double mutant 
strain. The lplA mutation was introduced into this strain to prevent possible bypass of 
the lipB mutation by LplA-catalyzed ligation of traces of intracellular octanoate or 
lipoate (Hermes et al., 2009). Glycerol was used as the carbon source to preclude bypass 
of succinate with acetate-dependent growth by fermentative metabolism. The B. subtilis 
genomic library contained a sufficient number of clones to cover 99.6% of the genome 
as calculated from the equation of Clarke and Carbon (Clarke et al., 1976). The eight 
cosmid clones that allowed growth of the lipB lplA strain carried overlapping fragments 
of the B. subtilis genome (Table 3-3) that contained a common region in which only a 
single candidate gene related to lipoic acid metabolism was found, the yqhM gene 
annotated as encoding a lipoate ligase. To test if yqhM was the gene responsible for 
complementation by the cosmid clones, the minimal gene was expressed from an 
arabinose inducible promoter. Expression of yqhM (or E. coli lipB or E. coli lplA) allowed 
growth of the lipB lplA double mutant strain, TM136 (Figure 3-1). Because the growth 
observed could be caused by either octanoyltransferase activity or high-level lipoyl 
ligase activity, I also expressed lipM in strain TM131, a lipA lplA strain, in the presence of 
lipoic acid. Expression of yqhM (or E. coli lipB) failed to allow growth of this strain, 
whereas expression of the E. coli lplA gene resulted in robust growth. Therefore, despite 
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its sequence similarity to E. coli LplA (Figures 3-8 and 3-9), YqhM lacks lipoate ligase 
activity and instead has octanoyltransferase activity (Figure 3-1). Therefore, I have 
renamed yqhM as lipM. 
Purification of GcvH  
To provide a substrate for in vitro studies of LipM, I purified the putative glycine 
cleavage H protein (GcvH) of B. subtilis 168 in its apo form from an E. coli strain deficient 
in lipoic acid biosynthesis. The pure protein formed a doublet when analyzed by 
SDS−PAGE (Figure 3-2A), but electrospray mass spectrometry gave a major peak at 
14944.2 amu (Figure 3-2B). This is 1.2 amu lower than that theoretically predicted, 
which I attribute to deamidation of the protein (which results in a negligible mass 
difference) perhaps at N73 which should be unusually labile because it is followed by a 
glycine residue (Jordan et al., 1997; Robinson et al., 2001). Deamidation of other LDs has 
been observed and does not affect modification  (Jordan et al., 1997). Note that GcvH 
migrates aberrantly during SDS−PAGE analysis (Figure 3-2A). It runs as though it is twice 
its actual size of 14.1 kDa. Such slow migration rates are often seen with small, very 
acidic proteins (GcvH has a calculated pI of 3.9) and can be attributed to an abnormally 
low level of SDS binding. 
Modification of LipM and Purification of the Apoprotein  
To directly test LipM for octanoyltransferase activity, I purified the protein 
obtained after high-level expression in E. coli, and it appeared homogeneous by 
SDS−PAGE (Figure 3-2A) and size exclusion chromatography, where it eluted as a 14 kDa 
protein mainly in the monomeric form with a variable small secondary peak that may be 
a multimer (Figure 3-2D). However, the protein obtained in the initial purifications of 
LipM was inactive and had an average molecular weight of 33338 ± 32 amu (five 
measurements), a value 143 amu greater than the expected value, which suggested that 
the protein had been post-translationally modified [the initiator methionine was 
retained as expected from the specificity of E. coli methionine aminopeptidase (Frottin 
et al., 2006; Xiao et al., 2010)]. However, LipM gave rather imprecise MALDI mass 
spectra that may have resulted from a combination of a heterogeneous set of 
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modifications and the smoothed and averaged data generated by the spectrometer 
(Figure 3-2C). To determine if the protein was post-translationally modified, I digested 
LipM with trypsin and subjected the resulting peptides to liquid 
chromatography−tandem mass spectrometry analysis. I found evidence of a series of 
modified peptides that had overlapping sequences and all contained residue C150. In 
some LipM molecules the predicted C150 modification was an octanoyl thioester, 
whereas in others a decanoyl adduct was present (Figure 3-3). By analogy to LipB, these 
data suggested that C150 is the LipM active site nucleophile and the octanoyl thioester 
modification is the acyl-enzyme intermediate (Zhao et al., 2005). 
The decanoyl adduct was previously found as a modification of M. tuberculosis 
LipB when the protein was expressed in E. coli, but not when expressed in a 
mycobacterium (Ma et al., 2006). In that work, it was proposed (albeit, not proven) that 
the M. tuberculosis LipB decanoic acid adduct arose by binding cis-3-decenoyl-ACP, a 
key intermediate in E. coli fatty acid biosynthesis by LipB, followed by Michael addition 
of the active site cysteine thiol to the double bond resulting in a thioether link to C-3 of 
the acyl chain. Because like M. tuberculosis, the B. subtilis unsaturated fatty acid 
synthetic pathway differs from that of E. coli, it seemed likely that in both cases the 
octanoyltransferase would accidently bind cis-3-decenoyl-ACP and the decanoyl adduct 
would form. To prevent the formation of a decanoyl adduct, I expressed LipM in an E. 
coli fabA mutant strain. This strain lacked the ability to make cis-3-decenoyl-ACP (hence 
unsaturated fatty acids), and therefore, growth of the strain required supplementation 
of the medium with an unsaturated fatty acid such as oleic acid (Henry et al., 1992). 
To reduce the level of the octanoyl-enzyme intermediate, I added triclosan, an 
inhibitor of fatty acid biosynthesis (McMurry et al., 1998), to the medium during LipM 
expression. I determined the levels of LipM with bound octanoate by GC−MS of butyl 
esters using an octanoyl-LipM standard prepared in vitro. Using this standard, a recovery 
efficiency of 93% based on complete conversion of LipM to octanoyl-LipM was found, 
which is within the expected efficiency for esterification (Hallmann et al., 2008). This 
method showed that the addition of triclosan resulted in a significant reduction in the 
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level of the octanoyl-enzyme intermediate (Figure 3-4), and thus by addition of triclosan 
and use of the fabA strain, I obtained LipM in a largely unmodified and active form. 
In vitro Demonstration of LipM Activity  
I employed the AasS acyl-ACP synthetase to generate acyl-ACPs in the LipM assay 
mixture and found that the transfer of the octanoyl group from octanoyl-ACP to B. 
subtilis GcvH occurred in a LipM-dependent manner (Figure 3-5). In the absence of the 
GcvH acceptor protein, LipB was converted to the octanoyl-enzyme intermediate. The 
octanoyl-LipM species was purified and shown to transfer the octanoyl moiety to either 
GcvH in the forward reaction or ACP in the reverse reaction, as expected of a 
catalytically competent intermediate. Because of the lengthy time of incubation, I 
expect that the relative levels of transfer in the forward and reverse directions reflect 
the equilibria of the transfer reactions. I also tested octanoyl-CoA as an octanoyl donor 
by using acyl-CoA synthetase to generate the substrate in the reaction mix. This system 
was used to demonstrate that LipM also uses octanoyl-CoA as a substrate, albeit poorly 
(Figure 3-6). This is not unexpected as CoA is a substrate mimic of ACP. To determine 
which of the substrates LipM preferred, I performed a double-label experiment with 
equal concentrations of octanoyl-CoA and octanoyl-ACP differentially labeled in the 
octanoyl moiety. Octanoyl-ACP was much the preferred substrate for modification of 
GcvH, although some modification caused by transfer from octanoyl-CoA was observed 
(Figure 3-6). 
C150 and K165 Are Key LipM Catalytic Residues  
I constructed point mutations in lipM to test the importance of the predicted 
active site residues. The residues mutated were the Cys found to be modified by LC-
MS/MS (LipM C150), and the conserved lysine found in all members of PF03099 (LipM 
K165) (Reche,2000). Mutation C150A or C150S resulted in loss of the overall catalytic 
activity and an inability to form the acyl-enzyme intermediate; the K165A mutant had 
weakened catalytic ability, and the K165R mutant remained active under these 
conditions (Figure 3-5C). 
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Bioinformatic Analysis of LipM  
Phylogenetic analysis of LipM and proteins with a high degree of sequence 
similarity revealed that these proteins form a clade distinct from other functional groups 
of related enzymes, as well as being distinct from LipB type octanoyltransferases 
(Figures 3-7 and 3-8). This suggests that other members of the LipM clade are also 
octanoyltransferases. The LipM clade groups with lipoate protein ligases with 73% 
bootstrap support, which is considered significant  (Hillis et al., 1993). This means that 
LipMs are closely related to LplAs and likely share a more recent ancestor with LplAs 
than with any other group of proteins, consistent with the current incorrect annotation 
of LipM as a lipoate protein ligase. 
Close homologues of LipM are found in firmicutes and cyanobacteria (Figure 3-
8). Although, relative to LipB, the cyanobacterial LipMs form a separate clade from 
firmicute LipMs, they have a similar insertion that contains the active site cysteine as in 
B. subtilis LipM. This and the high degree of amino acid sequence similarity (~50%) 
suggest that the cyanobacterial LipMs are octanoyltransferases. The cyanobacteria also 
encode a putative LipB type octanoyltransferase that (if both enzymes are active) would 
give these bacteria a pair of octanoyltransferase isozymes. The presence of two 
isozymes in cyanobacteria suggests that there may be a physiological difference 
between the two enzymes within at least these organisms. Further work is necessary to 
determine if there are physiologically relevant differences between the LipB and LipM 
types of octanoyltransferase. 
Using the SEED subsystem database (Overbeek et al., 2005), I found that 
firmicutes and cyanobacteria also encode putative lipoyl synthases, and thus, the sulfur 
insertion enzyme seems to be present. Moreover, the SEED database shows that 
putative firmicute lipM genes are functionally coupled to the glycine cleavage system; 
lipM is very often found adjacent to genes encoding putative glycine cleavage system P 
and T proteins. The covariance with putative LipA homologues and the functional 
coupling with the glycine cleavage system provide further indications that these LipM 
homologues are involved in lipoic acid biosynthesis. 
64 
 
 
DISCUSSION 
Using an approach unbiased by bioinformatics, I have identified a B. subtilis gene 
encoding a new type of octanoyltransferase. Our isolation of lipM on eight different 
cosmid clones suggests that it is the only B. subtilis 168 gene able to complement E. coli 
lipB, although this suggestion must be tested by genetic analyses. A B. subtilis strain 
lacking LipM activity should be a lipoate auxotroph assuming that the yhfJ gene encodes 
a lipoate ligase (Hermes et al., 2009). I and others have found that overproduction of E. 
coli lplA complements lipB null mutants (Figure 3-1) (Morris et al., 1994; Hermes et al., 
2009), and thus, I would expect to have also isolated the yhfJ gene. However, this was 
not the case. The most straightforward explanation for this result was that the level of 
yhfJ expression was insufficient to restore growth under our experimental conditions. 
Either high-level expression of wild type lplA or normal expression of an LplA mutant 
protein having increased octanoate affinity is required for lipB complementation (Figure 
3-1) (Hermes et al., 2009). Other possibilities are that our library is biased and lacked 
yhfJ clones and that yhfJ does not encode a lipoate ligase. I favor the biased library 
explanation because this would be consistent with the unexpectedly frequent isolation 
of LipM clones. Library bias due to gene toxicity is a known problem with B. subtilis 
genomic DNA libraries in E. coli and was even seen with a chromosomally integrated 
library (Ferrari et al., 1981). Although I used a vector with a single-copy F factor 
replication origin vector, basal expression from the second trfA-dependent replication 
origin (Wild et al., 2002) may also have been an issue. Indeed, growth of most isolates of 
our cosmid library was much better on glycerol or glucose minimal medium than on 
medium containing arabinose (data not shown), which would induce trfA expression 
resulting in greatly increased plasmid copy numbers (Wild et al., 2002). 
Upon purification of LipM, I found that the average mass determined by MALDI 
was greater than that calculated from the amino acid sequence, and this, and the 
precedent of the M. tuberculosis LipB decanoic acid adduct (Ma et al., 2006), strongly 
suggested that the protein was modified. Analysis of the LipM tryptic peptides indicated 
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that both the decanoic acid adduct and the octanoyl-LipM intermediate were present in 
these preparations. The level of octanoyl-enzyme intermediate was significantly 
decreased by addition of the fatty acid synthesis inhibitor, triclosan (which inhibits FabI, 
the enzyme responsible for the last step of the fatty acid synthesis cycle), during LipM 
expression. The uncertainties of peptide ionization efficiencies precluded quantitation 
of the levels of octanoylation by analysis of tryptic peptides, and thus, I developed a 
method for directly detecting the octanoyl groups as their butyl esters, a derivative that 
allows efficient recovery of short chain volatile acids such as octanoate (Hermes et al., 
2009). To the best of our knowledge, this is the first time this method has been adapted 
for quantification of a protein modification. 
Despite their marked differences in sequence, the LipM and LipB 
octanoyltransferases share the same general catalytic mechanism. The octanoyl moiety 
is transferred from octanoyl-ACP to the enzyme active site cysteine thiol to give the 
octanoyl-enzyme intermediate, the thioester bond of which is attacked by the ε-amino 
group of the LD lysine residue to give octanoyl-LD. The octanoyl moiety can also be 
transferred from the acyl enzyme intermediate back to ACP. However, the results of 
mutagenesis studies distinguish the detailed LipM mechanism from that of LipB. 
Although loss of the active site thiol by substitution of the cysteine residue with alanine 
or serine results in inactivation of both enzymes, the E. coli LipB C169A protein performs 
dead-end acylation of the enzyme (Zhao et al., 2005), whereas LipM C150A does not. 
Moreover, the LipB C169S protein forms a dead-end octanoyl ester (Zhao et al., 2005), 
whereas LipM C150S does not. This may simply be a result of the different environments 
of the active site nucleophile, or it may reflect a physiologically relevant mechanism for 
imparting resistance against self-inactivation to LipM. The members of the PF03099 
enzyme family have a strictly conserved lysine residue, the only totally conserved 
residue of the protein family (Reche,2000). Loss of the charge of the conserved lysine 
side chain inactivates M. tuberculosis LipB (Ma et al., 2006), whereas the LipM mutant 
protein retained some activity (Figure 3-6). From the available structures of LplA and 
LipB proteins, it appears that this residue is near the reactive carbonyl of the substrate. 
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This suggests it is important for stabilization of the oxyanion, as is the case in the 
mononucleotide binding fold (Schulz,1992). Other positively charged lysine and arginine 
side chains are in the vicinity of K165, which may explain why the LipM K165A mutant 
retains trace activity. The activity of the LipM K165R protein supports this notion 
because substitution of the longer positively charged side chain results in a protein with 
activity similar to that of the wild type protein. 
It is interesting that LipM and LipB, together with the LplA-LplB bipartite lipoate 
ligase (Hermes et al., 2009), share the property of anomalous migration in size exclusion 
chromatography. The three proteins all migrate as though they are approximately half 
of their known sizes. LipM elutes as a 14 kDa protein, whereas E. coli LipB elutes as 
though it were a 10 kDa protein (Chapter 2)(Nesbitt et al., 2005). The most 
straightforward explanation of this unusual behavior is that these proteins interact with 
the chromatographic matrix within the bead and thus emerge from the matrix more 
slowly than expected [this behavior is independent of the salt concentration of the 
eluate (Nesbitt et al., 2005). Given these data, it seems likely that both LipM and LipB 
are monomeric proteins, although confirmatory data obtained by another method (e.g., 
analytical ultracentrifugation) are clearly needed. 
As discussed above, LipB octanoyltransferases and LplA lipoate protein ligases 
have similar structures and together with the biotin protein ligases make up the 
divergent enzyme family PF03099. The LipM type of octanoyltransferase provides a 
bridge between the LipB and LplA proteins, in that LipM has the activity of LipB but an 
amino acid sequence that resembles that of LplA. Although LipM is homologous with E. 
coli LplA in terms of sequence, it is a considerably shorter protein. The characterized 
LipB octanoyltransferases are composed of a single domain, whereas canonical lipoate 
protein ligases possess a catalytic domain of a size similar to that of LipB with a C-
terminal accessory domain. Because nearly half of the sequences in the LplA subfamily 
contain only a single catalytic domain (Chapter 2), it is tempting to designate all of these 
“short LplAs” as octanoyltransferases. However, the accessory domain can also be a 
separate protein as recently demonstrated for the Thermoplasma acidophilum lipoate 
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ligase (Chapter 2) (Posner et al., 2009). Although the absence of an accessory domain 
indicates that the short proteins annotated as lipoate ligases lack lipoyl ligase activity 
(Chapter 2), for any given protein it remains possible that the protein is inactive because 
of the loss of its accessory domain protein. In the known case of a bipartite lipoate 
ligase, the accessory protein is encoded by a gene adjacent to the LplA homologue 
(Chapter 2). However, there is no reason that this must be the case (although it could 
simplify stoichiometric expression of the subunits). Indeed, there are putative bipartite 
ligases encoded by genes located far apart in the genome, such as in Pyrococcus furiosus 
(Chapter 2). 
The distinct phylogeny of LipM proteins should allow more correct prediction 
and annotation of genes currently annotated as encoding short lipoyl ligases. Because 
the octanoyltransferases and lipoate ligases perform different chemistry, 
octanoyltransferases and ligases could be distinguished by the octanoyltransferase 
active site cysteine and the neighboring residues. However, the residues that flank the 
active site cysteine residues of LipM and LipB show no similarity. Indeed, relative to 
LipB, the C150 region of LipM seems to reside on an inserted loop (Figure 3-7). As such, 
they are different octanoyltransferase types and must be considered separately. 
The LipM and LipB octanoyltransferases can be added to the list of enzymes that 
have undergone convergent evolution functionally and mechanistically (Doolittle, 1994; 
Omelchenko et al., 2010). As previously stated, these enzymes come from the same 
family and have a similar protein fold. Despite this, they have distinct primary structures 
indicating divergence at the sequence level. Therefore, it appears that 
octanoyltransferase activity has evolved from the same protein scaffold by two different 
paths. This highlights the multitude of evolutionary outcomes that are possible, which 
explains the rarity of true convergent evolution at the sequence level (Doolittle ,1994). 
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Table 3-1. Strains used in this chapter. 
strain relevant characteristics source 
MG1655 rph-1 CGSC* 
W3110 rph-1 IN (rrnD-rrnE) CGSC* 
JK1 rpsL8 (Morris et al., 1995) 
168 trpC2 BGSC* 
EPI300 recA1 endA1 araD139 Δ (ara, leu)7697 λ- rpsL (StrR) trfA dhfr Epicenter 
MC1061 recA1 araD139 Δ (araA-leu)7697 Δ (codB-lacI)3 λ- e14- rpsL150 
(Str) hsdR2 
  
TM136 rpsL lipB::Tn1000 lplA::Tn10  (Morris et al., 1995) 
TM131 rpsL lipA::Tn1000 lplA::Tn10  (Morris et al., 1995) 
Acella DE3 ompT hsdSB (rB- mB-) gal dcm (DE3) ΔendA ΔrecA EdgeBio 
MFH120 JC7623 lacZΔM15 Δ (fabA-lacZ)1 (Hyb)cat fadAB poxB::pMFH23 
(fabA
+
) 
 (Henry et al., 1992) 
ZX221 rpsL8 ΔlipB::FRT::cat (Chapter 2) 
QC144 rph-1 ΔlplA::FRT::aph (Chapter 2) 
QC146 rph-1 ΔlplA::FRT ΔlipB::FRT (Chapter 2) 
QC038 rpsL lipA::Tn1000 lplA::Tn10/pBAD322G (Chapter 2) 
QC035 rpsL/pBAD322G (Chapter 2) 
EMM99 E. coli BL21 (DE3)/pEM88 (Martinez et al., 2010) 
QC032 rpsL lipB::Tn1000 lplA::Tn10/pQC004 This chapter 
QC034 rpsL lipB::Tn1000 lplA::Tn10/pQC006 This chapter 
QC036 rpsL lipB::Tn1000 lplA::Tn10/pQC007 This chapter 
QC057 rpsL lipB::Tn1000 lplA::Tn10/pBAD322G This chapter 
QC067 EPI300 ΔlplA::FRT::aph/pEAK2 This chapter 
QC068 EPI300 ΔlplA::FRT::aphΔlipB::FRT::cat This chapter 
QC069 EPI300 ΔlplA::FRT ΔlipB::FRT This chapter 
QC087 rpsL lipA::Tn1000 lplA::Tn10/pQC004 This chapter 
QC088 rpsL lipA::Tn1000 lplA::Tn10/pQC006 This chapter 
QC089 rpsL lipA::Tn1000 lplA::Tn10/pQC007 This chapter 
QC097 Acella DE3/pQC015 This chapter 
QC101 EPI300 ΔlplA::FRT ΔlipB::FRT/pQC039 This chapter 
QC111 EPI300/pCC1FOS This chapter 
QC112 EPI300 ΔlplA::FRT ΔlipB::FRT/pCC1FOS This chapter 
QC134 rph-1 IN (rrnD-rrnE)1 DE (fabA-lacZ)1 (Hyb)cat This chapter 
QC142 rph-1 IN (rrnD-rrnE)1 DE (fabA-lacZ)1 (Hyb)cat/pCY598, pQC015 This chapter 
QC161 rph-1 ΔlplA::FRT ΔlipB::FRT/pQC057, pTARA This chapter 
*CGSC, The Coli Genetic Stock Center. BGSC, The Bacillus Genetic Stock Center. 
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Table 3-2. Plasmids Used in this chapter. 
plasmid relevant characteristics  source 
pBAD322G arabinose inducible expression vector (Cronan, 2006) 
pTARA pACYC origin, arabinose inducible T7 polymerase (Wycuff et al., 2000) 
pCC1Fos cosmid cloning vector Epicenter 
pCY598 RSF origin, arabinose inducible T7 polymerase (Cronan,2003) 
pET30b+ Kn, T7 promoter expression vector Novagen 
pET101TOPO T7 promoter expression vector Invitrogen 
pCR2.1 TOPO TA cloning vector Invitrogen 
pEAK2 Ts recA expression plasmid (Kouzminova et al., 2004) 
pSJ112 E. coli lipB expression plasmid (Jordan et al., 2003) 
pNRD136 sfp expression plasmid (De Lay et al., 2007) 
pMM88 B. subtilis acpP expression plasmid (Martinez et al., 2010) 
pQC004 B. subtilis 168 yqhM This chapter 
pQC006 E. coli lipB This chapter 
pQC007 E. coli lplA This chapter 
pQC015 B. subtilis 168 N-terminally hexahistidine-tagged yqhM This chapter 
pQC036 B. subtilis gcvH C-terminally hexahistidine tagged This chapter 
pQC039 cosmid carrying B. subtilis 168 (2538341..2570341) 
containing yqhM 
This chapter 
pQC057 B. subtilis 168 gcvH C-terminally hexahistidine-tagged This chapter 
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Table 3-3. Oligonucleotides used in this chapter. 
primer sequence 
Q005 TAAGAATTCACCATGCAAAAAGAAACTTGGCG 
Q006 TACGTCTAGAATCTTCCATACTTGGTGTTGTC 
Q022 CACCATGCATCATCATCATCATCATATGCAAAAAGAAACTTGGCG 
Q023 CCATTACAAGTTTACACTAATGAACTTG 
Q044 ACATGTCCACATTACGCCTGCT 
Q046 CGGCAAATCGAAGAGAAAGTT 
Q047 CATATGAGCATACCAAAAGATTTGCG 
Q048 TTAATGATGATGATGATGATGGTCTTCTTGTGTCATCTCTTCGTATTG 
Q051 CACCTAAATAGCTTGGCG 
Q053 TGCAGGTCGACTCTAGAG 
Q133 GGTTGAGGGGCGCGCGGTGGCGGGAAGC 
Q134 GCTTCCCGCCACCGCGCGCCCCTCAACC 
Q135 GTGGTTGAGGGGCGCCGTGTGGCGGGAAGCGCG 
Q136 CGCGCTTCCCGCCACACGGCGCCCCTCAACCAC 
Q137 TCCGCGGTCATCTGTTGCTTTTGACGCGCCTTCG 
Q138 CGAAGGCGCGTCAAAAGCAACAGATGACCGCGGA 
Q139 CGCGGTCATCTGTTTCTTTTGACGCGCCTTC 
Q140 GAAGGCGCGTCAAAAGAAACAGATGACCGCG 
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FIGURES 
 
 
 
Figure 3-1. Complementation of E. coli lipoic acid auxotrophs. Growth curves of lipoic 
acid auxotrophs carrying various plasmids are shown. Panel A: Growth tests for lipB 
complementation in minimal glycerol medium. Growth curves of the wild type (WT) and 
lipB lplA strains with the empty pCC1FOS vector are shown. Cosmid isolate 1 (Cos1) or 
pQC039 was also tested in the lipB lplA strain. Panel B: Growth tests for lipB 
complementation in minimal arabinose medium. Growth curves for the WT and lipB lplA 
strains carrying empty vector pBAD322G are shown. Plasmids carrying the indicated 
genes were tested in a lipB lplA strain for their abilities to support growth. Panel C: 
Growth tests for lplA complementation in minimal arabinose medium containing lipoic 
acid. The WT and lipA lplA strains carrying empty vector pBAD322G are shown. Plasmids 
carrying the indicated genes were tested in a lipA lplA strain for their abilities to support 
growth. Growth was measured by optical density. Panels B and C have the same color 
code. 
72 
 
 
 
 
Figure 3-2. Analysis of purified proteins. Panel A: SDS−PAGE of 0.2 μMol of purified LipM 
and 0.2 μMol of purified GcvH. Molecular mass standards are indicated in kilodaltons. 
Panel B: Electrospray ionization mass spectrum of GcvH. Calculated masses are 
represented by black circles. Panel C: MALDI mass spectra of purified LipM preparations. 
LipM− denotes the enzyme purified from cells of a wild type strain grown without 
triclosan or oleate, whereas LipM+ denotes the enzyme purified from cells of a ΔfabA 
strain grown with triclosan and oleate. The peak mass values for the LipM− and LipM+ 
proteins were 33300 and 33179, respectively. Panel D: Size exclusion chromatogram of 
LipM (the absorbance at 280 nm is plotted). The elution positions of chymotrypsinogen 
and ribonuclease A are designated by a triangle and a circle, respectively. 
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Figure 3-3. Liquid chromatography−tandem mass spectrometric analysis of LipM tryptic 
peptides. Panel A: Modification states of C150 detected. The theoretical peptides are 
shown with C150 in bold and underlined. The difference in mass from the modification 
is listed. The ion score is equal to −10 log (P), where P is the probability the result is 
random chance. Panel B: Sequence coverage of LipM. The LipM peptide sequences 
detected are shown in bold. 
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Figure 3-4. Gas chromatography−mass spectrometric analysis of LipM-bound octanoate. 
LipM-bound octanoyl moieties were assayed by transesterification to the butyl esters 
followed by GC−MS analysis. Panel A: The values are the molar percentages of octanoic 
acid per LipM preparation. The gray bar is for cultures without triclosan added (LipM), 
whereas the white bar is for cultures with triclosan added (LipM+). The error bars 
represent one standard deviation for LipM preparations from three independent 
cultures. Both purifications were from a ΔfabA strain. Panel B: Representative gas 
chromatogram of a LipM preparation. The butyl heptanoate internal standard and the 
analyte, butyl octanoate, are indicated. Panel C: Mass spectrum of the butyl octanoate 
from a LipM preparation. 
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Figure 3-5. Octanoyltransferase activities of wild type and mutant LipM proteins. Assay 
of the transfer of the octanoyl group from octanoyl-ACP to B. subtilis GcvH octanoyl-ACP 
as the substrate. Autoradiograms of dried SDS−PAGE gels are shown. Panel A: The [1-
14C]octanoyl-ACP was synthesized via AasS added to the reaction mixture. Synthesis of 
octanoyl-ACP required AasS, ATP, and holo-ACP, whereas formation of octanoyl-GcvH 
required apo-GcvH, LipM, and octanoyl-ACP. Panel B: Transfer of octanoate from 
purified [1-14C]octanoyl-LipM to an equimolar amount of either GcvH or holo-ACP as 
indicated. Panel C: Same assay mixture from panel A with 10-fold more LipM or mutant 
LipM proteins added to allow detection of the octanoyl-LipM intermediate: lane NE, no 
enzyme; lane KR, LipM K165R; lane KA, LipM K165A; lane CA, LipM C150A; lane CS, LipM 
C150S; and lane WT, wild type LipM. Panel D: Reaction as in lane 6 of panel A conducted 
with octanoate in place of [1-14C]octanoate. After incubation, GcvH was recovered from 
the reaction mixture by Ni2+ cheleate chromatography and analyzed by electrospray 
ionization mass spectrometry. The mass obtained was 15072.4 amu, a value 128.2 amu 
greater than that of the apoprotein (Figure 3-2) and in good agreement with the 
octanoyl moiety mass (126.2 amu). 
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Figure 3-6. Comparison of the octanoyl thioesters of ACP and CoA as LipM substrates. 
Assays of the transfer of the octanoyl group to B. subtilis GcvH using either octanoyl-CoA 
or octanoyl-ACP. Page A: Autoradiograms of dried SDS−PAGE gels are shown. [1-
14C]octanoate was converted to [1-14C]octanoyl-ACP or [1-14C]octanoyl-CoA by AasS or 
acyl-CoA synthetase (AcsA), respectively. The presence (+) or absence (−) of LipM is 
indicated. Page B: Double-label experiment with a mixture of purified [1-14C]octanoate-
CoA and purified [3H]octanoyl-ACP. The substrates were [1-14C]octanoate-CoA (column 
1), an equimolar mixture of both substrates (column 2), and [3H]octanoyl-ACP (column 
3). The error bars represent one standard deviation from six independent assays. 
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Figure 3-7. Alignment of LipM with enzymatically characterized LipB and LplA proteins. 
The alignment was performed as described in materials and methods and displayed 
using Jalview (Waterhouse et al., 2009). The sequence name indicates the enzyme type; 
the Uniprot code indicates the organism of origin, and the numbers indicate the amino 
acid residues displayed. Positions that are ≥50% similar are highlighted in gray. The 
catalytic cysteine residues of the octanoyltransferases are boxed and highlighted in 
black, as is the conserved PF03099 lysine residue. 
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Figure 3-8. Phylogeny of LipM. The minimum evolution tree of selected PF03099 protein 
sequences with bootstrap percentage confidence values shown for each branch is given. 
Phylogenetic analyses were conducted as described in Materials and Methods. The scale 
bar corresponds to a 20% difference in compared residues, on average, per branch 
length. Biotin protein ligase sequences were used as a related out-group to compare 
lipoate protein ligases, LipB octanoyltransferases, and LipM octanoyltransferases. 
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CHAPTER 4 
A NOVEL TWO-GENE REQUIREMENT FOR THE OCTANOYLTRANSFER REACTION OF 
BACILLUS SUBTILIS LIPOIC ACID BIOSYNTHESIS 
 
INTRODUCTION 
Homologues of the E. coli lipoic acid metabolism proteins are found in all 
domains of life, and thus unraveling the pathways by which this cofactor is synthesized 
and transferred to lipoate-dependent proteins is of broad biological significance. In 
contrast to the wealth of knowledge available on lipoic acid synthesis and utilization in 
E. coli, the existing information about these pathways in Gram-positive bacteria is 
fragmentary. It has been found that Listeria monocytogenes defective in proteins 
homologous to the E. coli LplA enzymes are unable to scavenge lipoic acid for 
modification of lipoyl domains (Keeney et al., 2007). However, L. monocytogenes is a 
natural lipoate auxotroph and does not encode the enzymes necessary for lipoic acid 
biosynthesis. Lipoic acid synthesis and attachment to target proteins is less understood 
in other organisms. Despite the presence of homologues to the E. coli enzymes in fungi, 
plants, protists and mammals, the mechanistic details of lipoic acid synthesis still remain 
unclear.  
Since B. subtilis cells grown on minimal media were known to contain essential 
lipoate-modified proteins, this bacterium must synthesize lipoic acid, and this was 
confirmed by demonstration of a functional lipoyl synthase (Martin et al., 2009). 
Moreover, the lipoate requirement of B. subtilis ΔlipA strains for growth in minimal 
medium was bypassed by addition of acetate and a mixture of three short-branched-
chain carboxylic acids: 2-methyl butyrate, isobutyrate, and isovalerate, metabolites that 
yield the products of two lipoylated enzymes, PDH and BKDH (acetate utilization is 
mediated by acetyl-CoA synthetase, the product of the acs gene, while an unknown 
enzyme converts the carboxylic acids to their CoA esters in vivo). Succinate 
supplementation to bypass the OGDH deficiency engendered by lipoic acid starvation 
was not required (Martin et al., 2009).  
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However, despite the presence of a functional LipA, the B. subtilis genome 
contained no open reading frame (ORF) that resembled the E. coli LipB 
octanoyltransferase, an activity required for production of the substrate for LipA. 
Recently, an LplA homologue named LipM was identified and shown to have 
octanoyltransferase activity in vitro (Chapter 3). We began the present study due to 
paucity of information on lipoic acid biosynthesis in Gram-positive bacteria.  Although 
LipM together with LipA should be sufficient for lipoic acid biosynthesis, the only in vivo 
analyses reported were performed in E. coli (Martin et al., 2009) (Chapter 3). Moreover, 
the additional uncharacterized LplA homologues encoded in the genome suggested that 
B. subtilis lipoic acid metabolism may be more complex than in E. coli, and we have 
found that this is the case. Natalia Martin, a collaborating graduate student in the 
laboratory of Diego de Mendoza, has now tested the role of LipM in B. subtilis and 
confirmed its proposed role as octanoyltransferase in vivo. Martin shows in this chapter 
that a lipM mutant is a lipoic acid auxotroph. In addition to lipM, the B. subtilis genome 
contains two ORFs, yhfJ and ywfL, which encode proteins having significant sequence 
similarity to characterized lipoyl ligases. In this chapter Martin and I show that these 
genes are involved in lipoic acid metabolism (see below), so we have renamed yhfJ as 
lplJ and ywfL as lipL.  These genes have been characterized by genetic, physiological and 
biochemical analyses 
 
EXPERIMENTAL PROCEDURES 
Bacterial Strains and Growth Conditions  
Bacterial strains used in the present study are listed in Table 4-1. E. coli and B. 
subtilis strains were routinely grown in Luria Bertani (LB) broth  (Sambrook et al., 2001). 
Spizizen salts  (Spizizen,1958), supplemented with 0.5% glucose, trace elements and 
0.01% each of tryptophan and phenylalanine were used as the minimal medium for B. 
subtilis. Different supplements added as needed were 0.5 mM DL-α-lipoic acid, 10 mM 
sodium acetate and 0.1 mM each BCFA precursor (isobutyric acid, isovaleric acid and 2-
methylbutiric acid). For the experiments involving gene expression under the control of 
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the xylose-inducible promoter (PxylA), 0.5% glycerol was used as a carbon source 
instead of glucose. Xylose was added to 0.1% as required. Antibiotics were added to 
media at the following concentrations (in µg ml-1) sodium ampicillin (Amp), 100; 
chloramphenicol (Cm), 5; kanamycin sulfate (Km), 5 and spectinomycin sulfate (Sp), 50. 
Genetic Techniques  
E. coli competent cells were transformed with supercoiled plasmid DNA using 
the calcium chloride procedure  (Sambrook et al., 2001).  Transformation of B. subtilis 
was carried out by the method of Dubnau and Davidoff-Abelson  (Dubnau et al., 1971). 
The amy phenotype was assayed with colonies grown for 48 h in LB starch plates by 
flooding the plates with 1% I2-KI solution  (Sekiguchi et al., 1975).  Under these 
conditions amy positive colonies produced a clear halo, whereas Δamy colonies gave no 
halo. 
Plasmids and Strains Construction 
Plamids used in this chapter are listed in Table 4-2. In all cases DNA fragments 
were obtained by PCR using the oligonucleotides described in Table 4-3. Chromosomal 
DNA from wild type B. subtilis was used as a template. Sequencing corroborated the 
identity and correct sequence of all the cloned fragments. Bacillus mutants were 
constructed by Natalia Martin.  
A strain with a deletion of the yqhM (lipM) gene was constructed by gene 
replacement with a kanamycin resistance determinant, through a double crossover 
event. For this purpose a 571 bp fragment, corresponding to the 5’ end of lipM and the 
upstream gene was PCR amplified with primers I and II and cloned into SacI and XbaI 
sites of plasmid pJM114  (Perego,1993). A 525 bp fragment containing the 3’ end of lipM 
and part of the downstream gene was PCR amplified with primers VII and VIII and 
cloned into SacI and XbaI sites of the previously generated plasmid. The plasmid 
obtained pNM07, was linearized with ScaI and used to transform strain JH642. 
Transformants were selected for kanamycin resistance. The resulting strain was named 
NM57.  
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An yhfJ (lplJ) knock out mutant was constructed as follows. A 520 bp fragment of 
the 5’ end of lplJ plus upstream sequences was PCR amplified using oligonucleotides V 
and VI and cloned into the XbaI site of vector pJM134 (M. Perego, unpublished) 
orientation of this insert was checked by restriction enzyme digestion with EcoRI and 
PstI.  Afterwards, a 516 bp  fragment of the 3’ end of lplJ and downstream region was 
PCR amplified using oligonucleotides XI and XII and inserted into the SalI and XhoI sites 
of that plasmid to give pNM48. Strain JH642 was transformed with pNM48 linearized 
with PvuII, yielding strain NM60. 
To construct a strain containing a deletion mutation in ywfL (lipL) gene a 552 bp 
fragment of the 5’end of lipL plus upstream gene sequences was PCR amplified with 
oligonucleotides III and IV and inserted between the SacI and SmaI sites of plasmid 
pJM134 (M. Perego, personal communication). Then, a 581 bp fragment containing the 
3’ end of lipL and part of the downstream gene was PCR amplified using 
oligonucleotides IX and X and inserted between the HindIII and KpnI sites of the 
previously generated plasmid to render plasmid pNM03. Plasmid pNM03 was linearized 
with ScaI and used to transform strain JH642. The resulting strain was named NM51.  It 
should be noted that essentially the entire coding sequences of the lipM, lipL and lplJ 
genes were removed in construction of the deletion strains.  
Strain CM28 was constructed by transformation of strain NM57 with plasmid 
pNM03 previously linearized with ScaI. Plasmid pNM07 was linearized with ScaI and was 
used to transform strain NM60, rendering strain NM65. To construct strain NM67 the 
spectinomycin resistant cassette from pNM03 was replaced by a kanamycin resistance 
cassette from vector pJM114 (Perego, 1993), yielding plasmid pNM47. This plasmid was 
linearized by digestion with ScaI and use to transform strain NM60, to give strain NM67. 
Strain NM68 was constructed as follows. A replacement of the spectinomycin resistant 
cassette from pNM03 with a chloramphenicol resistant cassette from vector pJM105A  
(Perego,1993) was performed. The resulting plasmid, pNM53, was linearized by 
digestion with ScaI and used to transform strain NM65. For strains NM65, NM67 and 
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NM68 selection of transformants was carried out in LB supplemented with acetate and 
BCFA precursors. 
To test complementation of strain NM57 with a wild type copy of the lipM gene, 
a 882 bp fragment containing lipM with its ribosome binding site was PCR amplified with 
oligonucleotides XVII and XVIII and the product inserted between the SalI and KpnI sites 
of pGES40 (Schujman, unpublished). This plasmid was digested with BamHI to obtain a 
fragment containing xylR PxylA-lipM, which was cloned into pJM116 previously digested 
with BamHI, yielding plasmid pNM57. Strain NM57 was transformed with this plasmid; 
transformants were screened for kanamycin and chloramphenicol resistance and amyE 
phenotype. The resulting strain was named NM08.  
Strain NM51 was complemented with a wild type copy of lipL gene as follows. A 
952 bp fragment containing lipL with its ribosome-binding site was PCR amplified with 
oligonucleotides XIII and XIV and cloned into SalI and KpnI sites of pGES40. This plasmid 
was digested with BamHI to obtain a fragment containing xylR PxylA-lipL, which was 
cloned into pJM116 previously digested with BamHI, yielding plasmid pNM58. Strain 
JH642 was transform with plasmid pNM58 to yield strain NM10 which was further 
transformed with plasmid pNM03 to give strain NM13.  
To express E. coli lipB in B. subtilis plasmid pNM59 was constructed as follows. A 
682 bp fragment containing the lipB gene was PCR amplified from plasmid pYFJ29  (Zhao 
et al., 2005) with oligonucleotides XL and XLI and inserted between the SalI and KpnI 
sites of pGES40. This plasmid was digested with BamHI to obtain a fragment containing 
xylR PxylA-lipB, which was cloned into pJM116 previously digested with BamHI, yielding 
plasmid pNM59. Strain JH642 and NM57 were transformed with plasmid pNM59 to 
yield strains NM09 and NM11. Strains NM09 and NM11 were then transformed with 
pNM03 to yield strain NM12 and NM14, respectively. 
For E. coli complementation analyses, coding sequences were amplified from 
genomic DNA by PCR and inserted into pBAD322G (Cronan, 2006). The lplJ coding 
sequence was amplified with primers Q003 and Q004 and the product was ligated to the 
vector NcoI and HindIII sites to give pQC003. The lipL coding sequence was amplified 
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with primers Q039 and Q040 and inserted into pCR2.1 using the TA cloning kit 
(Invitrogen) and then inserted into the NcoI and HindIII sites of pBAD322G to give 
pQC032. These manipulations placed these genes under the control of an arabinose 
inducible promoter. 
For purification of the protein products, their respective genes were amplified 
with primers that added a sequence encoding an N-terminal hexahistidine tag. These 
PCR products were first inserted into pET101 using the TOPO Cloning Kit (Invitrogen). 
The lplJ coding sequence was amplified using primers Q021 and Q004 to give pQC014, 
whereas the lipL coding sequence was amplified using primers Q0043 and Q0040 to give 
pQC033. These manipulations placed these genes under control of a T7 polymerase-
dependent promoter (Studier et al., 1986). 
Growth Curves of B. subtilis Cultures 
Growth of Bacillus was measured by Natalia Martin. Strains were grown 
overnight on liquid minimal medium supplemented with acetate and BCFA precursors. 
Cells were washed once with minimal medium and used to inoculate fresh media at an 
OD600 of 0.1-0.15. Cells were grown using a Bioscreen C with 300 µL per well with 
continuous and strong shaking. Growth (OD600) was measured every h. 
Complementation of E. coli Lipoate Auxotrophs 
  B. subtilis genes were expressed in E. coli from plasmids with an arabinose 
inducible promoter as described (Chapter 3).  Complementation of the lipB lplA strain 
TM136 was tested in M9 minimal medium containing 0.2% arabinose, 0.1% Vitamin-
Assay Casamino Acids, and gentamycin. Complementation of the lipA lplA strain TM131 
was tested using the same medium containing 5 µg/ml sodium lipoate. Growth was 
measured by optical density (OD600) in a Beckman DU600 spectrophotometer. 
 The activities of the lipoate dependent dehydrogenases were assayed using the 
continuous spectrophotometric assay previously described (Chapter 2). Briefly, 
derivatives of TM136 carrying various plasmids were subcultured to an OD600 of 0.1 in LB 
with 0.2% arabinose, 5 mM sodium acetate and 5 mM sodium succinate pH 7.0. Cells 
were harvested in late exponential phase at an OD600 of 0.7. The cells were lysed by two 
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passages through a French pressure cell and protein was quantified using the Bradford 
assay reagent (Bio-Rad) with bovine gamma globulin (Pierce) as the standard. PDH and 
OGDH activities were measured spectrophotometrically at 366 nm following the 
reduction of acetyl-pyridine adenine dinucleotide. 
 Strain QC168 was used to test the complementation properties of B. subtilis 
genes in a strain deficient in unsaturated fatty acid biosynthesis. Cultures were grown 
on M9 minimal agar with 0.4% glycerol, 0.1% Vitamin-Assay Casamino Acids, 5 mM 
sodium acetate, 5 mM sodium succinate, 0.5 mM sodium oleate, and 0.1% Tergitol NP-
40 and then restreaked on the same medium lacking acetate and succinate to test for 
complementation. 
Purification of protein substrates 
Purification of GcvH: Hexahistidine-tagged B. subtilis GcvH was heterologously 
expressed in E. coli and purified by nickel affinity and anion exchange chromatographic 
steps as previously described (Chapter 3). GcvH was verified to be in the unmodified 
form lacking the N-terminal methionine residue by electrospray mass spectrometry as 
previously described (Chapter 3) and was quantified by absorbance at 280 nm using a 
calculated extinction coefficient of 16,960 M-1 cm-1. 
Purification and Modification of B. subtilis AcpP: The native acyl carrier protein of 
B. subtilis was purified by nickel affinity and ion exchange chromatographic steps, as 
previously described.  Holo and octanoyl forms of ACP were also prepared as previously 
described (Chapter 3). 
Purification of Lipoate Metabolism Enzymes 
LipB was purified by nickel affinity and anion exchange as described  (Jordan et 
al., 2003). LipB was quantified by absorbance at 280 nm using an extinction coefficient 
of 22,920 M-1 cm-1.  LplJ was purified from strain QC103 by nickel affinity and anion 
exchange as described for T. acidophilum LplA (Chapter 2). LplJ was quantified by 
absorbance at 280 nm using an extinction coefficient of 34,380 M-1 cm-1.  LipM and LipL 
were also purified from the E. coli fabA strains QC142 and QC143, respectively, as 
described for LipM and analyzed by MALDI MS as previously described (Chapter 3). LipL 
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was also purified from strain QC083 grown in the absence of triclosan. LipM and LipL 
were quantified by absorbance at 280 nm using extinction coefficients of 45,380 and 
25,900 M-1 cm-1, respectively.  The purified proteins were concentrated with Vivaspin 
centrifuge concentrators (GE Healthcare) and flash frozen for storage as above except 
that the buffer contained 100 mM sodium chloride. 
Lipoate ligation Assay 
Lipoate ligase activity was assayed by observing a mobility shift upon 
modification by native gel electrophoresis as originally described by Miles and Guest  
(Miles & Guest, 1987). Assays contained 100 mM sodium phosphate (pH 7.0), 5 mM 
DTT, 1 mM sodium lipoate, 1 mM magnesium chloride, 1 mM ATP, 20 µM lipoyl domain 
and 1 µM LplJ. For assay of octanoylation by various enzymes, sodium octanoate was 
substituted for sodium lipoate and 10 µM enzyme was used. The assays were incubated 
at 37°C for 1 h and 10 µl of the assays were subjected to native Tris-glycine gel 
electrophoresis using a 20% acrylamide gel for four h at 100 V.  The proteins were 
visualized by staining with Coomassie Blue R-250  (Sambrook et al., 2001) or by western 
blotting with anti-lipoic acid antibody (Calbiochem) and anti-rabbit IgG HRP conjugate 
(Roche). Western blotting was carried out using standard methods with 5% dehydrated 
milk (Carnation) for blocking and antibody incubation steps  (Ausubel, 1987). 
Acyl-adenylate intermediate formation was assayed by thin layer 
chromatography and autoradiography as described for BirA  (Xu et al., 1997). The 
reactions contained 100 mM sodium phosphate (pH 7.0), 5 mM TCEP, 0.1 µM [α-32P] 
ATP (6000 Ci/mMol), 1 µM MgCl2, 0.1 mM sodium lipoate or octanoate, and 10 µM LplJ. 
GcvH was also added to 50 µM where indicated.  Reactions were incubated at 37°C for 
30 min before spotting onto a cellulose TLC plate. 
Assay of Octanoyl-[Acyl Carrier Protein]:Protein N-Octanoyltransfer 
For assays using B. subtilis extracts, 100 µg of extract protein was added instead 
of enzyme. Cultures were grown to an OD600 of 0.6, pelleted by centrifugation, 
resuspended 1:100 of the culture volume in 100 mM sodium phosphate buffer (pH 7.0), 
and sonicated for 10 min using a Misonix cup-horn sonicator cooled with circulating 50% 
87 
 
polyethylene glycol. Extracts were cleared by centrifugation and quantified using the 
Bradford assay (Bio-Rad) with bovine gamma globulin as a standard. For assay of 
transfer from octanoyl-ACP to both LipM and LipL, 50 µM sodium [1-14C]octanoate and 
10 µM enzyme were used in the absence of lipoyl domain. The reaction was analyzed 
using a modification of the method of Laskey and Mills  (Laskey et al., 1975) in which 10 
µl of the reactions were subjected to SDS-PAGE on a 4-20% gradient gel which was 
soaked in Amplify fluorographic reagent (GE Healthcare), dried, and exposed to 
preflashed Biomax XAR film (Kodak) at -70°C for 24 h. 
Immunoblotting Analyses 
Immunoblotting analysis of Bacillus crude extracts was performed by Natalia 
Martin. Preliminary blotting experiments were also performed by me, but are not 
shown. B. subtilis wild type and mutants strains were grown overnight in minimal 
medium supplemented with acetate and BCFA precursors at 37°C. Cells were 
resuspended in fresh media of the same composition and cultured at 37°C. A 1-ml 
aliquot of each culture was harvested after 22 hours of growth. The samples were 
centrifuged and the pellets were washed with buffer (20 mM Tris-HCl [pH 8.0], 150 mM 
NaCl). They were resuspended in 180 µl of lysis buffer (50 mM Tris-HCl [pH 8.0], PMSF 
10 µM) per OD600 unit. Resuspended cells were disrupted by incubation with lysozyme 
(100 µg/ml) for 15 min at 37°C followed by 5 min of boiling in the presence of loading 
buffer. Each sample was fractionated by sodium dodecyl sulfate-gel electrophoresis in a 
12% acrylamide gel. Proteins were electroeluted to a nitrocellulose membrane and 
detected using anti-lipoate rabbit antibody and a secondary anti-rabbit immunoglobulin 
G conjugated to horseradish peroxidase (Bio-Rad). The bands were visualized by use of 
the ECL Plus Western Blotting Detection System (GE). The blots were scanned and the 
intensity of the bands was quantified by ImageQuant 5.2. 
Purification of the B. subtilis PDH Complex 
Purification of the PDH complex was performed by Natalia Martin with guidance 
from me. Cultures were grown at 37°C in LB supplemented with 0.5% glucose, 10 mM 
sodium acetate, 0.1 mM of each BCFA precursor and the appropriate antibiotic until an 
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OD600 of 1-1.5 when cells were harvested. Purification was carried out similarly as 
previously described by (Hodgson et al., 1983). Briefly, cell pastes were suspended in 50 
mM sodium phosphate buffer, (pH 7.0) containing 5 mM EDTA, Complete EDTA-free 
protease inhibitor cocktail (Roche), lysozyme (6 mg/ml) (Sigma) and DNAse I (5 µg/ml) 
(Sigma) and stirred for 2 h. Cells were lysed by three passages through a French pressure 
cell at ~20,000 psi. Lysates were cleared by centrifugation at 44,000 x g for 30 min.  The 
cleared lysate was treated with 32 µg/ml ribonuclease A and incubated at 15°C for 70 
min to degrade ribosomes. The samples were centrifuged for 30 min. at 44,000 x g. The 
solution of approximately 50 mg of protein/ml was layered on top of a sucrose step 
gradient (12.5% w/v and 70% w/w). Centrifugation was performed for 3 h at 180,00 x g. 
The brown protein band at the interface of the 12.5% and 70% sucrose layers was 
drawn off. Sucrose was removed by overnight dialysis against 50 mM sodium phosphate 
buffer (pH 7.0) containing 5 mM EDTA and 0.15 mM phenylmethanesulphonylfluoride.  
The samples were concentrated using Vivaspin concentrators (Sartorius), loaded onto a 
column of Sephacryl HR-500 26/16 (GE) and eluted with 50 mM sodium phosphate 
buffer containing 5 mM EDTA (pH 7.0). Fractions containing pure complex as judged by 
SDS PAGE were pooled and dialyzed overnight against 50 mM sodium phosphate buffer, 
15% glycerol and 1 mM tris (2-carboxyethyl)phosphine (Sigma). Samples were then 
concentrated using Vivaspin concentrators (Sartorius), flash frozen in dry ice and 
ethanol, and stored at -80°C. PDH activity was assayed in the preparation purified from 
strain NM60 extracts to confirm that the purified complex was indeed the PDH complex. 
Protease Digestion of the B. subtilis Pyruvate Dehydrogenase Complex 
Digestion of the PDH complex was performed by Natalia Martin with guidance 
from me. B. subtilis pyruvate dehydrogenase complex (1 ml; 5-20 mg/ml) in 50 mM 
sodium phosphate buffer (pH 7.0) was digested at 30°C with Staphylococcus aureus V8 
protease (Wako) (1% w/w) for 100 min at which time a second addition of protease (1% 
w/w) was made. Following a total digestion time of 180 min 
phenylmethanesulphonylfluoride was added to a final concentration of 1 mM to block 
further digestion.  After digestion the samples were centrifuged for 30 min at 14,000 
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rpm in a bench top centrifuge and supernatants analyzed by 20% native polyacrylamide-
gel electrophoresis. The peptides were sliced from the gel and submitted to the UIUC 
Mass Spectrometry Lab for LC-MS/MS analysis. 
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Analysis 
 Interpretation and search of LC-MS/MS data was done by both Martin and me. 
Trypsin digestion and LC-MS/MS analysis was performed by the University of Illinois 
Biotechnology Center Protein Sciences Facility as follows. Gel slices were crushed and 
rinsed with water. 25 µl of trypsin (12.5 µg/ml) in 25 mM ammonium bicarbonate was 
added and the samples were digested in a CEM Discover microwave reactor for 15 min 
at 55oC and 50 watts. The gel pieces were extracted with 100 µl of 50% acetonitrile and 
5% formic acid for 10 minutes with sonication. The extracts were dried down in a 
vacuum centrifuge and resuspended in 13 µl of 5% acetonitrile and 0.1% formic acid. 
Analysis by LC-MS was carried out on a Waters Q-Tof API-US Quad-ToF mass 
spectrometer with a nanoAcquity UPLC system. The columns used were Waters 
nanoAcquity UPLC (75 m x 150 mM 3 µm Atlantis dC18) and Atlantis dC18 5 µm 
Nanoease trap columns. A 60 min linear gradient of 1% to 60% acetonitrile in 0.1% 
formic acid was used to elute the peptides from the columns. MS/MS data were 
collected using the Data Directed Analysis method in MassLynx to fragment the top four 
ions in each survey scan. ProteinLynx (Waters) was used to process the mass spectral 
data into peak list files for analysis by Mascot (Matrix Science). Database searches were 
performed against the NCBI non-redundant database with taxonomy restrictions 
 
RESULTS 
LipM is Responsible for Octanoyl Transfer In Vivo 
B. subtilis was recently demonstrated to encode a functional lipoate synthase 
called LipA  (Martin et al., 2009). However, BLAST searches against B. subtilis genome 
showed no open reading frame (ORF) that resembled the E. coli LipB 
octanoyltransferase, an activity required for production of the substrate of LipA. 
Instead, two ORFs, YhfJ and YqhM, annotated as encoding putative lipoyl ligases were 
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present that, respectively, shared 33% and 23% identity with E. coli LplA. A third ORF, 
YwfL that encoded a protein of unknown function having 22% identity with YhfJ was also 
found.  Since all three genes are involved in lipoic acid metabolism (see below), they 
have been renamed.  In this paper we have renamed yhfJ and ywfL as lplJ and lipL, 
respectively, whereas yqhM was previously renamed lipM (Chapter 3).  
Recently, cosmids containing B. subtilis genomic fragments were isolated that 
complemented growth of an E. coli lipB strain and failed to complement an lplA lipA 
strain (Chapter 3).  All complementing cosmids contained the lipM gene, and this gene 
was shown to be responsible for restoration of lipoic acid synthesis to the E. coli lipB 
strain.  The pattern of complementation indicated that lipM encoded an 
octanoyltransferase, and the LipM protein was shown to catalyze octanoyl transfer in 
vitro by the same general acyl-enzyme intermediate mechanism used by LipB (Chapter 
3).  Based on the frequency that complementing cosmid clones were found, it was 
suggested that LipM might be the sole B. subtilis octanoyltransferase.  However, no 
lipoate ligase encoding cosmids were isolated, and since growth of the B. subtilis lipA 
strain on lipoic acid would require ligase activity, the question of cosmid bank bias was 
raised (Chapter 3).  To definitively test whether or not LipM was the sole B. subtilis 
octanoyltransferase, we constructed strain NM57 in which lipM was replaced with a 
kanamycin-resistance determinant. 
Strain NM57 (∆lipM) was auxotrophic for lipoic acid when grown in minimal 
medium but grew as well as the wild type strain, JH642, in the presence of lipoic acid 
(Figures 4-2 and 4-3A).  As previously observed for a ∆lipA mutant strain  (Martin et al., 
2009) the requirement for lipoic acid could be bypassed by addition of both acetate and 
branched chain fatty acid (BCFA) precursors (Figures 4-2 and 4-3A), which upon 
conversion to their CoA esters are the products of the two lipoylated B. subtilis 
enzymes, PDH and BKDH, that are required for growth in minimal medium. Cells grown 
in this medium were devoid of lipoylated proteins detectable by western blotting 
(Figure 4-3). Mass spectrometry also demonstrated that lipM was required for 
modification of lipoyl domains by the biosynthetic pathway (see below). 
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To confirm that the growth phenotype observed in this mutant strain was due to 
the absence of lipM, complementation analyses were carried out.  A construct in which 
lipM was placed under control of a xylose-inducible promoter (PxylA) was introduced 
into the ∆lipM strain NM57 giving the lipM amyE::PxylA-lipM strain, NM08. Induction of 
lipM expression in strain NM08 allowed growth in minimal medium thereby indicating 
that the absence of a functional copy of lipM (rather than a polar effect on the 
downstream genes) was the cause of the growth phenotype of strain NM57 (Figure 4-
2A).  Moreover, LipM could be functionally replaced by expression of E. coli lipB. The 
lipB gene was placed under PxylA and the construct was introduced into the ∆lipM 
strain NM57 to give the lipM amyE::PxylA-lipB strain, NM11.  Upon induction of LipB 
expression, strain NM11 grew in minimal medium, indicating that the LipB octanoyl 
transferase activity functionally replaced LipM.  Similar complementation experiments 
were performed with a ∆lipL strain (see below).  These results, together with those of 
Chapter 3, demonstrate that LipM functions as the sole B. subtilis octanoyltransferase. 
Bacillus subtilis LplJ is a lipoate:protein ligase  
The ability of exogenous lipoic acid to allow growth of both a ∆lipM strain and a 
lipA conditional mutant indicated that B. subtilis must encode a lipoate scavenging 
activity (Martin et al., 2009). The most likely candidate for this role was YhfJ (LplJ), which 
was annotated as a putative lipoyl ligase and has 33% identity to E. coli LplA. We first 
found that expression of lplJ restored E. coli lipB lplA strains to prototrophy (Figure 4-
4A). Since prototrophy could result from either octanoyltransfer or ligation of traces of 
endogenous octanoate (Hermes et al., 2009), we also tested complementation of a E. 
coli lplA lipA strain in the presence of lipoate. Growth was also restored in this strain 
(Figure 4-4B) and it was accompanied by activation (hence lipoate modification) of the 
E. coli 2-oxoacid dehydrogenases (Figure 4-4C). Therefore, in complementation tests LplJ 
behaved like LplA. We then constructed strain NM60, a B. subtilis ∆lplJ strain. The ∆lplJ 
strain grew normally in minimal medium in the absence of supplements (Figure 4-1) and 
had a wild type pattern of lipoylated proteins (Figure 4-3). This behavior was expected 
because ∆lplA strains of E. coli lacking lipoate scavenging activity show growth defects 
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only when the strains are additionally blocked in the lipoic acid synthetic pathway by a 
lipA or lipB mutation (Morris et al., 1994; Morris et al., 1995) (Figure 4-1). Based on this 
precedent the ∆lipM ∆lplJ double mutant strain, NM65, was constructed. As expected, 
this strain was found to be unable to grow in minimal medium either in the presence or 
absence of lipoic acid (Figure 4-1), indicating that LplJ is the sole B. subtilis lipoic acid 
salvage enzyme.  
Given that proteins with significant sequence identity to E. coli LplA have been 
shown to catalyze octanoyl transfer, it could not be assumed that the B. subtilis lipoate 
salvage enzyme catalyzed a ligase reaction. Therefore, we purified the hexahistidine-
tagged protein to homogeneity (Figure 4-5A) and assayed it for both the overall and first 
partial reaction of the ligase reaction. In the absence of an acceptor domain, synthesis 
of both octanoyl-adenylate and lipoyl-adenylate intermediates was readily 
demonstrated by use of ATP labeled in the α-phosphate. Moreover, upon addition of an 
acceptor lipoyl domain the adenylate intermediates were hydrolyzed to AMP (Figure 4-
5B). Gel mobility shift assays showed that LplJ modified the E. coli lipoyl domain from 
PDH (E2AceF) and GcvH with either lipoate or octanoate. Western blotting with anti-lipoic 
acid antibody confirmed lipoylation of the acceptor proteins and demonstrated that the 
antibody recognized lipoylated proteins and not octanoylated proteins (Figure 4-5C). 
Finally, modification of GcvH was confirmed by electrospray mass spectrometry of the 
reaction products (Figure 4-5D). From these data we conclude that B. subtilis LplJ 
catalyzes a classical lipoate ligase reaction analogous to that of E. coli LplA. 
The Unexpected Requirement for LipL 
A third ORF, lipL (formerly ywfL), encodes a protein annotated as of unknown 
function. LipL seems more divergent from authentic lipoyl ligases than LipM and has 
only 22% sequence identity with LplJ. Our results, together with those previously 
reported  (Martin et al., 2009) (Chapter 3), indicated that B. subtilis like E. coli has an 
octanoyltransferase (LipM), a sulfur insertion enzyme (LipA) and a lipoate ligase (LplJ).   
However, unlike E. coli, these enzymes were not sufficient for either synthesis or 
efficient scavenging of lipoic acid, as demonstrated by the phenotype of B. subtilis ∆lipL 
93 
 
strains. Strains devoid of LipL were unable to grow in minimal medium as observed for 
strains lacking either lipM (Figure 4-1) or lipA  (Martin et al., 2009).  However, in 
contrast to the growth phenotypes of lipM and lipA strains, addition of lipoic acid only 
partially restored growth of the ∆lipL strain NM51.  The growth behaviour of the ∆lipL 
strain denoted a block in the endogenous lipoylation pathway because, like the lipA 
conditionally mutant strain and ∆lipM strains, the ∆lipL strain grew as well as its wild 
type parent in minimal medium supplemented with acetate and BCFA precursors.  
The residual growth of the ∆lipL strain in minimal medium containing lipoic acid was due 
to LplJ activity because the ∆lipL ∆lplJ double mutant strain, NM67, failed to grow in this 
medium. Hence the ∆lipL strain retained some ability to transfer exogenously provided 
lipoate to the unmodified acceptor proteins. Expression of a functional copy of the lipL 
gene under the control of a xylose-dependent promoter in the non-essential amyE locus 
restored growth of the ∆lipL strain in minimal medium (Figure 4-1B) indicating that the 
absence of a functional copy of lipL was the cause of the growth phenotype of strain 
NM51. 
The growth phenotype of the ∆lipL strain indicated that it should have decreased 
levels of protein lipoylation and any residual modification should be abolished upon 
introduction of a ∆lplJ lesion. This was the case (Figure 4-3).  Immunoblot analysis of 
crude extracts of strain NM51 (∆lipL) with anti-lipoate antibodies showed that GcvH was 
lipoylated to a level similar to that seen in the wild type strain. However, only one of the 
two high molecular weight bands observed in the wild type strain was detected in strain 
NM51 and thus the total amount of protein lipoylation of this strain was more than 3-
fold less than those seen in extracts of the wild type strain (Figure 4-3). Strain NM51 
required both acetate and BCFA precursors for growth indicating that the BKDH and 
PDH E2 subunits of were nonfunctional in absence of LipL. Thus, the band observed 
seems likely to be the nonessential OGDH E2 subunit that may migrate together with 
low levels of lipoylated PdhC insufficient to overcome the acetate requirement.  The 
putative OGDH E2 band was not present in extracts of the ∆lipL ∆lplJ strain, NM67, 
(Figure 4-3) indicating that LplJ was responsible for the residual lipoylation seen in the 
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absence of lipoic acid supplementation. Interestingly, in this strain the immunoblot 
signal of GcvH was about two-fold stronger than that of extracts from the wild type 
strain (Figure 4-3). This observation shows that lipoyl-GcvH is more abundant in this 
strain. This suggests that when GcvH is lipoylated by the concerted action of LipM and 
LipA, lipoyl-GcvH accumulated because in the absence of LipL and LplJ the GcvH lipoyl 
moiety could not be transferred to other lipoyl acceptors. Another possible explanation 
would be that LplJ scavenges and attaches octanoate to the acceptor proteins to serve 
as a LipA substrate as occurs in E. coli  (Hermes & Cronan, 2009). However, this does not 
seem to be the case in B. subtilis since no lipoylated proteins were detected in a ∆lipM 
strain (Figure 4-3). 
To provide further evidence for the role of LipL in protein lipoylation, 
complementation experiments with E. coli lipB were performed. As described above, 
lipB was placed under a xylose-inducible promoter (PxylA) and this construct was 
introduced into the chromosome of B. subtilis strain NM51 to give strain NM12 (∆lipL 
amyE::Pxyl-lipB).  Induction of LipB expression allowed growth not only of the ∆lipL 
strain NM12, but also of the ∆lipM ∆lipL double mutant strain CM28 (Figure 4-6). 
However, when expressed in E. coli mutant strains, LipL had no detectable ability to 
replace either E. coli LplA or LipB (Figure 4-4). A plausible explanation for this 
observation was that LipL might become inactive when expressed in E. coli. When B. 
subtilis LipM is expressed in E. coli, some molecules carry a covalently attached 
decanoate moiety derived from cis-3-decenoyl-ACP, an essential intermediate of 
unsaturated acid biosynthesis in E. coli (Chapter 3) that is not present in B. subtilis. A 
similar inability to exclude cis-3-decenoyl-ACP was reported for Mycobacterium 
tuberculosis LipB (Ma et al., 2006). In the case of LipM an unmodified protein was 
obtained by expression of the protein in an E. coli fabA mutant which lacks the ability to 
make cis-3-decenoyl-ACP.  The inability of LipL to relieve the lipoate requirement cannot 
be due to formation of a covalently attached decanoate because a fabA lipB lplA strain 
also failed to grow (Figure 4-4D).  
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Although LipL expression failed to restore the growth of an E. coli ∆lipB strain, 
lipB expression allowed growth of a B. subtilis ∆lipL strain on minimal medium. These 
results indicated that LipM and LipL are both required for octanoylation of E2 lipoyl 
domains and that the two proteins either catalyze sequential reactions or participate in 
octanoyl transfer as a complex.  The latter explanation seems unlikely since LipM 
expressed in E. coli is active both in vivo and in vitro (Chapter 3).  Moreover, crude 
extracts of B. subtilis ∆lipL mutants readily catalyzed the LipM reaction, transfer of 
octanoate from octanoyl-ACP to GcvH (Figure 4-7).  
Given that lipoic acid synthesis proceeds through several sequential steps, it 
seemed possible that intermediates attached to the lipoyl domains of the E2 subunits 
might accumulate in some mutant strains.  Therefore we purified the PDH complexes of 
wild type and various mutant strains and released their lipoyl domains by limited 
proteolysis with the Staphylococcus aureus V8 glutamyl protease as previously 
described (Packman et al., 1988).  The isolated domains were resolved from the other 
digestion products by polyacrylamide gel electrophoresis run under native conditions. 
The gel slices containing the domain bands were excised, crushed and subjected to in-
gel trypsin digestion. The resulting peptides were analyzed by liquid chromatography-
tandem mass spectrometry as described in Experimental Procedures.  The PDH 
complexes were purified from extracts of strains NM60 (∆lplJ); NM65 (∆lipM ∆lplJ); 
NM67 (∆lipL ∆lplJ) and NM68 (∆lipM ∆lipL ∆lplJ) as described in Experimental 
Procedures (the strains all lacked LplJ in order to preclude ligation of any traces of 
octanoic acid or lipoic acid present in the culture medium).  PDH peptides were 
detected with significant scores in all samples (Figure 4-8) and modification was 
determined using an error tolerant search as described in Experimental Procedures to 
determine the presence or absence of posttranslational modifications of the target 
lysine residue (K43). K43 was found in three forms-unmodified, octanoylated and 
lipoylated-in the peptides derived from the ∆lplJ strain NM60, whereas the peptides of 
the other strains were unmodified (Figure 4-8). These results indicate that PDH was not 
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modified in ∆lplJ strains when either LipM or LipL was nonfunctional and that LipL is 
required for E2 lipoyl domain modification rather than for sulfur insertion. 
Although no novel PDH E2p-bound intermediates were present, this does not 
rule out a sequential mechanism in which another protein functions as an 
octanoyl/lipoyl carrier. Indeed the observed accumulation of lipoylated GcvH in a ∆lipL 
∆lplJ strain (Figure 4-3) suggested that this small protein was a good candidate for an 
octanoyl/lipoyl carrier. 
 
DISCUSSION 
Lipoic acid synthesis in B. subtilis is clearly more complex than in E. coli.  E. coli 
requires only two proteins to make this cofactor, whereas in this paper we demonstrate 
that B. subtilis requires three proteins: LipA, LipM (an isozyme of LipB), and an 
unexpected protein LipL.  Inactivation of any of the three genes that encode these 
proteins results in lipoic acid auxotrophy.   The two LipA proteins are interchangeable 
between B. subtilis and E. coli, as are LipM and LipB.   In contrast, LipL has a curious 
behavior.  Its expression in E. coli fails to complement a ∆lipB mutation whereas 
expression of LipB complements a B. subtilis ∆lipL strain. Therefore, LipL and LipM have 
distinct roles in lipoate biosynthesis. A plausible hypothesis is that LipM and LipL might 
form a complex to transfer an octanoyl group from octanoyl-ACP to the acceptor 
proteins. However this explanation seems unlikely since LipM alone complements the 
function of LipB in vivo (Chapter 3) and the data in this and the companion paper 
indicates that LipM and LipL catalyze two sequential steps in octanoyl transfer with 
GcvH as an intermediate required for the lipoylation of most (if not all) of the other B. 
subtilis apoproteins. 
Strains lacking LipL (ΔlipL), unlike ∆lipM strains, grow poorly in the presence of 
exogenously added lipoic acid (Fig. 4-2) indicating that LipL has a role in lipoic acid 
scavenging. Indeed, ΔlipL ΔlplJ strains fail to grow in the presence of exogenously 
supplied lipoic acid, confirming that LplJ is required for the low level of lipoylation of the 
complexes seen in the ΔlipL strain.  These data suggest that its lipoyl ligase activity may 
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be less efficient in the absence of LipL. These results could be explained if the PDH and 
BKDH E2 subunits are much poorer LplJ substrates than GcvH. That is, LipL would be 
both a facilitator of LplJ action as well as a necessary intermediate in LipM action. 
Our results clearly indicate the presence of unexpected diversity in lipoic acid 
metabolism among bacteria. It should be pointed out that LipL homologues can be 
found in pathogenic bacteria closely related to B. subtilis such as Staphyloccocus aureus 
and Bacillus anthracis. Thus, utilization of this pathway for protein lipoylation may be 
more widespread than previously appreciated. Finally, due to the involvement of lipoic 
acid metabolic proteins in pathogenesis, multidrug resistance and intracellular growth 
of pathogens, the discovery of new enzymes should provide potential new targets for 
antimicrobial agents.  In the next chapter we report biochemical and genetic data that 
support the above model in which GcvH is an octanoyl/lipoyl carrier and demonstrate 
that LipL is a novel amidotransferase. Further work is needed to determine the 
importance of this new pathway in pathogenesis. The strong phenotype of a ∆lipL 
strains suggests LipL might be an excellent target for antimicrobials. 
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Table 4-1. Strains used in this chapter.  
Strain Relevant characteristics Source or reference 
B. subtilis   
JH642 trpC2 pheA1 Laboratory stock 
NM57  JH642 lipM:: Km
r 
 This chapter 
NM08 NM57 amyE::Pxyl-lipM  This chapter 
NM11 NM57 amyE::Pxyl-lipB  This chapter 
NM51 JH642 lipL:: Sp
r
 This chapter 
NM09 JH642 amyE::Pxyl-lipB  This chapter 
NM10 JH642 amyE::Pxyl-lipL  This chapter 
NM12 NM51 amyE::Pxyl-lipB  This chapter 
NM13 NM51 amyE::Pxyl-lipL  This chapter 
CM28 NM57 lipL:: Sp
r 
 This chapter 
NM14 CM28 amyE::Pxyl-lipB  This chapter 
NM60 JH642 lplJ:: Sp
r 
 This chapter 
NM65 NM60 lipM:: Km
r 
 This chapter 
NM67 NM60 lipL:: Sp
r 
 This chapter 
NM68 NM65 lipL:: Cm
r 
 This chapter 
E. coli   
DH5α supE44 thi-1 ΔlacU169 (f80lacZΔM15) endA1 recA1 hsdR17 
gyrA96 relA1 trp6 cysT329 
Laboratory stock 
MG1655 rph-1 CGSC* 
EMM99 E. coli BL21 (DE3) / pEM88 (Martinez et al., 2010) 
TM131 rpsL8 lipA::Tn1000 lplA::Tn10 (Morris et al., 1994) 
TM136 rpsL8 lipB::Tn1000 lplA::Tn10 (Morris et al., 1994) 
JK1 rpsL8 (Morris et al., 1994) 
MFH120 JC7623 lacZΔM15 φ (fabA-lacZ)1 (Hyb)cat fadBA poxB::pMFH23 (Henry et al., 1992) 
QC031 rpsL8 lipB::Tn1000 lplA::Tn10/ pQC003 This chapter 
QC032 rpsL8 lipB::Tn1000 lplA::Tn10/ pQC004 (Chapter 3) 
QC035 rpsL8 / pBAD322G (Chapter 2) 
QC038 rpsL8 lipA::Tn1000 lplA::Tn10/ pBAD322G (Chapter 2) 
QC057 rpsL8 lipB::Tn1000 lplA::Tn10/ pBAD322G (Chapter 3) 
QC080 rpsL8 lipB::Tn1000 lplA::Tn10/ pQC032 This chapter 
QC081 rpsL8 lipA::Tn1000 lplA::Tn10 / pQC032 This chapter 
QC086 rpsL8 lipB::Tn1000 lplA::Tn10/ pQC003 This chapter 
QC087 rpsL8 lipB::Tn1000 lplA::Tn10/ pQC004 (Chapter 3) 
QC134 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat (Chapter 3) 
QC142 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pCY598, pQC015 (Chapter 3) 
QC143 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pCY598,pQC033 This chapter 
QC161 rph-1 ΔlplA::FRT ΔlipB::FRT / pQC057, pTARA (Chapter 3) 
QC168 rpsL lipB::Kn lplA::Tc φ (fabA- lacZ)1 (Hyb)cat This chapter 
QC175 rpsL lipB::Kn lplA::Tc φ (fabA- lacZ)1 (Hyb)cat / pBAD322G This chapter 
QC176 rpsL lipB::Kn lplA::Tc φ (fabA- lacZ)1 (Hyb)cat / pQC003 This chapter 
QC177 rpsL lipB::Kn lplA::Tc φ (fabA- lacZ)1 (Hyb)cat / pQC004 This chapter 
QC178 rpsL (SmR) lipB::Kn lplA::Tc φ (fabA- lacZ)1 (Hyb)cat / pQC032 This chapter 
*CGSC, E. coli genetic stock center.
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Table 4-2. Plasmids used in this chapter. 
Plasmids Relevant Characteristics* Source or Reference 
pGES40 pBluescript (Stratagene) containing the xylR gene and 
PxylA promoter 
(Schujman, unpublished) 
pJM116 Integrative vector to construct transcriptional fusions to 
lacZ; integrates at the amyE locus of B. subtilis; Cm
r
 
(Dartois et al., 1996) 
pJM105A Integrational vector; Cm
r
 (Perego,1993) 
pJM114 Integrational vector; Km
r
 (Perego,1993) 
pJM134 Integrational vector; Sp
r
 (Perego,1993) 
pBAD322G arabinose inducible expression vector (Cronan,2006) 
pTARA pACYC origin, arabinose inducible T7 polymerase (Wycuff et al., 2000) 
pCY598 RSF origin, arabinose inducible T7 polymerase (Cronan,2003) 
pET101/D-TOPO T7 promoter expression vector Invitrogen 
pCR2.1 TOPO TA cloning vector Invitrogen 
pNM03 pJM134 containing lipL interrupted with a Sp
r
 cassette This chapter 
pNM07 pJM114 containing lipM interrupted with a Km
r
 cassette This chapter 
pNM48 pJM134 containing lplJ interrupted with an Sp
r
 cassette This chapter 
pNM47 pJM114 containing lipL interrupted with a Km
r
  cassette
 
This chapter 
pNM53 pJM105A containing lipL interrupted with a Cm
r
  cassette This chapter 
pNM57 Contains xylR PxylA-lipM into BamHI site of pJM116 This chapter 
pNM58 Contains xylR PxylA-lipL into BamHI site of pJM116 This chapter 
pNM59 Contains xylR PxylA-lipB into BamHI site of pJM116 This chapter 
pSJ120 E. coli LipB expression vector (Jordan et al., 2003) 
pQC003 LplJ expression vector This chapter 
pQC004 LipM expression vector (Chapter 3) 
pQC015 N-terminal hexahistidine LipM expression vector (Chapter 3) 
pQC032 LipL expression vector This chapter 
pQC033 N-terminal hexahistidine lipL expression vector This chapter 
*Cmr, Gmr Kmr, Spr, Ampr denote resistance to chloramphenicol, gentamicin, kanamycin, 
spectinomycin and ampicillin, respectively. 
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Table 4-3. Primers used in this chapter. 
Primer name Sequence (5’-3’) 
I  ggagctcGTTGTAAATCTCAGTGCAGCC 
II  CTTctAgaGCCTGAGTCTATAAACCGCCA 
III  AgaGctcGACATACAAACGAGAATGAGC 
IV  TTTCccggGCATCAGTAAATCAATC 
V  gGagCtcGATGCTGATATAGAACAGTTTCA 
VI ATTctagaGCGGATCATTGATATTTTGATTG 
VII AAACgtcGacCGCTTCAGATGAATG 
VIII CTTcTcgAgGGGCATCATCTTCTTC 
IX  CCGaAgcttTGAGCGGAATGCAAAG 
X  GTgGtAccCCACCAGGAGTTTCGCG 
XI TGGGgtCgacACGAAAGAGGATTTC 
XII CAGCcTcgaGCTTGGCCACATAATA 
XIII AGTTgTCGacCAATAAGCCTAACATGAAAGGG 
XIV AGGgtAccgGatcCTTGAGATAAAAAATGCATG 
XVII CTATgtcgACGGTAAGGAAGGTCTTAAAATGCA 
XVIII CGGGTaccggatCCTGTTTACCGCTTATAATTC 
XL  GTGTcgacGAATggaggCTTCATATGTATCAGG 
XLI AGgtacCGgatcCAAGCTTAAGCGGTAATATATTCG 
XLVI TGAAAgcTtTGGTATCTTCTTATTGTAGTGCTG 
XLVII CTTggtaccggATCCTGTTTTAGTCTTCTTGTG 
L  AGTGGaTccAAGAGCATGGGAAAG 
LI TTgtCgACTCGTGTTCTCCTGAGTAA 
LII GAGtcGACACAAGAAGACTAAAACAG 
LIII AAAGActGCAGTGAAATTCACCGCCA 
Q003 GAGACATGTTATTTATAGACAATCAAAATATCAATG 
Q004 TATAAGCTTCTCCTGCCTCCATTATTT 
Q021 CACCATGCATCATCATCATCATCATATGTTATTTATAGACAATCAAAATATCAATG 
Q036 GAGCAATTGACCATGCATCATCATCATCATCATATGTTATTTATAGACAATCAAAATATCAATG 
Q039 CACCATGGCAAACCAACCGATTGA 
Q040 CGTTCACCCAAATACCTTTGCA 
Q043 CACCATGCATCATCATCATCATCATATGGCAAACCAACCGATTGA 
Lowercase letters indicate variations with respect to the wild-type B. subtilis sequence. 
Restrictions sites are underlined. 
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FIGURES 
 
 
Figure 4-1. Growth phenotypes of B. subtilis mutant strains. The strains were grown 
overnight in minimal medium supplemented with acetate and branched chain fatty acid 
(BCFA) precursors. The cultures were centrifuged and the cells resuspended in minimal 
medium without supplements (white bars); minimal medium supplemented with lipoic 
acid (grey bars) or with acetate and BCFA precursors (black bars). The OD600 values of 
the cultures were measured after 17 h of growth at 37°C. The results shown are the 
averages of results from three independent experiments. These data were produced by 
Natalia Martin. 
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Figure 4-2. Characterization of B. subtilis strains blocked in lipoic acid (LA) synthesis. 
Panel A. Growth of bacterial strains JH642 (wild type), NM57 (∆lipM) and NM08 (∆lipM 
amyE::Pxyl-lipM). Panel B. Growth of wild type (JH642), NM51 (∆lipL) and NM13 (∆lipL 
amyE::Pxyl-lipL). The strains were streaked onto minimal medium-glycerol plates 
containing the supplements indicated above and incubated for 24 h at 37°C. These data 
were produced by Natalia Martin. 
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Figure 4-3. Immunoblotting analyses of mutant strains with an anti-lipoic acid antibody. 
The strains were grown overnight in minimal medium supplemented with acetate and 
BCFA precursors. The cells were diluted in fresh medium of the same composition and 
grown for 22 h before analysis.  The black bars denote the molecular weight standards 
(MWM). These data were produced by Natalia Martin. 
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Figure 4-4. Complementation of E. coli lipoic acid auxotrophs with B. subtilis genes as 
described in Experimental Procedures. Panel A: Growth of the lipB lplA strain TM136 
containing plasmids expressing the genes indicated on the figure. Culture optical density 
at 600 nm is reported. Panel B: Growth of lipA lplA strain TM131 containing plasmids 
expressing genes indicated as in panel A. Lipoic acid is also added to the medium as a 
substrate for ligation. Panel C: The 2-oxoacid dehydrogenase activities of the lipB lplA 
strain TM136 carrying plasmids encoding the genes indicated. The wild type strain was 
strain JK1. Panel D: Growth of lipB lplA fabA strain QC168 containing plasmids 
expressing the genes indicated. Note that the host strain was fabA to prevent possible 
decanoyl adduct modification of the B. subtilis proteins. Growth of the strain carrying 
the p (lplJ) plasmid on the unsupplemented plate is due to scavenging of the 
endogenous octanoic acid present in E. coli by high levels of ligase  (Hermes et al., 
2009).
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Figure 4-5. The B. subtilis lipoate salvage enzyme is a lipoate-protein ligase. Panel A: An 
SDS-PAGE gel (4-20% acrylamide) containing ~2 µg of each of the indicated purified 
proteins is shown. The molecular weight marker standards in kilodaltons are given. 
Panel B: Formation of the acyl adenylate intermediates by LplJ in the first partial 
reaction of the ligase reaction using [α-32P]ATP incorporation assayed by thin layer 
chromatography. Addition of an acyl acceptor domain results in consumption of the 
intermediate with production of AMP. Panel C: Gel shift assay of LplJ using either the 
E2AceF E. coli hybrid lipoyl domain or B. subtilis GcvH as acyl acceptors. The proteins were 
visualized by either Coomassie R250 staining or by western blotting with anti-lipoic acid 
antibody (Anti-LA) as indicated. Panel D: Electrospray mass spectra of GcvH after LplJ 
treatment with either octanoate or lipoate as acyl donors. Panel E: Assay of purified 
proteins for octanoyl ligation using GcvH as the substrate acceptor domain. NE denotes 
the control reaction that lacked enzyme. 
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Figure 4-6. Complementation of B. subtilis mutants deficient in lipoate synthesis by 
expression of E. coli LipB. B. subtilis strains JH642 (wild type), NM57 (∆lipM), NM11 
(∆lipM amyE::Pxyl-lipB), NM51 (∆lipL), NM12 (∆lipL amyE::Pxyl-lipB), CM28 (∆lipL ∆lipM) 
and NM14 (∆lipL ∆lipM amyE::Pxyl-lipB) were streaked onto minimal medium-glycerol 
plates with or without the addition of 0.1% xylose and incubated for 24 h at 37°C. These 
data were produced by Natalia Martin. 
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Figure 4-7.  LipM acts before LipL. Autoradiogram of an SDS-PAGE gel of the products of 
octanoyltransfer assays from octanoyl-ACP (synthesized with AasS) to GcvH. The enzyme 
source were crude extracts of the indicated B. subtilis strains. All strains, including the 
“WT”,  carried an ∆lplJ lesion to prevent possible complications by ligation of octanoate.  
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Figure 4-8. Liquid chromatography-tandem mass spectrometric analysis of PDH lipoyl 
domain tryptic peptides. Panel A. The modification states of PDH residue K43 detected. 
Panel B. The sequence of the PDH lipoyl domain is given.  The sequences of the peptides 
detected that contained K43 are shown in bold type. “None” denotes that no distinct 
peaks for modified forms were observed. These data were produced primarily by Natalia 
Martin with my guidance. 
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CHAPTER 5 
A NOVEL AMIDOTRANSFERASE REQUIRED FOR LIPOIC ACID  
COFACTOR ASSEMBLY IN BACILLUS SUBTILIS 
 
INTRODUCTION 
Comparative genomics allows for detection of incomplete metabolic models. 
Analysis of discrepancies in our knowledge provides opportunities for new discoveries. 
Here I describe the analysis of an “extra” protein required for lipoic acid metabolism in 
Bacillus subtilis, homologues of which are found in nearly all sequenced Firmicutes 
genomes. The Firmicutes, also known as the low G+C gram-positive bacteria, are a 
phylum present throughout the environment and includes many pathogens. B. subtilis is 
the best characterized of this group and has been subject to intense genetic study since 
the discovery of its natural competence in 1958 (Spizizen,1958).  B. subtilis is a 
facultative spore-forming bacterium that grows in chemically defined medium lacking 
lipoic acid (Spizizen,1958).  In general, lipoic acid is required for aerobic, energy-
conserved metabolism of 2-oxoacids and glycine, pyruvate dehydrogenase being the 
canonical lipoate-requiring enzyme (Perham,2000). In B. subtilis, pyruvate 
dehydrogenase activity is required for growth under both aerobic and anaerobic 
conditions (Nakano et al., 1997), and thus, it is clear that B. subtilis must synthesize the 
cofactor (Spizizen,1958). 
The lipoyl domain modifying enzymes are grouped with those that modify 
biotinyl domains into Pfam PF03099. There are very few residues that are absolutely 
conserved within the family, a lysine residue being the sole conserved residue  (Reche, 
2000). However, there is sufficient transitive homology throughout the sequences to 
allow grouping  (Reche,2000).  Despite this lack of sequence conservation, the enzymes 
have considerable structural similarity including a conserved folding pattern  (Ma et al., 
2006). Lipoyl ligases have an additional accessory domain, which has been shown to be 
required for adenylation, but not for acyltransfer (Chapter 2). Comparisons of the crystal 
structures of LplA obtained with and without the acyl adenylate intermediate show that 
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the accessory domain rotates away from the active site following adenylate formation, 
thereby allowing interaction with the substrate lipoyl domain (Fujiwara et al., 2010). 
Interestingly, many proteins of the LplA family lack a C-terminal accessory domain. This 
may be due to the domain being a separate protein, as is the case in Archaea (Chapter 
2). One of these single domain LplA homologues, B. subtilis LipM, has been shown to be 
a new ACP:GcvH octanoyltransferase isozyme (Chapter 3). 
GcvH is a lipoyl acceptor protein that consists of a single lipoyl domain and is a 
key component of the glycine cleavage system. Although the glycine cleavage system is 
lipoic acid dependent, its inactivation is not known to cause a growth defect in any 
bacterium. The well-characterized glycine cleavage systems consist of four proteins, 
GcvH, GcvT, GcvP and GcvL. In B. subtilis expression of only the T and P subunits is under 
control of a glycine-activated riboswitch  (Mandal et al., 2004). No dedicated GcvL 
subunit is apparent, but this function (oxidation of the lipoate moiety) may be provided 
by the E3 subunit that is shared among the 2-oxoacid dehydrogenases, as is the case in 
E. coli  (Steiert et al., 1990). Given its key role in transfer of the methylamine group of 
glycine from the P subunit to the T subunit, it is surprising that GcvH is not encoded 
together with the T and P subunits, but rather at a remote genomic location where no 
recognizable riboswitch is detected  (Mandal et al., 2004). In this chapter I demonstrate 
that B. subtilis GcvH is both a substrate and a required component of the lipoic acid 
biosynthesis pathway. 
Based on the E. coli model, the characterized LipA lipoyl synthase  (Martin et al., 
2009) and the newly described LipM octanoyltransferase (Chapter 2) should suffice for 
lipoic acid synthesis and attachment in B. subtilis. However, a third gene, lipL, is also 
required for lipoyl domain modification. LipL belongs to the Pfam PF03099 family and 
lacks an accessory domain. In this chapter I describe the novel biosynthetic requirement 
for LipL and the unexpected reaction catalyzed by this new enzyme. Based on these data 
I present a novel pathway for lipoic acid biosynthesis. 
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EXPERIMENTAL PROCEDURES 
Media and Chemicals 
E. coli strains were grown on LB rich or M9 minimal media  (Sambrook et al., 
2001) under aerobic conditions at 37oC unless otherwise indicated. Antibiotics (Sigma 
Chemical Co) were used at the following concentrations for E. coli (in µg/ml): sodium 
ampicillin, 100; kanamycin sulfate, 50; spectinomycin sulfate, 50; chloramphenicol, 12; 
gentamycin sulfate, 25 and tetracycline hydrochloride, 12. Difco Vitamin-Assay 
Casamino Acids was obtained from Becton, Dickenson. [1-14C]octanoic acid and [1-
14C]octanoyl-CoA were purchased from Moravek. American Radiolabeled Chemicals 
provided [α-32P]ATP. The pH of buffers and solutions is reported at room temperature. 
Bacterial Strains and Plasmids 
Strains and plasmids used are shown on Table 4-1 and Table 4-2 respectively. 
Primers used in this chapter are given in Table 4-3. Standard techniques for DNA 
manipulation and cloning were employed unless otherwise indicated  (Sambrook et al., 
2001). PCR amplification was performed using Taq (New England Biolabs) or Pfu 
(Stratagene) polymerase according to the manufacturer’s recommendation, except with 
the addition of 5% dimethyl sulfoxide to Pfu reactions. 
 The genes encoding proteins containing lipoyl domains were placed under the 
control of a T7 promoter. The lipoyl domain from B. subtilis PdhC (E2PdhC) was identified 
by alignment with the B. stearothermopolis lipoyl domain isolated by V8 protease 
digestion (Packman et al., 1988) and this portion of the pdhC gene was PCR amplified 
using primers Q030 and Q031 (the latter primer added a termination codon). After 
digestion with NcoI and BamHI this product was inserted into pET28b+ cut with the 
same enzymes to give pQC023. The full-length pyruvate dehydrogenase E2p subunit 
(pdhC) was PCR amplified using primers Q095 and Q096 (which added a C-terminal 
hexahistidine tag) and inserted into pCR2.1 using the TA cloning kit. The pdhC insert was 
then moved into pRSF-1b using the NcoI and BamHI sites to give pQC047. The 
biotin/lipoic acid protein (BLAP) was PCR amplified using primers Q034 and Q042 (which 
added a C-terminal hexahistidine tag) and inserted into pCR2.1 using the TA cloning kit. 
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The BLAP insert was then moved into pET28b+ using the NcoI and BamHI sites to give 
the pQC026. 
 In order to minimize proteolysis of the full length PdhC, the protein was 
expressed in a strain lacking the OmpT protease, which cleaves the flexible linker region  
(Lessard et al., 1998). The ompT::Km mutation was constructed as described (Baba et 
al., 2006) to give strain RMK98. The ompT::Km mutation was transduced to strain 
QC146 with a phage P1 stock grown on strain RMK98 to give strain QC171. The 
kanamycin cassette was removed (Datsenko et al., 2000) to give strain QC172 and the 
deletion was confirmed by PCR using primers Q113 and Q114. 
 Mutants of LipL were produced by modification of pQC033 using QuickChange 
mutagenesis as per the manufacturers recommendations (Agilent). Primers were used 
for the corresponding mutations were: Q147/Q148 for K148A, Q149/Q150 for K148R, 
Q151/Q152 for C150A, Q153/Q154 for C150R, Q171/Q172 for C39A, Q173/Q174 for 
C39S, Q175/Q176 for Y180A, Q177/Q178 for Y180F. 
B. subtilis mutant strains were constructed by Natalia Martin. The gcvH deletion 
mutant, strain NM20, was obtained by transformation of strain JH642 with plasmid 
pNM67. This plasmid was constructed as follows. A 418 bp fragments from the 5’ end 
and upstream region of the gene was PCR amplified with oligonucleotides L and LI 
(Table 5-3)and inserted into BamHI and EcoRI sites of pJM114 (Perego,1993).  In the 
same manner a 434 bp fragment containing the 3’ end and downstream region of the 
gene was PCR amplified with oligonucleotides LII and LIII and cloned into XhoI and KpnI 
sites from the previously generated plasmid, yielding plasmid pNM67. This plasmid was 
linearized and used to transform JH642. 
Strain NM20 was complemented with an ectopic wild type copy of gcvH under 
an IPTG dependent promoter (Pspac) integrated at the amyE gene. To this end plasmid 
pNM70 was constructed by cloning of a 456 bp PCR-amplified fragment generated with 
primers XLVI and XLVII into the HindIII and BamH sites of pGES485 (Schujman GE, 
unpublished). Plasmid pNM70 was linearized and used to transformed strain NM20, 
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yielding strain NM21. Transformants were selected on kanamycin plus spectinomycin 
plates and screened for amyE phenotype. 
Purification of Lipoyl Domains 
 Purification of GcvH. Hexahistidine-tagged B. subtilis GcvH was heterologously 
expressed in E. coli and purified by nickel affinity and anion exchange chromatographic 
steps as previously described (Chapter 3). GcvH was verified to be in the unmodified 
form lacking the N-terminal methionine residue by electrospray mass spectrometry as 
previously described (Chapter 3) and was quantified by absorbance at 280 nm using a 
calculated extinction coefficient of 16,960 M-1 cm-1. 
The E. coli E2p (1,3) hybrid lipoyl domain (LDAceF) was purified by acid treatment 
followed by ion exchange chromatography as described previously  (Zhao et al., 2003). 
Mass spectroscopy analysis was performed as described for GcvH (Chapter 3). The E2AceF 
was in the unmodified form and lacked the N-terminal methionine residue. The E2AceF 
lacks tryptophan and tyrosine residues, it was quantified using the Bradford assay 
reagent (Bio-Rad) with bovine gamma globulin (Pierce) as a standard.  
To purify E2PdhC, strain QC063 was grown in LB with kanamycin to an OD600 of 
0.6. Protein expression was induced with 1 mM IPTG and the culture was incubated for 
another 2 h before the cells were pelleted by centrifugation and frozen at -80C. The cells 
were lysed by passage through a French pressure cell and the E2PdhC was purified by pH 
precipitation and anion exchange chromatography and prepared for mass spectrometry 
as described  (Zhao et al., 2003). The anion exchange protocol allows resolution of the 
unmodified and modified forms of the domain as shown by 20% native PAGE. The 
modification state of the E2PdhC was verified to be in the unmodified form without the N-
terminal methionine by electrospray mass spectrometry as described above for ACP 
(Chapter 3). E2PdhC was quantified by absorbance at 280 nm using an extinction 
coefficient of 6,990 M-1 cm-1.  
The B. subtilis BLAP protein was expressed using strain QC152 and purified by 
nickel affinity and anion exchange chromatographic steps as described for LplA (Chapter 
2).  BLAP was verified to be in the unmodified form lacking the N-terminal methionine 
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by electrospray mass spectrometry as described for ACP (Chapter 3) and was quantified 
by absorbance at 280 nm (extinction coefficient of 5,500 M-1 cm-1). B. subtilis PdhC was 
expressed using strain QC191 and purified by nickel affinity and anion exchange as 
described for LplA (Chapter 2). PdhC was quantified by absorbance at 280 nm using an 
extinction coefficient of 18,450 M-1 cm-1. To determine if the C-terminal hexahistidine 
tag interfered with complex formation, I subjected pure PdhC to size exclusion 
chromatography as described for LipM (Chapter 3). 
Purification of Lipoate Metabolism Enzymes 
LipB was purified by nickel affinity and anion exchange as described  (Jordan et 
al., 2003). LipB was quantified by absorbance at 280 nm using an extinction coefficient 
of 22,920 M-1 cm-1.  LplJ was purified from strain QC103 by nickel affinity and anion 
exchange as described for T. acidophilum LplA (Chapter 2). LplJ was quantified by 
absorbance at 280 nm using an extinction coefficient of 34,380 M-1 cm-1.  LipM and LipL 
were also purified from the E. coli fabA strains QC142 and QC143, respectively, as 
described for LipM and analyzed by MALDI MS as previously described (Chapter 3). LipL 
was also purified from strain QC083 grown in the absence of triclosan. LipM and LipL 
were quantified by absorbance at 280 nm using extinction coefficients of 45,380 and 
25,900 M-1 cm-1, respectively.  The purified proteins were concentrated with Vivaspin 
centrifuge concentrators (GE Healthcare) and flash frozen for storage in as above except 
that the buffer contained 100 mM sodium chloride. 
Trypsin Digestion and LC-MS/MS Analysis of LipL  
Trypsin digestion and LC-MS/MS analysis of LipL was performed as previously 
described for LipM (Chapter 3). Analysis was performed on LipL from QC083 grown 
without triclosan and from the fabA strain QC143 grown with triclosan. 
Lipoic Acid Ligation Assay 
Octanoyl ligase activity was assayed to determine the LD substrate specificity of 
LplJ. The reaction contained 100 mM sodium phosphate (pH 7.0), 50 mM sodium 
chloride, 5 mM TCEP, 0.25 mM sodium [1-14C]octanoate, 1 mM magnesium chloride, 1 
mM ATP, 20 µM lipoyl domain and 1 µM LplJ. The reaction was analyzed using a 
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modification of the method of Laskey and Mills (Laskey et al., 1975) in which 10 µl of the 
reactions were subjected to SDS-PAGE on 4-20% gradient gels which were soaked in 
Amplify fluorographic reagent (GE Healthcare), dried, and exposed to preflashed Biomax 
XAR film (Kodak) at -70°C for 24 h. 
Assay of octanoyl-[Acyl Carrier Protein]:Protein N-octanoyltransfer 
Octanoyltransfer by LipM and LipB was assayed in order to determine the lipoyl 
domain substrate specificity of these enzymes. Assays using AasS were performed as 
previously described (Chapter 3) with different lipoyl domains substituted for GcvH. 
Reactions were analyzed as described above with LplJ. 
Assay of amidotransfer 
Amidotransfer was assayed by coupling to lipoyl ligation by LplJ. The reactions 
contained 100 mM sodium phosphate (pH 7.0), 50 mM sodium chloride, 5 mM TCEP, 
0.25 mM sodium [1-14C]octanoate, 1 mM magnesium chloride, 1 mM ATP, 20 µM GcvH, 
20 µM PdhC, 1 µM LipL, and 1 µM LplJ. The reactions were analyzed as described above 
for the LplJ assays.  
Amidotransfer was also assayed by coupling to octanoyltransfer by LipM. The 
reactions contained 100 mM sodium phosphate (pH 7.0), 50 mM sodium chloride, 5 mM 
TCEP, 0.25 mM sodium [1-14C]octanoate, 1 mM magnesium chloride, 1 mM ATP, 50 µM 
holo-AcpP, 2 µM AasS, 20 µM GcvH, 20 µM PdhC, 10 µM LipL and 10 µM LipM. 
Reactions were analyzed as described for the LplJ assays above. 
B. subtilis crude extracts were also assayed for LipM and LipL activities. The 
cultures were grown in Spizizens minimal salts (Spizizen,1958) supplemented with 0.5% 
glucose, 10 mM sodium acetate, 10 mM sodium succinate, 0.1 mM sodium isovalerate, 
0.1 mM sodium isobutyrate, and 0.1 mM sodium 2-methylbutyrate. Cultures were 
grown to an OD600 of 0.6, pelleted by centrifugation, frozen at -80°C, and lysed in 100 
mM sodium phosphate (pH 7.0) by sonication. The reaction conditions were the same as 
the LipM coupled assay with enzyme or 50 µg of extract protein added where indicated. 
Reactions were analyzed as described for the LplJ assays above. 
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In order to directly assay amidotransfer [1-14C]octanoyl labeled GcvH was 
prepared using LplJ. The reaction contained 100 mM sodium phosphate (pH 7.0), 50 mM 
sodium chloride, 5 mM TCEP, 1 mM sodium [1-14C]octanoate, 2 mM ATP, 0.5 mM GcvH, 
and 10 µM LplJ. The reaction was allowed to proceed at 37°C for 2 h. Then the reaction 
was diluted 20-fold in 25 mM sodium MES buffer (pH 6.1) and purified using anion 
exchange chromatography using AKTA purifier10 (GE Healthcare) with a 1.8 ml POROS 
QE anion exchange column with a flowrate of 5 ml per minute. Protein was bound with 
25 mM sodium MES buffer (pH 6.1) and eluted with a 0-1 M gradient of lithium chloride, 
where octanoyl GcvH eluted at 480 mM.  Purified lipoyl domains were stored as above 
except 5 mM TCEP was the reducing agent. Amidotransfer from purified 14C-octanoyl 
GcvH to various LDs was directly assayed. The reactions contained 100 mM sodium 
phosphate (pH 7.0), 50 mM sodium chloride, 5 mM TCEP, 20 µM [1-14C]octanoyl-GcvH, 
20 µM of different lipoyl domains, and 1 µM LipL. Amidotransfer reactions with mutant 
LipL proteins were performed with 10 µM LipL or mutant LipL plus E2PdhC domain as an 
additional lipoyl domain. The LipL acyl-enzyme intermediate was visualized using the 
same assay conditions lacking an acceptor domain and with 10 µM LipL or mutant LipL. 
The reactions were analyzed as described for the LplJ assays above. 
Immunoblotting Analysis 
Immunoblotting of crude extract was performed by Natalia Martin as described 
in Chapter 4. 
Phylogenetic Analysis and Bioinformatics  
I determined the phylogeny of select amino acid sequences of the LipB/LplA/BirA 
superfamily (PF03099), the biotin_lipoyl_domain superfamily (PF00364), and the glycine 
cleavage system H protein family (PF01597) (Finn et al., 2010). Alignment was 
performed using Dialign-TX with low scoring region length 4, low quality region length 
40, and unlimited sensitivity (Subramanian et al., 2008). The edges of the alignment 
were trimmed using Jalview (Waterhouse et al., 2009) so only the relevant domains 
remained. A minimum evolution tree was constructed with bootstrap analysis of 1000 
replicates using Mega4 (Tamura et al., 2007) using the default settings. All positions 
117 
 
containing gaps and missing data were eliminated from the dataset (complete deletion 
option). There were a total of 63 positions in the final dataset comparing lipoyl domains. 
There were a total of 57 positions in the final dataset that compared catalytic domains.  
Display of protein structures and structural alignments were performed using 
the Swiss PDB viewer (Kaplan et al., 2001). Protein extinction coefficients and 
theoretical masses were calculated using Protparam at the EXPASY website (Gasteiger et 
al., 2003) and used to determine molarity. The extinction coefficients were calculated 
on the assumption that all cysteine residues were in the reduced state. 
 
RESULTS 
Expression, Purification and Modification of LipL 
LipL (YwfL) was readily expressed in E. coli and purified as a soluble 
hexahistidine-tagged protein (Figure 5-1A). However, upon expression in E. coli 
Mycobacterium tuberculosis LipB and B. subtilis LipM are modified by attachment of acyl 
moieties (Ma et al., 2006) (Chapter 3). To determine if LipL purified from E. coli was 
modified, the protein was subjected to trypsin digestion and the resulting peptides were 
analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS). LipL was 
unusually amenable to this analysis, giving 88% coverage (Figure 5-1A). Two sites of 
modification were found: cysteine residues C39 and C150. Lipoyl and octanoyl 
modifications were present at both sites (Figure 5-1B) indicating that LipL accepted 
octanoate and lipoate from sources in E. coli. Assuming the reaction catalyzed by this 
enzyme is the same in B. subtilis, the substrates must be common to both organisms. 
The two cysteine residues are located on opposite sides of the LipL active site cleft (see 
below).  Unlike LipM and M. tuberculosis LipB, no decanoyl Michael adduct was found 
when LipL was expressed in a wild type strain of E. coli. 
LipM is Specific for GcvH 
Although LipM readily catalyzed octanoyltransfer from ACP to GcvH (Chapter 3), 
it was puzzling to find that the lipoyl domain of the B. subtilis pyruvate dehydrogenase 
PdhC subunit (E2PdhC) was a poor octanoyl acceptor substrate (Figure 2A). This was first 
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considered to be an artifact caused by using overly truncated lipoyl domains. However, 
the full length PdhC subunit was also a poor substrate. PdhC was purified in good yield 
and eluted slightly before catalase by size exclusion, indicating an octahedral complex. 
This was expected and indicates that the C-terminal hexahistidine tag does not interfere 
with complex formation. Moreover, E. coli LipB was able to modify all of the B. subtilis 
lipoyl domains tested indicating that the acceptor proteins were properly folded.  
However, the enigmatic biotin lipoyl acceptor protein (BLAP), a protein previously 
reported to be biotinylated and lipoylated when expressed in E. coli (Cui et al., 2006) 
(Figure 5-2) is not modified by any enzyme tested.   
These data led to the hypothesis that LipL is essential for PdhC modification and 
hence growth. To test this scenario octanoyltransfer assays were done with octanoyl-
ACP (generated in situ) as the acyl donor substrate (Chapter 3).  Similar to previous 
results (Figure 5-2) addition of only LipM and LipL failed to result in octanoylation of 
either E2PdhC or LipL (Figure 5-3A, lane 3). It was only in the presence of GcvH that 
octanoylation of LipL and E2PdhC proceeded (Figure 5-3A, lane 6).  
A similar phenomenon was also seen for the LplJ, which was identified and well 
characterized as a lipoyl ligase (Chapter 4). Although LplJ was able to ligate octanoate to 
the E. coli lipoyl domain (E2AceF), no modification of either B. subtilis E2PdhC or of full-
length B. subtilis PdhC was seen in vitro (Figure 5-2B). Addition of LipL to the LplJ 
reaction failed to give modification of E2PdhC (Figure 5-3B, lane 3). Only when GcvH, LipL 
and LplJ were all present did modification of E2PdhC proceed (Figure 5-3B, lane 5). These 
observations argued that modified GcvH was an obligate intermediate in the 
modification of E2PdhC. It also showed that LipL is required for PdhC modification. 
LipL is a Novel Amidotransferase 
Since an amide linkage attaches the octanoyl moiety of octanoyl-GcvH, LipL 
seemed to catalyze a novel amidotransfer reaction in which the active site cysteine thiol 
of LipL would attack the octanoyl-GcvH amide linkage to form octanoyl-S-LipL and would 
subsequently transfer the octanoyl moiety to E2PdhC to form a new amide moiety (Figure 
5-4D).  To test if LipL was a novel GcvH:E2 amidotransferase LipL activity was assayed 
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using purified [1-14C]octanoyl-GcvH as the donor substrate. Transfer of the octanoyl 
moiety to each of the PDH domains tested was observed whereas BLAP was not 
modified (Figure 5-4A). Transfer from GcvH to LipL was also observed (Figure 5-4C).  
I performed site-directed mutagenesis of residues conserved in the PF03099 
family to explore the LipL reaction mechanism. LipM K162 is a residue that is strictly 
conserved in PF03099 whereas Y180 is conserved in the LipL transamidase subfamily 
(Figure 5-5). Unfortunately, when expressed in E. coli both K162 substitutions (K162R 
and K162A) resulted in low levels of insoluble proteins, whereas substitutions of alanine 
or phenylalanine for Y180 had no effect on catalysis. I also mutated residues C39 and 
C150, both of which had been found to be modified by LC-MS/MS (Figure 5-1A). 
Replacement of C39 with alanine or serine had no effect on catalysis whereas 
replacement of C150 with either alanine or serine resulted in loss of transfer to E2PdhC 
(Figure 5-4B) and the inability to form an octanoyl-enzyme intermediate (Figure 5-4C). 
Given the above observations, I propose a mechanism for lipoyl domain amidotransfer 
by LipL (Figure 5-4D). 
Amidotransfer was also assayed in crude extracts of various B. subtilis mutant 
strains. Although LipM activity was observed, no amidotransfer by LipL was seen unless 
the extracts were supplemented with purified LipL and LipM (Figure 5-6). The reason for 
this discrepancy is not clear. Perhaps higher concentrations of octanoyl-GcvH are 
required to detect LipL activity, although transfer was not seen using purified [1-
14C]octanoyl-GcvH as a substrate (data not shown). Additionally, LipL may be present in 
low amounts under the growth conditions used or LipL may become inactivated during 
extract preparation. 
GcvH is Required for Protein Lipoylation In Vivo 
Our in vitro results argued that GcvH was an essential intermediate in lipoylation 
of PdhC and possibly BkdB. To test the model for lipoic acid biosynthesis in B. subtilis, 
Natalia Martin disrupted gcvH.  The ∆gcvH strain was a lipoic acid auxotroph, the same 
phenotype shown by ∆lipA and ∆lipM strains.  As observed in the other lipoate 
auxotrophs, the lipoate requirement of the ∆gcvH strain was bypassed by addition of 
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acetate and BCFA precursors. In vivo results showing that bypass of a ∆lipL mutation 
requires both acetate and branched chain fatty acid (BCFA) precursors indicates that 
LipL is also required for lipoic acid modification of the BkdB subunit of the essential 
branched chain dehydrogenase. Lipoic acid also restored growth suggesting that LplJ 
ligated lipoic acid to E2PdhC in the absence of GcvH (Figure 5-7A). Expression of a 
functional ectopic copy of the gcvH gene under the control of an inducible promoter 
allowed growth of the ∆gcvH strain when induced with IPTG (Figure 5-7B). This proves 
that the growth deficiency was due to the absence of a functional copy of the gcvH 
gene. When uninduced, growth is impaired although some is observed, likely due to 
basal expression from the spac promoter. Moreover, the expression of the E. coli lipB 
gene in a ΔgcvH mutant strain restored growth in minimal medium (data not shown). 
These results indicated that the LipB octanoyl transferase activity was sufficient to 
overcome the absence of GcvH, confirming its role in the octanoyl transfer from ACP to 
the lipoyl domains. 
LipM octanoyltransferase activity with GcvH as the acceptor was previously 
demonstrated in vitro (Chapter 3). Western blotting analysis with anti-lipoic acid 
antibodies showed a lipoylated protein of apparent mass of 20 kDa (Figure 5-7C). As 
shown in the companion paper, the GcvH band was detected in extracts of strains in 
which lipM was active. The gel migration of the band is consistent with the previously 
reported migration rate of GcvH (Chapter 3) and disruption of gcvH resulted in loss of 
the 20 kDa band (Fig 5-3C) thereby confirming its identity. Disruption of gcvH resulted in 
a complete loss of biosynthetic lipoic acid assembly (Figure 5-7C), confirming that GcvH 
was required in B. subtilis lipoic acid biosynthesis.  Upon supplementation with lipoic 
acid the ∆gcvH strain showed strong lipoylation of the dehydrogenase E2 subunits 
(Figure 5-7C) consistent with the robust growth seen in this medium (Figure 5-7A). 
These results confirm that the results of our biochemical assays are physiologically 
relevant. 
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LipL and LipB are Mechanistically Convergent 
Phylogenetic analysis of LipL compared to other members of PF03099 shows 
significant, albeit modest, support for B. subtilis LipL as part of a deeply branching clade 
related to lipoate protein ligases (Figure 5-8A). LipL is also closely related to LipM 
octanoyltransferases, which branch off later from the same lipoate protein ligase clade 
(Chapter 3). Indeed, the unpublished B. halodurans LipL structure (PDB entry 2P5I) is the 
closest available structure to LipM. The positions of the catalytic cysteine residues (C150 
in both proteins) are very similar in LipM and LipL. Upon structural alignment of LipL 
with M. tuberculosis LipB (PDB 1W66) the catalytic cysteine residues are located only 
2.34 Å apart (Figure 5-9). This was unexpected because the residues are contributed by 
different loops that are ~45 residues removed in sequence alignments (Chapter 3). 
Therefore, it appears that LipL and LipB have undergone mechanistic convergence 
within their active sites using the same protein scaffold. 
 
DISCUSSION 
I report delineation of a new pathway of lipoic acid synthesis in which octanoyl 
moieties are transferred from the ACP of fatty acid synthesis to the GcvH protein of the 
glycine cleavage system by LipM. I characterized the pathway in B. subtilis, although 
orthologous genes are present in other Firmicutes which synthesize lipoic acid. The 
octanoyl moieties are then transferred by LipL, a novel GcvH:E2 amidotransferase, from 
GcvH to E2 subunits to form active dehydrogenase complexes (Figure 5-10).  Note that 
at this stage of our investigations it is not clear at what step(s) LipA acts. It is possible 
that LipA inserts the sulfur groups before LipL transfer, after LipL transfer, or at both 
steps. 
The requirement for LipL is due to the specificity of the LipM for GcvH. I find 
significant in vitro modification of the E2AceF by LplJ, but not by LipM (Figure 5-2) 
suggesting LplJ may be less specific than LipM. However, LipM complements an E. coli 
lipoic acid auxotroph (Chapter 3), which demonstrates modification of E2AceF. These data 
indicate that restoration of growth is a much more sensitive assay than the in vitro 
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radiolabel assay. This is expected since growth results from protein lipoylation which 
results in dehydrogenase catalysis with a concomitant amplification of the signal. 
Another difference is that lipoylation of PdhC may occur in vivo after the protein has 
been assembled into the PDH complex rather than as the free subunit I tested in vitro. 
The E2AceF and E2PdhC domains clearly form different clades indicating different 
conserved residues (Figure 5-8B). This may explain why LplJ is able to modify E2AceF but 
not E2PdhC. The residues responsible for the observed differences in substrate 
recognition will require further study. 
The amidotransfer reaction (also called transamidation) catalyzed by LipL was 
unexpected, but not unprecedented. The sortase transpeptidases that anchor proteins 
to the outer surfaces of various gram-positive bacteria use a Cys-His-Asn triad in their 
amidotransfer reaction (Clancy et al., 2010). Moreover, peptide bond synthesis 
catalyzed by cysteine proteases (Morihara et al., 1981) employs this same catalytic triad. 
The DD-transpeptidase/carboxypeptidases of bacterial cell wall biosynthesis employ a 
Ser-Lys-Tyr catalytic triad (Silvaggi et al., 2003) and substitution of cysteine for the 
nucleophilic serine residue in closely related enzymes often results in active enzymes 
(Hadonou et al., 1992). In our work, LipL residues C39 and C150 were found to be 
acylated.  However, C39 was not essential for catalysis (Figure 5-4B) and is not 
conserved in more diverse members of the LipL clade (Figure 5-5). (Acylation of C39 may 
have resulted by trans-thioesterification from C150 during the overnight trypsin 
digestion.)  Mutagenesis of LipL C150 resulted in loss of enzymatic activity and the 
inability to form an acyl-enzyme intermediate (Figure 5-4), which is the same result seen 
upon mutagenesis of the active site LipM cysteine residue (Chapter 3).  Based on the B. 
halodurans LipL crystal structure K162 and Y180 are less than 3 Å from C150 (Figure 5-
10). I found that these residues are conserved in all members of the LipL clade (Figure 5-
9). From these data, it seemed likely that LipL employed a Cys-Lys-Tyr catalytic triad 
similar to those seen in other amidotransferases. However, I found that Y180 was not 
required for amidotransfer as the Y180F and Y180A proteins was active. Therefore, I 
propose that LipL amidotransferases utilize a Cys-Lys dyad as do the LipB and LipM ACP-
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octanoyltransferases (Ma et al., 2006) (Chapter 2).  If so, this would a novel active site 
configuration for an amidotransferase (transamidase). 
The B. subtilis biotin-lipoyl acceptor protein (BLAP) was reported to be at least 
partially modified with lipoate when expressed in E. coli (Cui et al., 2006). In that work 
the concentration of lipoic acid added to the culture medium corresponded to >60,000-
fold excess over that needed for half-maximal growth of a lipA strain (Reed et al., 1993). 
As previously reported (Cui et al., 2006), I found that most of the BLAP was in the 
unmodified form after two hours of expression. It was thought that BLAP might a good 
candidate for intermediate carrier in lipoic acid biosynthesis. However, I assayed BLAP 
as an octanoyl acceptor and found it was not modified by any enzyme tested (Figure 5-
2, 5-3A). The role of BLAP in B. subtilis remains unknown, but it does not appear to be 
involved in lipoic acid metabolism.  
Although the data presented in these papers provide a good working model of 
lipoic acid biosynthesis, a conflicting view of lipoic acid scavenging emerges. As shown in 
the companion paper, addition of external lipoic acid only partially restored growth of a 
∆lipL mutant and modification of E2PdhC by LplJ was not seen in vitro (Figure 5-2B) 
whereas growth of the ∆gcvH strain was fully restored by lipoic acid (Figure 5-5A) and 
the dehydrogenase E2 subunits became highly modified (Figure 5-5C). One possibility is 
LplJ activity may be lower in a lipL strain or higher in a gcvH strain. If there is an 
allosteric or regulatory effect, it would have to be large, as Natalia Martin finds the 
phenotypes are the same over a wide range of lipoic acid concentrations (0.5 nM-0.5 
mM) (data not shown). An alternative explanation would be that deletion of lipL results 
in global changes in gene expression making lipoyl scavenging insufficient to restore the 
required enzymatic activities. This may be why an unusual E2 lipoylation pattern was 
seen in the western blot of a ΔlipL strain (Chapter 4). 
A similar mechanism based on genetic analyses has been proposed for the yeast, 
Saccharomyces cerevisiae, where it was found that the glycine cleavage system H 
protein Gcv3 is not only a target for lipoylation, but also is necessary for the lipoylation 
of the other lipoate-modified proteins, the 2-oxoacid dehydrogenases (Schonauer et al., 
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2009). These workers favor a model of complex formation and allosteric interactions. A 
model in which Lip2, the yeast LipB homolog, transfers the octanoyl moiety from 
octanoyl-ACP to Gcv3, where two sulfur atoms are inserted into the acyl chain by Lip5 
(the yeast LipA homolog) was also proposed (Hiltunen et al., 2010). The lipoyl moiety 
would then be transferred to the 2-oxoacid dehydrogenases by a LplA homologue called 
Lip3.  It is tempting to speculate that Lip3 might perform the same reaction as B. subtilis 
LipL. 
It is not clear why B. subtilis routes the synthesis of the essential lipoate cofactor 
through GcvH.  Given that this bacterium has a predominately aerobic life style, if 
routing were needed, PDH would seem more the likely intermediate especially since the 
role of the glycine cleavage system in bacterial metabolism is obscure. It should be 
noted that GcvH lipoyl domains are highly divergent from the dehydrogenase E2 lipoyl 
domains (Figure 5-8B).  This divergence may explain how GcvH behaves as a distinct 
acceptor protein.  In B. subtilis, strains carrying a gcvH disruption grow well when 
provided with lipoic acid or the products of the inactivated dehydrogenases (Figure 5-
7A), which indicates that GcvH does not play an essential role in amino acid or single 
carbon metabolism. Natalia Martin showed that E. coli lipB complements both ∆lipM 
and ∆lipL mutant strains (data not shown). Some evolutionary pressure may exist for B. 
subtilis to maintain the specificity of LipM for GcvH. Instead of a rational phenomenon, 
it may be the result of constructive neutral evolution (Gray et al., 2010). It may be that 
LipM coevolved with the glycine cleavage system and LipL provided a means for it to be 
used for other dependent complexes. A more careful bioinformatic analysis may reveal 
the ancestral states of the pathway. 
B. subtilis is predicted to encode all five known lipoic acid dependent complexes: 
pyruvate dehydrogenase, 2-oxoacid dehydrogenase, branched keto acid 
dehydrogenase, acetoin dehydrogenase and glycine cleavage system. Amidotransfer of 
octanoyl/lipoyl moieties may provide B. subtilis with the ability to quickly adapt to 
changing environments by transferring lipoic acid among different enzymes. 
Alternatively, the extra step in the biosynthetic pathway may provide additional 
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opportunities for regulatory control. B. subtilis has previously been shown to utilize 
lipoic acid as a sulfur source (Mansilla et al., 1997).  Although it is unlikely that lipoic acid 
would be a significant source of sulfur in most environments, lipoylation could be used 
as an indirect readout of sulfur availability. No transcriptional regulation of lipoic acid 
biosynthesis has been found in E. coli (Cronan unpublished) or Salmonella enterica  
(Smith et al., 1991). However, B. subtilis lplJ has been shown to be induced during spore 
outgrowth (Keijser et al., 2007) and lipM and lplJ are induced in response to valine (Ye et 
al., 2009). Constitutive expression of GcvH would allow it to be always available to act as 
a lipoate transfer protein regardless of glycine supplementation. Clearly, there is much 
to be learned about the physiological and ecological implications of this pathway. 
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TABLES 
 
Table 5-1. Strains used in this chapter. 
Strain Genotype Source 
  Escherichia coli:   
MG1655 rph-1 CGSC* 
RMK98 MC1061 fadK::his6-cat ΔompT::FRT  This chapter 
QC146 rph-1 ΔlplA::FRT ΔlipB::FRT  (Chapter 2) 
QC152 rph-1 ΔlplA::FRT ΔlipB::FRT / pTARA, pQC026 This chapter 
QC172 rph-1 ΔlplA::FRT ΔlipB::FRT ΔompT::FRT  This chapter 
QC191 rph-1 ΔlplA::FRT ΔlipB::FRT ΔompT::FRT / pQC047, pTARA This chapter 
QC222 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pQC077, pCY598 This chapter 
QC223 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pQC078, pCY598 This chapter 
QC224 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pQC079, pCY598 This chapter 
QC225 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pQC080, pCY598 This chapter 
QC255 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pQC086, pCY598 This chapter 
QC256 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pQC087, pCY598 This chapter 
QC257 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pQC088, pCY598 This chapter 
QC258 rph-1 IN (rrnD-rrnE)1 φ (fabA-lacZ)1 (Hyb)cat / pQC089, pCY598 This chapter 
  Bacillus subtilis:   
JH642 trpC2 pheA1 Laboratory stock 
NM20 JH642 gcvH:: Km This chapter 
NM21 NM20 amyE::Pspac-gcvH This chapter 
*CGSC, E. coli genetic stock center. 
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Table 5-2. Plasmids used in this chapter. 
Plasmids Relevant Properties Source 
Ptara pACYC origin, arabinose inducible T7 polymerase (Wycuff et al., 2000) 
pCY598 RSF origin, arabinose inducible T7 polymerase (Cronan,2003) 
pCR2.1 TOPO TA cloning vector Invitrogen 
pSJ120 E. coli LipB expression vector (Jordan et al., 2003) 
pQC023 B. subtilis E2p lipoyl domain expression vector This chapter 
pQC026 C-terminal hexahistidine BLAP expression vector This chapter 
pQC033 N-terminal hexahistidine LipL expression vector Chapter 4 
pQC047 C-terminal hexahistidine PdhC expression vector This chapter 
pQC077 N-terminal hexahistidine LipL K162R mutant expression vector This chapter 
pQC078 N-terminal hexahistidine LipL K162A mutant expression vector This chapter 
pQC079 N-terminal hexahistidine LipL C150A mutant expression vector This chapter 
pQC080 N-terminal hexahistidine LipL C150S mutant expression vector This chapter 
pQC086 N-terminal hexahistidine LipL C39A mutant expression vector This chapter 
pQC087 N-terminal hexahistidine LipL C39S mutant expression vector This chapter 
pQC088 N-terminal hexahistidine LipL Y180A mutant expression vector This chapter 
pQC089 N-terminal hexahistidine LipL Y180F mutant expression vector This chapter 
pGES485 Integrational vector; Sp This chapter 
pJM114 Integrational vector; Km (Perego,1993) 
pNM67 pJM114 containing gcvH interrupted with a kanamycin cassette This chapter 
pNM70 pGES485 containing gcvH cloned into HindIII-BamHI sites This chapter 
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Table 5-3. Primers used in this chapter. 
Oligonucleotides Sequence 5’-3’ 
Q030 ttaaccatggcatttgaatttaaacttcc 
Q031 aatggatccttaaaattgaagatcttcgtaacc 
Q034 gaaacagcacctataaaggaggca 
Q042 ttaatgatgatgatgatgatgttgagtggaattgctcagttcg 
Q095 taaggtaccaaggagatataccatggcatttgaatttaaacttc 
Q096 attggatccttagtgatggtgatggtgatgcgcctccattaaaattaattg 
Q113 aacggataagacgggcataa 
Q114 gggatgaaggaacgtcattt 
Q147 ctatgacctcagtataaatggcaaagcgttcgccggcatct 
Q148 agatgccggcgaacgctttgccatttatactgaggtcatag 
Q149 cagctatgacctcagtataaatggcaaacgtttcgccggcatctct 
Q150 agagatgccggcgaaacgtttgccatttatactgaggtcatagctg 
Q151 ctatgaaattgaagggtcttattctcccggcagcta 
Q152 tagctgccgggagaataagacccttcaatttcatag 
Q153 agcctatgaaattgaagggtcttatgctcccggcagctat 
Q154 atagctgccgggagcataagacccttcaatttcataggct 
Q0171 gcaatggatgatacgctagccatgtccgtcggaaaagg 
Q0172 ccttttccgacggacatggctagcgtatcatccattgc 
Q0173 cgcaatggatgatacgctatccatgtccgtcggaaa 
Q0174 tttccgacggacatggatagcgtatcatccattgcg 
Q0175 gcggcggagtcgctgttcaaattgctctctgtgcagata 
Q0176 tatctgcacagagagcaatttgaacagcgactccgccgc 
Q0177 cggcggagtcgctgttcaaatttttctctgtgcaga 
Q0178 tctgcacagagaaaaatttgaacagcgactccgccg 
L agtggatccaagagcatgggaaag 
LI ttgtcgactcgtgttctcctgagtaa 
LII gagtcgacacaagaagactaaaacag 
LIII aaagactgcagtgaaattcaccgcca 
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FIGURES 
 
 
Figure 5-1. Panel A: Modifications of LipL detected after trypsin digestion followed by 
LC-MS/MS analysis. The theoretical peptides are shown with the modified cysteine 
residues in bold and underlined. The mass difference of the modification is given. The 
ion score is equal to -10log (P) where P is the probability the result is random chance. 
Panel B: Sequence coverage of LipL by LC-MS/MS analysis. The LipL peptide sequences 
detected are underlined. 
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Figure 5-2. Specificity of B. subtilis LipM, B. subtilis LplJ, and E. coli LipB for various lipoyl 
domains. The lipoyl domain tested as a substrate is indicated at the top of each lane and 
by an arrow. The [1-14C]octanoyl-ACP substrate is indicated by and arrow (for A and C).  
Autoradiograms of SDS-PAGE gels separating lipoyl domain substrate specificity assays 
are shown. The substrate [1-14C]octanoyl-ACP is indicated by an arrow. Free sodium [1-
14C]octanoate was used as a substrate for LplJ. Panel A: LipM octanoyltransfer to lipoyl 
domains from [1-14C]octanoyl-ACP generated using AasS. Panel B: Ligation of [1-
14C]octanoate by LplJ to lipoyl domains. Panel C: LipB octanoyltransfer to lipoyl domains 
from [1-14C]octanoyl-ACP generated using Vibrio harveyi acyl-ACP synthetase (AasS).  
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Figure 5-3. Panel A: Component controls for a coupled AasS/LipM/LipL assay starting 
with [1-14C]octanoate, which becomes ligated to ACP by AasS. Following the reaction the 
proteins were resolved by SDS-PAGE and visualized by autoradiography. The identities 
of the [1-14C]octanoylated proteins are indicated. Panel B: Component controls for a 
coupled LplJ/LipL assay as in Panel A. The starting substrates for ligation by LplJ in every 
condition are [1-14C]octanoate and ATP. 
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Figure 5-4. Autoradiograms of SDS-PAGE gels of assays for LipL-catalyzed amidotransfer 
from purified [1-14C]octanoyl-GcvH to lipoyl domains. Panel A: Amidotransfer of the [1-
14C]octanoyl moiety from purified octanoyl-GcvH to the unmodified lipoyl domain 
indicated. Each reaction contained purified WT LipL. Panel B: Amidotransfer from 
purified [1-14C]octanoyl-GcvH to the E2PdhC. The purified LipL wild type (WT) or point 
mutant proteins indicated were used as enzyme sources. Panel C: Additional enzyme 
was added to facilitate detection of the octanoyl-LipL intermediate. Wild type (WT), 
C150A point mutant, C150S point mutant LipL were assayed as well as a control lacking 
LipL (NE). Panel D: Schematic of the LipL amidotransfer reaction is shown with the acyl-
LipL intermediate. 
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Figure 5-5. Alignment of members of the LipL clade. Positions having 50% or greater 
similarity are highlighted in grey. The catalytic cysteine residue (C150 in B. subtilis LipL), 
the other modified cysteine residue (C39 in B. subtilis LipL), and the conserved PF03099 
lysine residue are highlighted in black. BACSU is Bacillus subtilis 168, BACHD is Bacillus 
halodurans, LISMO is Listeria monocytogenes, LACBA is Lactobacillus brevis and STRPC is 
Streptococcus pyogenes serotype M12 (strain MGAS9429). This alignment is part of the  
larger one used to create Figure 8A. 
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Figure 5-6. Autoradiograph of an SDS-PAGE gel of octanoyltransfer assays using AasS 
generated [1-14C]octanoyl-ACP as a substrate. Extracts of the mutant strains indicated 
were used as a source of enzyme for transfer to GcvH and PdhC. All strains also contain 
a disruption in lplJ. Purified LipM and LipL were added to replace the missing protein(s) 
where indicated with a plus sign.  
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Figure 5-7. Growth and lipoylation phenotypes of a B. subtilis ∆gcvH strain. Growth of 
strains on minimal glucose media plates with the supplements indicated after 48 hours 
at 37°C. LA denotes lipoic acid. Panel A: Growth of strains JH642 (wild type) and NM20 
(ΔgcvH). Panel B: Growth of strains JH642 (wild type) and NM21 (ΔgcvH amyE:: Pspac-
gcvH). Panel C: Lipoylation of GcvH in B. subtilis crude extracts. SDS-PAGE and 
immunoblotting with anti-LA antibody was done as described in Experimental 
Procedures. Cells were grown 22 hours in minimal media with or without lipoate added 
as indicated. Crude extracts of B. subtilis wild type (WT) and ∆gcvH strains were used as 
indicated. Data collected from experiments performed by Natalia Martin. 
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Figure 5-8. Minimum evolution phylogenetic analysis of alignments with bootstrap 
percentage values shown for each branch. The trees are drawn to scale, with branch 
lengths in the same units as those of the evolutionary distances used to infer the 
phylogenetic tree. The scale represents a 50% difference in compared residues per 
length. Panel A: Analysis of selected catalytic domains from PF03099 the structurally 
related biotin ligases are used as the out-group. Panel B: Selected lipoyl domains 
involved in lipoic acid metabolism are shown. 
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Figure 5-9. Structure of LipL and comparison with that of LipB. Panel A: The unpublished 
structure of LipL from B. halodurans (PDB 2P5I). The modified cysteine residues, C39 and 
C150, detected by LC-MS/MS are shown in red. Panel B: Structural alignment of LipL 
from B. halodurans with LipB from M. tuberculosis (PDB 1W66) (Ma et al., 2006). The 
active site adduct is shown in purple. Panel C: Close up view of the structural overlay 
with the LipB decanoyl adduct removed. The active site cysteine sulfur atoms are 
colored orange whereas carbon atoms are white. The distance between the two sulfur 
atoms is 2.4 Å. 
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Figure 5-10. Current models for lipoic acid biosynthesis in E. coli and B. subtilis. Lipoic 
acid synthesis in E. coli is accomplished by two enzymes whereas B. subtilis requires 
three enzymes. B. subtilis also requires GcvH as an intermediate carrier where E. coli 
does not. Data are lacking to determine whether LipA acts before or after LipL. I propose 
that B. subtilis, LipA uses octanoyl-LD (both octanoyl-GcvH and octanoyl-E2) as 
substrates, and therefore can act before or after LipL. 
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CHAPTER 6 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
SUMMARY AND NARRATIVE OF FINDINGS 
 In this Thesis I describe three new enzymes that make post-translational 
modifications of proteins for lipoic acid metabolism, adding to our knowledge of 
physiologically relevant lipoylation pathways (Figure 6-1). The first enzyme, the 
heterodimeric lipoyl ligase LplA-LplB, was well characterized structurally. The previously 
published suggestion (McManus et al., 2006) that this lipoyl ligase requires a small 
protein upstream was correct. This was also verified by a study concluded at the same 
time as mine  (Posner et al., 2009). The study by Posner et al. also demonstrated that 
the E2 is lipoylated in T. acidophilum extracts. Some spots at the bottom of the lane may 
be the H protein, which I and Natalia Martin have found is not amendable to western 
blotting  (Posner et al., 2009). My study in Chapter 2 goes further to find that this small 
protein, which is homologous to the C-terminal domain of other characterized ligases, 
and is required for adenylation but not lipoyl transfer. I call this the accessory domain. 
This finding was later supported by structural work that revealed that the C-terminal 
domain is in one conformation for adenylation but then rotates away from the active 
site for transfer (Fujiwara et al., 2010). This structural study casts doubt on the notion of 
a terinary complex composed of LplA, LplB, and lipoyl domain, as suggested by size 
exculsion (Posner et al., 2009). In Chapter 2, I found that LplA and LplB migrate 
anomalously by size exclusion, so they would co-migrate with the lipoyl domain. Futher 
experimental tests of the association of LplB (or the C-terminal domain) and the 
catalytic subunit in the presence of their substrates would be informative. It appears an 
Asp residue is conserved in the accessory domain (Figure 2-7). This residue is near 
others that contact the catalytic domain in structural studies of E. coli LplA  (Fujiwara et 
al., 2010). The contacting residues revealed by the structure are not conserved, 
however. Further experimental work could also explore residues important for 
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association of these two domains, and by extension for enzymatic activity.  By surveying 
the LplA catalytic domain protein family, I find many members are not predicted to have 
a C-terminal domain, or a candidate for a separate one, in the same genome.  This casts 
doubt on the annotation of other single domain proteins homologous to T. acidophilum 
LplA as lipoyl ligases. 
 The second enzyme I characterize in Chapter 3 is one such single-domain ligase 
homologue, LipM. I identified this gene using a complementation strategy which is 
unbiased by sequence similarity. Although the only gene found to be capable of 
complementing an E. coli lipB lplA mutant proved to be one of three genes in the 
genome with similarity to previously characterized proteins, this type of 
complementation strategy is a powerful and informative one. I have not been the first, 
nor will I be the last to use it. Although the complementation studies per se were 
straightforward, I had problems demonstrating activity with heterologously expressed, 
purified protein. Years went by where I tried looking for activity by various methods 
with various components added. Through careful analysis by mass spectrometry I found 
the mass was too large. Out of desperation I analyzed pure LipM by trypsin digest and 
LC-MS/MS, which was possible due to the Protein Sciences Center across the street. 
Although the technique is prone to false positives I found convincing evidence that LipM 
was modified by octanoate (the expected substrate) and decanoate (a covalent adduct). 
As a result I recommend that any protein purified should be subject to mass 
spectrometric analysis. MIT Professor of Biochemistry, Joanne Stubbe, goes further to 
recommend that proteins should be purified and studied from the native host at native 
expression levels (Cotruvo et al., 2011). From purification and derivitization I found that 
about 2% of the active site was modified with octanoate. This supports the finding of 
Bachar Hassan  (Hassan et al., 2011) that octanoyl-ACP, not lipoyl-ACP, is the 
physiologically relevant substrate. This also supports the assumption that LipM and LipB 
are largely irreversible.  Spurred on by the LC-MS/MS result I cloned and purified 
different lipoyl domains to test as a substrate. As reported in Chapter 3, the glycine 
cleavage system H protein worked well. The first four lipoyl domains I tried as substrates 
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did not work. The initial survey of the LplA family was interesting so I decided to do a 
more careful phylogenetic analysis of the family. I verified that LipM is more closely 
related to lipoyl ligases than to LipB octanoyltransferases. This is interesting because it 
doesn’t fit the definition of a non-homologous isofunctional enzyme (Omelchenko et al., 
2010). Although it is homologous to LipB, it is clear that it follows a different 
evolutionary path. Therefore, it appears that LipB and LipM are functionally convergent. 
This assumes the common ancestor of LipB and LipM was not an octanoyltransferase. It 
would be difficult to account for the sequence divergence if this were not the case. 
Because LipM catalyses the same reaction as LipB, it is a novel isozyme. A structure of 
LipM is lacking and efforts to obtain one are underway by the de Mendoza lab and 
others in Argentina. Orthologs of both LipM and LipB are encoded by cyanobacteria in 
the same genomes. It would be interesting to determine the interplay of these two 
enzymes in a photosynthetic organism. Although the role of lipoic acid biosynthesis in 
virulence has been determined for acomplexan parasites, no studies have been 
conducted in bacteria. 
 In Chapter 4 and 5, Natalia Martin and I combine our efforts to figure out lipoic 
acid biosynthesis in B. subtilis. It is certain I wouldn’t have gotten this far in this 
investigation without this collaboration, and I am fortunate things worked out for the 
best. Members of Diego de Mendoza’s lab had been musing about lipL for some time 
and they called my attention to it early in our collaboration. I added lipL to the list of 
genes I would study, while Martin knocked out everything predicted to be involved in 
lipoic acid biosynthesis. Our first results conflicted: Martin found that lipM and lipL were 
required for lipoic acid biosynthesis, while I found only lipM complemented E. coli. To 
make matters worse, I could not detect in vitro activity from either protein. This was 
unexpected because lipM could complement lipB, leaving us in an uncomfortable 
position for a couple years. It caused me to reevaluate everything, which reinforces that 
in biochemistry especially “the devil is in the details”. My first clue to what the problem 
was came from some early western blots I performed, where a small lipoylated protein 
showed up on some of my blots. It wasn’t reproducible so I dismissed it. The second clue 
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came when I assayed octanoylation of the full length E2 subunit by LipL and LipB with 
radiolabeled octanoyl-ACP as a substrate. Making octanoyl-ACP in the reaction with 
AasS was a convenience that improved signal and made the assay easier. I saw no 
activity until I added B. subtilis crude extract. It was then that I saw a faint small band. It 
seemed this was an intermediate protein substrate. I guessed it was GcvH and am 
fortunate that I was right, because identifying it through purification would have been 
much more work. I demonstrated activity of LipM. I tried “one last” series of 
experiments with LipL, but this time with GcvH added as well. Less than two months 
later I had activity for LipL as well. It was a new enzyme. Other amidotransfer reactions 
had been described. This one used novel substrates, and LipL does not resemble other 
amidotransferases by any metric. 
 A more careful analysis of lipoic acid scavenging and LipL should be done. Early in 
my studies I was puzzled by the distribution of LipL homologues in all Firmicutes that use 
lipoic acid, including ones that are natural auxotrophs. My data suggest that LplJ is fairly 
specific, while Martin’s data show that ligation depends on lipL but not gcvH. This is 
confusing, as one would have predicted from the ligation deficiency of a lipL strain that 
a gcvH would also be deficient in lipoic acid scavenge. A natural lipoic acid auxotroph 
would be ideal to determine the importance of LipL in scavenging. Of natural 
auxotrophs, Listeria is also interesting because of the uncertainty regarding the 
mechanisms for utilization of lipoyl peptides (Keeney et al., 2007). 
 
OBSERVATIONS ON PHYLOGENY 
 The metabolism of biotin and lipoic acid share common ancestry, although biotin 
biosynthesis requires additional enzymes. The enzymes responsible for sulfur insertion 
are homologous. The domains modified by lipoic acid and biotin, the lipoyl domain and 
biotin carboxyl carrier protein, respectively, are homologous. The enzymes that modify 
them are homologous as well. All such modification enzymes discovered so far belong to 
the BPL-LipB-LplA superfamily. Although it is a single Pfam entry (PF03099), it contains 
members catalyzing different reactions by the same mechanism, so it is best considered 
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a superfamily (Gerlt et al., 2001). The conserved reaction throughout the superfamily is 
the acylation of substrate proteins. LipL is the first member characterized that 
additionally catalyzes the reverse of this reaction. It should also be possible for a LipL-
like enzyme to transfer the acyl-enzyme intermediate to water instead of to another 
lipoyl domain, therefore acting as a lipoamidase. The only lipoamidase characterized so 
far is not in PF03099 (Jiang et al., 2005). Three major clades comprise PF03099, 
originally exemplified by biotin ligases, ACP:LD octanoyltransferases, and lipoate ligases 
(Figure 6-2). This study has characterized three novel enzymes from the lipoate ligase 
family. After these findings it is clear that the members of the LplA clade catalyze 
different reactions that are mechanistically similar, so it can also be considered a 
superfamily (Figure 6-3). 
 From examining the phylogeny of the lipoate ligase family we can draw some 
interesting conlcusions. Both the mammalian lipoyltransferases and yeast LIP3 are part 
of the same clade, shown in Figure 6-3. This suggests that LIPT and LIP3 are performing 
the same reaction, and that the transfer reaction of LIPT studied in vitro is not the 
physiologically relevant reaction. As suggested in Chapter 4, amidotransfer catalyzed by 
LIP3 would be consistent with the current data. The LIPT clade derives from within the 
major lipoate protein ligase clade near the proteobacterial LplA’s. This is consistent with 
the idea that LIPT and LIP3 derived from the mitochondrial predecessor before the 
endosymbiotic event. 
 The lipoyl ligase clades are distributed throughout the tree. Also, the earliest 
clade characterized so far contains the T. acidophilum lipoyl ligase. Both of these 
properties suggest that the LplA family ancestor may have been a ligase. The more 
deeply branching clades characterized also include LipL and LipM clades, which do not 
have an accessory domain. This suggests the common ancestor lacked an attached 
accessory domain. So the best guess is the LplA family common ancestor was a bipartite 
lipoyl ligase or of a similar function predispositioning it to becoming a ligase. It would be 
interesting to assay the T. acidophilum LplA subunit for amidotransfer activity. It is 
tempting to speculate some members of this family are bifunctional.  
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PHYLOGENETIC DISTRIBUTION OF ENZYMES 
The distribution of lipoic acid metabolic enzymes in selected organisms is shown 
in Table 6-1. By reevaluating the components of lipoic acid metabolism in different 
organisms, some discrepancies are apparent. Both Picrophilus torridus and Ferroplasma 
acidarmus have a putative lipA and two lipBs in their genome. However, they do not 
have anything resembling an acyl carrier protein. Are they making lipoic acid, and if so 
how? 
The members of the LplA family are subdivided into clades as shown in figure 6-
3. Enzymes that have been characterized experimentally are in bold. The LplA clade 2 
contains three studied members, although they are not well characterized. This clade 
has LplA2 (or LipL2) from Plasmodium falciparium, which weakly complements an E. coli 
lipB lplA when lipoic acid is added (Allary et al., 2007); LplA from rice (Oryza sativa), 
which complements E. coli lipB lplA with improved complementation when lipoic acid is 
added (Kang et al., 2007) ; and C. trachomatis LplA, which was found to be inactive 
(Ramaswamy et al., 2010). The lack of lipoyl ligase activity of the Chlamydia trachomatis 
member can be attributed to a missing accessory domain, although it is not known if the 
missing domain exists. The lack of activity of some of these ligases may be due to lipoyl 
domain specificity as described for P. falciparum LplA2 during complementation studies 
in E. coli (Allary et al., 2007). It is likely this clade consists of lipoyl ligases although the 
lack of activity of some members means further work is required to definitively know 
the function of members of this clade. 
We characterized B. subtilis LipM in Chapters 3, 4, and 5. Sequenced 
cyanobacterial genomes including Prochlorococcus marinus are predicted to encode a 
LipB and LipM octanoyltransferase. It would be interesting to examine their roles in 
metabolism and photosynthesis. The C. trachomatis LipM homologue (LplA1) has been 
recently characterized and has detectable lipoyl ligase activity, while the LplA and LipA 
lack activity (Ramaswamy et al., 2010). It is unexpected that the LipM has ligase activity 
and it should be studied further to see if it is an ACP:LD octanoyltransferase as well. This 
enzyme may be a novel example of a bifunctional enzyme.  
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It is clear that our understanding of lipoic acid metabolism and the LplA family is 
much improved by the findings of this Thesis. We were previously ignorant of additional 
functions, so our uncertainty is also correspondingly increased. This is similar to what 
was found in other superfamilies (Gerlt et al., 2001). It seems that protein families could 
differ in the amount of functional diversity, although it is difficult to be sure, as families 
lacking diversity may appear so from ignorance. Lack of understanding of diverse 
protein functions is a significant hurdle to gene annotation. From study of diverse 
proteins functions and their mechanisms we gain greater predictive power. 
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TABLES 
 
Table 6-1. Distribution of enzymes and homologues. 
 LipA LipB LipM LIPT LplA C1 LplA C2 LplA C3 LipL 
Arabidopsis thaliana X X    X   
Bacillus subtilis 168 X  X  X   X 
Chlamydia trachomatis L2 X  X   X   
Escherichia coli K12 X X   X    
Enterococcus faecalis     XX   X 
Homo sapiens X X  X     
Listeria monocytogenes EDGe     XX   X 
Picrophilus torridus DSM9790 X XX       
Plasmodium falciparum 3D7 X X   X X   
Prochlorococcus marinus MED4 X X X      
Pseudomonas aeruginosa PA01 X X      X 
Saccharomyces cerevisiae X X  X     
Thermoplasma acidophilum DSM1728       X  
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Figure 6-1. Lipoic acid metabolism and lipoyl domain modification. Four different types 
of enzymes modify the lipoyl domain. Panel A: Lipoyl ligases are capable of utilizing free 
lipoic acid, which is produced by lipoamidase, Lpa, and perhaps by other processes. 
Panel B: The ACP:LD octanoytransferases LipB or LipM work with the lipoyl synthase, 
LipA, to make lipoic acid on the lipoyl domain. Panel C: The novel 
lipoylamidotransferase, which can shuffle lipoyl and octanoyl groups to different lipoyl 
domains. 
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Figure 6-2. The BPL-LipB-LplA protein superfamily pylogenetic tree obtained from Pfam 
PF03099. The tree was inferred by the neighbor-joining method using FastTree. The 
frequency each branch occurred during bootstrap resampling with 100 replicates is 
shown. The blue clade contains characterized LipB ACP:LD octanoyltransferases. The 
green clade contains characterized BirA and BPL biotin-protein ligases. The red clade 
contains characterized lipoate protein ligases as well as other enzyme characterized in 
this Thesis. 
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Figure 6-3. The LplA family tree extracted from the full tree in figure 6-2. The frequency 
each branch occurred during bootstrap resampling with 100 replicates is shown. Clades 
that contain one member with lipoate-protein ligase activity are colored red and 
individually numbered. The clade contining B. subtilis LipL is colored purple. The clade 
containing B. subtilis LipM is colored blue. The turquoise clade contains both 
mammalian lipoyltransferases and LIP3p from S. cerevisiae. 
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